Stressed Out! : Stress physiology in anxious children by Dieleman, G.C. (Gwen)
P a g e  | 1 
 
Stellingen behorende bij het proefschrift 
Stressed Out! 
Stress physiology in anxious children 
1. Low autonomic arousal is a marker for the development of externalizing problems during 
childhood, while high autonomic arousal is a marker of early and persistent internalizing 
problems (this thesis). 
2. A child with a clinical anxiety disorder experiences persistent stress, as indexed by a basal 
hypoactivation of the hypothalamic-pituitary-adrenal axis, elevated sympathetic, and lowered 
parasympathetic autonomic nervous system activity (this thesis). 
3. The specific psychophysiological profile that is associated with clinical specific phobia provides 
evidence that it is a valid taxonomic construct (this thesis). 
4. Increase in basal hypothalamic-pituitary-adrenal axis functioning is associated with successful 
standardized stepped-care cognitive behavioral therapy treatment of children with an anxiety 
disorder (this thesis). 
5. In children with a clinical anxiety disorder a higher pretreatment sympathetic reactivity in 
response to a stressor is associated with less improvement in anxiety symptoms one year later 
(this thesis). 
6. It is increasingly clear that mind-body dualism is at best an oversimplified way of conceptualizing 
human illness and at worst the source of serious practical problems that adversely affect patient 
care (Sharpe & Walker,2010). 
7. The decentralization and simultaneous transformation of youth care in the Netherlands cannot 
be realized successfully as a sharp budget cut in youth care was introduced. 
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8. The demographic development in the age structure of residents (i.e., fewer children and more 
elderly) of the Netherlands demands extra investment in education, physical and mental 
health(care) of children and young people in the Netherlands to bear the societal costs of a large 
group of elderly residents. 
9. Current service configuration of distinct child and adolescent mental health and adult mental 
health services is considered the weakest link where the care pathway should be most robust 
(Singh, S. e.a. (2013). Seventh Framework Programme: “THE MILESTONE PROJECT”). 
10. The increased assessment of metrics and key performance indicators to compare care and 
research institutions has unintended negative consequences on quality of care and research. 
11. “A person’s a person, no matter how small.” (Dr. Seuss, author). 
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Chapter 1 
General introduction 
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INTRODUCTION 
 
Anxiety is a basic human emotion with expressions falling on a continuum from mild to severe (Pine et 
al., 2009). The studies presented in this thesis extend the knowledge on the role of stress physiology as a 
cause, correlate, and predictor of pediatric anxiety. 
 
Of fraidy-cats 
Anxiety is not typically pathologic but commonly adaptive when it facilitates anticipation of threat or 
danger. The organisms’ responses to danger and the underlying brain circuitry engaged by threats 
reflect these adaptive aspects of anxiety (Pine et al., 2009). Pure anxiety problems have a low 
prevalence at toddler age, but become more prevalent during later childhood (Gilliom, Shaw, 2004; 
Basten et al., 2016). To some extent, many fears and anxieties in pre-school aged children are age-
appropriate and in keeping with normal development (Egger, Angold, 2006). This has made it difficult to 
discern age-appropriate behavior, reflecting normal development, from persistent anxiety problems and 
underlines the need to identify early risk factors for deviant developmental pathways. 
Maladaptive and pathologic anxiety is characterized by persisting or extensive degrees of 
anxiety and avoidance associated with subjective distress or impairment (American Psychiatric 
Association, 2000). 
It can be hypothesized that children with an anxiety disorder function under conditions of 
persistent stress, with an excessive and prolonged stress system activation. Variations in the activity of 
the hypothalamic-pituitary-adrenal (HPA) axis and the autonomic nervous system (ANS), two major 
physiological stress systems, have been implicated as possible biological markers of pathological anxiety 
in children (Feder et al., 2004; Dietrich et al., 2007). Normally, activation of these stress systems leads to 
behavioral and physical adaptive changes that improve the ability to survive. However, children with an 
anxiety disorder may perceive the world as full of stressors that demand endless vigilance and coping, 
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with no possibility to relax and to regard their living environment as safe (Sapolsky, 2002). The 
developing stress systems of children and adolescents may be especially vulnerable to stress-induced 
changes. For instance, permanent HPA-axis dysfunctioning in early life has repeatedly been linked to 
chronicity and recurrence of affective disorders and affective symptoms (Flory et al., 2009; Nicolson et 
al., 2010). 
 
Figure 1. Schematic presentation of the autonomic nervous system. From: Blausen.com staff. "Blausen 
gallery 2014". Wikiversity Journal of Medicine. DOI:10.15347/wjm/2014.010. ISSN 20018762 
 
 
The hypothalamic-pituitary-adrenal axis and the autonomic nervous system 
Humans have different stress systems, two of which have been mostly studied: the ANS and the HPA-
axis. The ANS has two branches: the sympathetic nervous system and the parasympathetic nervous 
system. The autonomic nervous system regulates critical life functions on a moment-to-moment basis 
through its sympathetic and parasympathetic branches. The sympathetic branch of the ANS is engaged 
within seconds of stressor presentation, which ensures an immediate response, which rapidly subsides 
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as the result of the reflex activation of the parasympathetic branch (McKlveen et al., 2016). To be able to 
respond to a threatening situation, the body prepares itself for fight or flight. This autonomic activation 
leads to an increase in heart rate, blood pressure, sweat gland activity, and respiration. Subjectively, the 
individual feels tense and flushed, has palpitations, shortness of breath and increased perspiration. In 
many cases, both of these systems have opposite actions where one system activates a physiological 
response and the other inhibits it. Heart rate is controlled by the sympathetic and parasympathetic 
branches of the autonomic nervous system, skin conductance is controlled by the sympathetic branches 
of the ANS, and high frequency variations in heart rate (heart rate variability) is a proxy for the 
parasympathetic component of autonomic cardiac control. 
 
  
Figure 2. Basic hypothalamic–pituitary–adrenal axis summary (corticotropin-releasing hormone=CRH, 
adrenocorticotropic hormone=ACTH). Original work from Jessica Malisch and Theodore Garland Feb. 25, 
2004. 
 
Besides the ANS, the HPA axis is the major physiological stress response system. Cortisol is the end 
product of the adrenal axis in humans. During non-stress conditions the HPA-axis shows a diurnal 
pattern of cortisol secretion, with peak levels approximately 30 minutes after waking up and a 
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subsequent decline during the day (Wust et al., 2000). The HPA-axis stress response occurs on a slower 
time scale than the ANS response (Ulrich-Lai, Herman, 2009). Upon stressor initiation, corticotropin-
releasing hormone (CRH) is released and travels to the anterior pituitary. In turn, CRH triggers the 
release of adrenocorticotropic hormone (ACTH). By way of systemic circulation, ACTH acts at the adrenal 
cortex to induce the release of cortisol. Glucocorticoids are then able to spread via systematic 
circulation to peripheral targets as well as central targets in the brain. Glucocorticoids can act both to 
augment and suppress sympathetically mediated changes in e.g. cardiovascular function, metabolism, 
and immune function. Glucocorticoids exert their effects through binding to mineralocorticoid (MR) and 
glucocorticoid receptors (GR). The MR is indicated to be important for perceiving resting levels of 
glucocorticoids for circadian regulation of the HPA-axis, whereas the GR is thought to be important for 
perceiving stress-induced levels of glucocorticoids. The MR and GR are expressed in key stress-
regulatory regions, such as the medial prefrontal cortex, hippocampus, amygdala, hypothalamus, and 
hindbrain, with MR expression being more limited than that of GR (McKlveen et al., 2016). 
 
Of fraidy-cats, wild tigers and feeling blue 
Anxiety disorders are among the most prevalent psychiatric disorders in children and adolescents 
(Verhulst et al., 1997; Bittner et al., 2007), with separation anxiety disorder, specific phobia, and social 
phobia being the most frequent childhood anxiety disorders (Beesdo-Baum, Knappe, 2012). High 
comorbidity rates between anxiety disorders have been reported (e.g. Beesdo, Knappe, Pine, 2009), 
which will be addressed in Chapter 2. The high degree of comorbidity amongst anxiety disorders in 
children and adolescents seems to point in the direction of one taxonomic construct, instead of a 
number of separate disorders. However, previous research supports the idea of specific phobia as a 
distinct taxonomic entity: in a twin study two genetic factors were identified that exclusively predispose 
to two broad groups of anxiety disorders dichotomized as generalized and panic anxiety plus 
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agoraphobia versus the specific phobias. Social phobia was influenced by both genetic factors (Hettema 
et al., 2005). Few studies have compared the endocrine and autonomic profiles between different 
pediatric anxiety disorders, and if so the focus was on one specific anxiety disorder with a disorder-
specific stimulus to elicit stress reactions. At present, it is still unclear as to what extent ANS or HPA-axis 
activity relates to anxiety in general, or whether they are specific correlates of certain types of anxiety 
disorders. This will be addressed in Chapter 5. 
Anxiety and depressive symptoms in children and adolescents are often comorbid, with 
comorbidity rates ranging from 21 to 54% in population-based studies (e.g. Essau, Conradt, Petermann, 
2000; Costello et al., 2003; Ferdinand et al., 2005). Childhood anxiety and depression might be two 
different disorders that often co-occur, or they could be different manifestations of the same underlying 
vulnerability. Furthermore, internalizing and externalizing problems in childhood often co-occur (Fanti, 
Henrich, 2010) and show heterotypic stability, i.e. there is lack of measurement invariance in profiles 
across ages suggesting that children are very likely to show different patterns of problems across the 
preschool period (Basten et al., 2016). Given the above, comorbid externalizing problems and depressive 
symptoms need to be considered when studying risk factors and (bio)markers in anxious children, as 
described in Chapters 3, 4 and 5. 
 
The need to treat 
Childhood anxiety has been associated with a range of negative outcomes, including academic 
underachievement, drug dependency, and an increased risk for developing other psychiatric disorders 
(Woodward, Fergusson, 2001; Bittner et al., 2007). After the onset of the first anxiety disorder in 
childhood, a pattern with multiple anxiety disorders often develops by adolescence or early adulthood 
(Wittchen et al., 2003). The development of these secondary negative outcomes seems to increase with 
the ‘load’ of anxiety, i.e. the number of anxiety disorders (Woodward, Fergusson, 2001). Given the 
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differences in outcome, one could argue that the causes and correlates of a high anxiety ‘load’ may 
differ from those of a low anxiety ‘load’ (described in Chapter 5). 
The chronic and pathological anxiety experienced by children and adolescents in a clinical 
population is on average more severe than the reported anxiety reported by children and adolescents 
from the general population, hence it may have a greater impact on the stress systems and influence its 
future functioning. In addition, children and adolescents in the general population who experience 
chronic anxiety, but remain untreated,  have a significantly poorer prognosis and high persistence 
(Ferdinand, Verhulst, 1995; Ferdinand, Verhulst, Wiznitzer, 1995). 
Cognitive behavioral therapy (CBT) is the treatment of choice for children with an anxiety 
disorder, with a remission rate of 59% following treatment (James et al., 2013). A 7- to 19-years follow-
up study of the long-term outcomes of treated childhood anxiety disorders showed that patients with a 
poorer response to CBT, had higher rates of panic disorder, substance abuse and dependency in 
adulthood than the successfully treated patients (Benjamin et al., 2013). It is, therefore, important to 
identify predictors of symptom improvement in treated children with an anxiety disorder, which will be 
discussed in Chapter 7. 
Several studies investigated possible clinical predictors of treatment outcome in children with 
anxiety disorders. Some studies reported that higher anxiety severity predicts a less favorable outcome 
(Last, Hansen, Franco, 1998; Liber et al., 2010; Hudson et al., 2013; Compton et al., 2014). A few studies 
showed that children with comorbid mood disorders are more likely to remit to their primary anxiety 
disorder following treatment (Liber et al., 2010; Hudson et al., 2013). Various studies examined the role 
of parental characteristics as predictors of treatment outcome in children, but an inconsistent pattern of 
findings resulted (Legerstee et al., 2008; Hudson et al., 2013; Compton et al., 2014). Because clinical 
characteristics are weak or inconsistent indicators of response to CBT, there is an increasing interest in 
identifying biomarkers to predict differential treatment response (Lester, Eley, 2013). Despite the 
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evidence of altered pre-treatment HPA axis and autonomic functioning in anxiety-disordered children, 
studies that have assessed the concomitant changes in stress physiology during treatment or that have 
investigated stress physiology as a predictor of therapy outcome are lacking. This will be addressed in 
Chapter 6. 
 
AIM OF THIS THESIS 
 
The main aim of the present thesis is to extend the knowledge on the role of stress physiology as a 
cause, correlate, and predictor of pediatric anxiety disorders with the ultimate goal to improve 
treatment and prognosis. More specifically, the aim is to examine the specificity of the association of 
stress physiology with child anxiety problems and its subtypes, given the high co-occurrence with other 
anxiety disorders, externalizing and depressive problems. In addition, we examine the trajectory of an 
anxiety disorder and the concomitant change in stress physiology, and stress physiology as a predictor of 
therapy outcome. 
 
Study samples 
The studies described in this thesis were embedded in four study samples. 
 
General population samples 
The first study population is the TRacking Adolescents’ Individual Lives Survey (TRAILS). TRAILS is a 
prospective cohort study of Dutch early adolescents aged 10-12 years, who are followed biennially. The 
present study used data from the first (2001-2002; T1 mean age 11.09 years, SD 0.55) and second (2003-
2004; T2 mean age 13.56 years, SD 0.53) assessment wave. The TRAILS target sample consisted of young 
adolescents from five municipalities in the North of the Netherlands, including both urban and rural 
areas. 
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The second study population is the Generation R Study (“R” for Rotterdam). This study is a 
longitudinal, population-based cohort in which children are followed up from fetal life forward. The 
initial cohort comprised 9,778 pregnant women with a delivery date between April 2002 and January 
2006, living in Rotterdam, the Netherlands. The aim of Generation R Study is to identify early 
environmental and genetic determinants of growth, development, and health. Generation R focuses on 
a wide range of issues relating to physical development, childhood diseases, use of health care, and 
behavior and cognition. The study in this thesis was conducted within the Focus cohort of the 
Generation R Study, a population-based prospective cohort from fetal life onwards (Tiemeier et al., 
2012). All children were born between February 2003 and August 2005. The cohort consists of Dutch 
children and their parents and is ethnically homogeneous, to rule out confounding and effect 
modification by ethnicity. Measurements of infant autonomic indices were added to the protocol of the 
examination round at age 14 months, while assessment was already ongoing. We obtained physiological 
measurements for 528 infants. 
 
Patient sample and control group 
The third study population is a clinical sample of 184 children and adolescents aged 8 to 16 years with a 
primary diagnosis of generalized anxiety disorder, separation anxiety disorder, social phobia or specific 
phobia. Eligible for participation were children and adolescents consecutively referred between 
September 2002 and May 2007 to the outpatient clinic of the department of Child and Adolescent 
Psychiatry of either the Erasmus Medical Center in Rotterdam or Leiden University Medical Center – 
Curium. All consecutive referrals to these departments were assessed with the Anxiety Disorders 
Interview Schedule for DSM-IV-Child Version (ADIS-C). All children and adolescents participated in a 
standardized stepped-care CBT program for childhood anxiety disorders, consisting of two phases (Van 
der Leeden et al., 2011). In the first phase, children were treated with the FRIENDS program, an 
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evidence-based treatment program for anxiety disorders (Barrett, Lowry-Webster, Turner, 2000), which 
encompassed 10 child sessions and 4 separate parent sessions. The FRIENDS program comprised 
psychoeducation, relaxation and breathing exercises, exposure, problem-solving skills training, social 
support training and cognitive restructuring exercises (Shortt, Barrett, Fox, 2001; Liber et al., 2008). 
Parent sessions comprised mainly psychoeducation. All children that were not successfully treated in the 
first phase, as determined by ADIS-C at three months follow-up, received supplementary CBT. The 
second phase consisted of 10 manualized sessions, in which parents and child participated together in 
each session. 
 
The fourth study population, which acts as a control group for children aged 8 to 12 years from the 
patient sample, is a general population sample drawn from a larger general population sample from the 
Dutch province of Zuid-Holland (see “2003 sample” in Tick, Van der Ende, Verhulst, 2007), the Zuid-
Holland study. Of the 2,286 eligible respondents, 1,710 (74.8%) parents of children aged 6-18-year olds 
participated in this study of Tick, Van der Ende and Verhulst (2007). A subsample of 508 8-12-year-olds 
living in municipalities relatively close to the city of Rotterdam was selected to participate in a study 
investigating stress physiology. All 8-12-year-olds with scores above the borderline or the clinical cut-off 
on the internalizing and/or externalizing problem scales on the Child Behavior Checklist (CBCL; 
Achenbach, Rescorla, 2001) were invited. This resulted in a selection of 140 children. Furthermore, 156 
children aged 8-12 were randomly selected from the remaining 368 children with scores below the 
borderline cut-off, evenly distributed with regard to degree of urbanization, age and sex. From this 
subsample three children were excluded because their parents did not speak the Dutch language. Of the 
remaining 293 eligible respondents, 231 (78.8%) participated. 
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Methylphenidate treatment in children with ADHD was discontinued the day before and on the 
day of measurements (clinical sample N=7, general population N=6) because methylphenidate 
treatment can increase heart rate and blood pressure (Ballard et al., 1976). 
 
Outline 
First, given the high degree of comorbidity amongst anxiety disorders in children and adolescents, it is 
important to extend the knowledge about the taxonomy of anxiety disorders. The main focus of Chapter 
2 is the investigation of homotypic and heterotypic longitudinal patterns of symptoms of different 
anxiety disorders in TRAILS, a large population-based sample of young adolescents. 
Second, there is a need to establish the specificity of the association of stress physiology with 
child anxiety problems, given the high co-occurrence with externalizing and depressive problems. In 
Chapter 3, we study the tripartite model, in which symptoms of anxiety and depression are viewed 
along three dimensions. This model groups symptoms of depression and anxiety into three subtypes: 
negative affectivity, positive affectivity, and physiological hyperarousal. In the Zuid-Holland study, a 
general population sample of children, we examined whether basal and reactive HPA-axis functioning, 
as a proxy for physiological hyperarousal, and perceived arousal before, during and after stress 
differentiate anxious from depressive children. Chapter 4 discusses the longitudinal associations 
between infant autonomic functioning and early childhood internalizing and externalizing problems 
simultaneously in the Generation R Study, a large general population sample. Establishing the specificity 
in a longitudinal design reduceses the risk of reverse causation. 
Third, despite a large body of literature detailing an association with stress physiology and 
anxiety, gaps in our knowledge remain. At present, it is still unclear as to what extent stress physiology 
relates to anxiety in general, or whether it is a specific correlate of certain types of anxiety disorders. 
Few studies have compared the stress physiology between different pediatric anxiety disorders, and if 
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so the focus was on one specific anxiety disorder with a disorder-specific stimulus. Chapter 5 discusses 
whether HPA-axis, ANS and perceived arousal measures can distinguish children with different primary 
diagnoses of clinical anxiety disorders (the clinical sample), and from a general population reference 
group (the Zuid-Holland study). In addition, we explore the association of between stress physiology and 
the number of clinical disorders. 
Fourth, despite the evidence of altered pre-treatment HPA axis and autonomic functioning in 
anxiety-disordered children, studies that have assessed the trajectory of an anxiety disorders and 
concomitant change in stress physiology, or stress physiology as a predictor of therapy outcome in 
childhood anxiety disorders are lacking. In Chapter 6, we study the relation between the trajectory of an 
anxiety disorder during treatment and the concomitant change in cortisol levels in a clinical sample of 
children and adolescents with an anxiety disorder. Finally, in Chapter 7, we investigate the longitudinal 
association of stress physiology at pre-treatment baseline with anxiety and depressive symptoms at 
one-year follow-up in a clinical sample of children with an anxiety disorder treated with cognitive 
behavioral therapy. In addition, we explore the longitudinal association of stress physiology with 
depressive symptoms. 
The concluding chapter of this thesis, Chapter 8, discusses the main findings of the studies 
described in this thesis, including methodological considerations and implications for research and 
clinical practice. 
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Chapter 2 
Homotypic versus heterotypic continuity of anxiety symptoms in young adolescents: evidence for 
distinctions between DSM-IV subtypes 
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ABSTRACT 
 
Objective: to investigate homotypic and heterotypic longitudinal patterns of symptoms of separation 
anxiety disorder (SAD), generalized anxiety disorder (GAD), social phobia (SoPh), panic disorder (PD), 
and obsessive compulsive disorder (OCD) in young adolescents from the Dutch general population. 
 
Method: 2,067 individuals (51.4% girls) from a Dutch community sample, who were assessed for the 
first time when they were aged 10 to 12 years, were followed up across a period of two years. At both 
assessments, anxiety symptoms were assessed with the RCADS, a self-report questionnaire. 
 
Results: Regression analyses indicated that homotypic continuity was relatively high for SAD, SoPh, and 
PD (for PD especially in girls), and relatively low for GAD. 
 
Conclusions: In many studies, anxiety disorders are treated as one group of disorders, and some widely 
used assessment instruments do not even contain scales that tap different anxiety dimensions. In the 
present study, evidence for homotypic continuity was found for symptoms of separation anxiety and 
social anxiety, and for panic symptoms in girls, underscoring the usefulness of making distinctions 
between these different anxiety constructs. 
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INTRODUCTION 
 
Anxiety disorders are among the most prevalent psychiatric disorders in children and adolescents 
(Costello et al., 1996; Verhulst et al., 1997; Essau, Conradt, Petermann, 2000), are persistent, and are 
associated with impaired functioning (McGee, Stanton, 1990; Ferdinand, Verhulst, 1995; Ferdinand, 
Verhulst, Wiznitzer, 1995; Verhulst et al., 1997; Pine et al., 1998; Canino et al., 2004). The high degree of 
comorbidity amongst anxiety disorders in children and adolescents seems to point in the direction of 
one taxonomic construct, instead of a number of separate disorders. High comorbidity rates have been 
reported by many authors (Newman et al., 1996; Masi et al., 1999; Essau, Conradt, Petermann, 2000; 
Verduin, Kendall, 2003). Evidence for a higher order factor that explains the presence of different types 
of anxiety has been found in children (Nauta et al., 2004) and adults (Krueger, 1999; Vollebergh et al., 
2001; Hettema et al., 2005). Negative affectivity (NA) (Clark, Watson, 1991; Lonigan et al., 1999; 
Chorpita, 2002; Lonigan, Phillips, Hooe, 2003; Clark, 2005) may be one of the higher order factors that 
may explain the finding of heterotypic continuity. NA represents displeasurable engagement with the 
environment and a sense of high subjective distress (Lonigan, Phillips, Hooe, 2003), and is often 
considered as a temperament trait that is associated not only with anxiety, but with depression as well 
(Clark, 2005). 
Using data collected at the first assessment wave of a study that was also used to conduct the 
research that is being described in the present manuscript, support was found for the presence of one 
single anxiety dimension, instead of a number of separate anxiety concepts (Ferdinand et al., 2006b). 
The sample of this previous study consisted of 10- to 12-year-olds from the Dutch general population, 
who completed a self-report questionnaire for anxiety symptoms. Based on item scores on this 
questionnaire, latent class analysis did not detect classes of individuals with, for instance, high scores on 
items tapping separation anxiety, and simultaneously low scores on items tapping panic or social 
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anxiety. Instead, high scores on one anxiety dimension implicated high scores on the other anxiety 
dimensions as well. However, other studies found evidence for separate anxiety dimensions. By 
performing factor-analyses, several authors found that DSM-IV anxiety disorders, such as generalized 
anxiety disorder, separation anxiety disorder, social phobia, and panic disorder represent different 
problem dimensions in children and adolescents (Spence, 1997; Chorpita, Daleiden, 2000; Muris et al., 
2002). 
Longitudinal studies can provide valuable information regarding taxonomic constructs. For 
instance, it was found that symptoms of social phobia in adolescents predicted similar symptoms in 
adulthood (Pine et al., 1998). The prediction of a disorder by the same disorder is called homotypic 
continuity. However, social phobia symptoms also predicted simple phobia in adulthood. The prediction 
of a disorder by another disorder is called heterotypic continuity (Costello et al., 2003). Several 
mechanisms may explain heterotypic continuity. Heterotypic continuity may occur by chance. In other 
words, disease A may disappear, and disease B may occur subsequently, as a coincidence. However, in 
that case, continuity would not be reflected in statistical significance. More likely reasons for heterotypic 
continuity would be that disease A would be the cause of disease B, or that disease A and B share a 
common vulnerability factor. 
The aim of the present study was to investigate homotypic and heterotypic longitudinal patterns 
of symptoms of separation anxiety disorder, generalized anxiety disorder, social phobia, panic disorder, 
and obsessive compulsive disorder in young adolescents from the Dutch general population. For this 
purpose, individuals from a community sample, who were assessed for the first time when they were 
aged 10 to 12 years, were followed up across a period of two years. At both assessments, anxiety 
symptoms were assessed with a self-report questionnaire. Given mixed results of previous studies, we 
did not formulate specific hypotheses regarding the level of homotypic or heterotypic continuity of 
different types of anxiety. 
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METHODS 
 
Sample and procedure 
The TRacking Adolescents’ Individual Lives Survey (TRAILS) is a prospective cohort study of Dutch early 
adolescents aged 10-12 years, who are followed biennially. The present study used data from the first 
(2001-2002) and second (2003-2004) assessment wave. The TRAILS target sample consisted of young 
adolescents from five municipalities in the North of the Netherlands, including both urban and rural 
areas. More details about the sample selection have been published elsewhere (De Winter et al., 2005). 
Of all subjects who were approached at wave 1 (N=3,145), 6.7% were excluded. The exclusion 
criteria were (1) adolescent incapable to participate because of mental retardation or a serious physical 
illness or handicap and (2) Dutch-speaking parent or parent surrogate not available, and not feasible to 
administer a part of the measurements in parent’s own language. Of the remaining 2,935 young 
adolescents, 24% did not want to cooperate, and 76.0% cooperated with the study at wave 1 (N=2,230, 
mean age 11.09 years, SD .55, with 50.8% girls). Most frequent reasons for non-response were ‘not 
interested’ (33.8%), participation in other research or unfavorable experiences with research (15.4%), 
too much of a burden on the child (12.2%), lack of time (10.3%), concerns about privacy and 
confidentiality (8.0%), and the child’s refusal to participate because friend(s) did not participate (4.0%). 
In 34 cases (1.2%) we failed to contact anyone of the household (De Winter et al., 2005). Responders 
and non-responders did not differ with respect to the proportion of single parent families, or the 
prevalence of teacher-rated problem behavior. Furthermore, no differences between responders and 
non-responders were found regarding associations between socio-demographic variables and mental 
health outcomes (De Winter et al., 2005). To assess anxiety symptoms, the Revised Child Anxiety and 
Depression Scale (RCADS) (Chorpita, Daleiden, 2000) was used at wave 1, and also at wave 2. For 20 
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cases, RCADS data were not obtained at wave 1 because respondents were not present during the 
measurements that were conducted in the classrooms, and could not be reached afterwards. Hence, 
RCADS data of 2,210 pre-adolescents were available at wave 1. 
At the second assessment wave, following similar procedures as at wave 1, RCADS information 
was obtained from 2,067 individuals. This was 95.5% of those for whom wave 1 RCADS information had 
been collected (51.4% girls). To examine possible selective attrition, a stepwise logistic regression 
analysis was performed with ‘wave 2 RCADS information available’ as a dependent variable, and wave 1 
age, sex, and the wave 1 RCADS Total Anxiety score (that was constituted by summing scores on the five 
anxiety dimensions that were assessed with the RCADS in the present study, see below) as possible 
predictors. The RCADS Total Anxiety score and sex did not predict attrition. However, younger age 
predicted attrition significantly (odds ratio = .17, Wald = 93.1, p < .001; Model chi-square = 109,551, df = 
1, p < .001). Cox and Snell R-square of the regression model was .048, which indicated that the effect of 
age was small. Further, most importantly, the level of anxiety at the initial assessment did not influence 
cooperation at wave 2. 
 
Measures 
The Revised Child Anxiety and Depression Scale (RCADS) (Chorpita, Daleiden, 2000) is a revision of the 
Spence Children’s Anxiety Scale (SCAS) (Spence, 1997). It is a self-report questionnaire with 47 items, 
that are scored on a 4-point scale (0 = never, 1 = sometimes, 2 = often, 3 = always). The questionnaire 
covers six scales, corresponding with DSM-IV dimensions of anxiety disorders and depressive disorder. 
The following five scales were used for the present study: separation anxiety disorder (SAD), generalized 
anxiety disorder (GAD), social phobia (SoPh), panic disorder (PD), and obsessive compulsive disorder 
(OCD) (see Table 1). The scale major depressive disorder (MDD) was not used. The internal consistencies 
of the scales that were used were (respectively at wave 1/wave 2) .66/.59 for SAD, .80/.72 for GAD, 
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.78/.88 for SoPh, .75/.72 for PD, and .68/.66 for OCD. The factor structure—for all six scales together—
that was originally based on data from 1,641 children and adolescents from a community sample from 
Hawaii (Chorpita, Daleiden, 2000), was confirmed by confirmatory factor analysis in the TRAILS sample 
at wave 1 (fit indices of NNFI = .96, RMSEA = .05, and SRMR = .05, indicating an adequate fit to the 
sample data) (Ferdinand et al., 2006b). The association of RCADS dimensions of anxiety with 
corresponding DSM-IV anxiety disorders was supported by previous research (Nauta et al., 2004). 
 
Table 1. RCADS items 
 
SAD SoPh 
Fears being alone at home Worried when does poorly at things 
Scared to sleep alone Worried when somebody angry 
Scared to sleep away from home Worried will do badly at school 
Fears being away from parents Worried about mistakes 
Worried in bed at night Worried what others think 
Trouble going to school Scared to take a test 
Afraid of being in crowded places Worried might look foolish 
 Afraid to talk in front of class 
 Afraid to look foolish in front of people 
GAD PD 
Worried something awful will happen to family  Suddenly trouble breathing without reason 
Worried bad things will happen to self When has a problem, feels shaky 
Worried something bad will happen to self Suddenly trembling, shaking without reason 
Thinks about death Suddenly dizzy, faint without reason 
Worried about things When has a problem, stomach feels funny 
Worried about what will happen When has a problem, heart beats really fast 
 Suddenly feeling scared without reason 
 Suddenly heart beats too fast without reason 
 Worried suddenly get scared without reason 
 
 
Statistical analyses 
First, to obtain information regarding comorbidity between different types of anxiety problems in the 
study sample, correlations among wave 1 RCADS scale scores were computed for each sex. Then, 
Pearson correlations were computed between wave 1 and wave 2 RCADS scale scores, separately for 
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each sex group. Correlations provide insight in the associations between measures. However, by just 
computing correlations, it cannot be judged if continuity is homotypic or heterotypic. For instance, the 
magnitude of a correlation between wave 1 SAD and wave 2 SoPh scores depends on the correlation 
between wave 1 SAD and wave 1 SoPh scores. The higher correlations between wave 1 SAD and wave 1 
SoPh are, the higher the correlation between wave 1 SAD and wave 2 SoPh will be. In other words, if 
assessment of continuity would solely be based on correlations, comorbidity at wave 1 would artificially 
inflate estimations of the extent of heterotypic continuity between wave 1 and wave 2. 
To correct for the effects of wave 1 comorbidity rates, regression analyses were conducted. 
First, it was assessed which part of continuity in anxiety problems was typically homotypic. For this 
purpose, for scores on each of the five RCADS scales at wave 2, a set of regression analyses was 
conducted, with wave 2 RCADS SAD, GAD, SoPh, PD, and OCD scores as dependent variables. These 
analyses were conducted to investigate how much of the variance in a specific RCADS scale score at 
wave 2 was not accounted for by an overall elevation in different types of anxiety at wave 1, but instead, 
specifically by its own counterpart at wave 1. We will now describe the regression analyses that were 
conducted for wave 2 SAD. Those for GAD, SoPh, PD, and OCD were similar. In the first block of the 
analyses, wave 1 scores on GAD, SoPh, PD, and OCD were entered simultaneously as predictors. Then, in 
a second block, wave 1 scores on the SAD scales were added, to see how much of the variance in wave 2 
scores was predicted specifically by wave 1 SAD scores, and not by scores on the other RCADS scales at 
wave 1. This variance reflects specific homotypic continuity. In the third block, sex was added. In the 
fourth block, an interaction between sex and SAD was added. If this interaction was significant, analyses 
were conducted for girls and boys separately. For each next block, the variance that was accounted for 
by the variable in this block was computed (R2). 
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Second, it was assessed which part of continuity in anxiety problems was specifically heterotypic. For 
this purpose, for scores on each of the five RCADS scales at wave 2, a set of regression analyses was 
conducted, with wave 2 RCADS SAD, GAD, SoPh, PD, and OCD scores as dependent variables. These 
analyses were conducted to investigate how much of the variance in a specific RCADS scale score at 
wave 2 was not accounted for by its own counterpart at wave 1, but instead, by the other wave 1 
anxiety scale scores. We will now describe the regression analyses that were conducted for wave 2 SAD. 
Those for GAD, SoPh, PD, and OCD were similar. In the first block of the analyses, wave 1 SAD scores 
were entered as predictor. Then, in the second block, scores on wave 1 GAD, SoPh, PD, and OCD scales 
were added, to see how much of the variance in wave 2 scores was specifically predicted by other 
RCADS scales at wave 1. This variance reflects specific heterotypic continuity. In the third block, sex was 
added. 
To judge the magnitude of effects, Cohen’s rules for effects sizes can be used (Cohen, 1988). 
According to Cohen, R2 between 1.0% and 5.9% is small, between 5.9% to 13.8% medium, and above 
13.8% large. 
 
RESULTS 
 
Means and standard deviations at wave 1 were calculated for SAD (mean=.375, SD=.356), GAD 
(mean=.666, SD=.454), SoPh (mean=.779, SD=.427), PD (mean=.428, SD=.363), and OCD (mean=.597, 
SD=.445). Means and standard deviations were also calculated for wave 2 SAD (mean=.236, SD=.291), 
GAD (mean=.485, SD=.427), SoPh (mean=.684, SD=.465), PD (mean=.301, SD=.321), and OCD 
(mean=.339, SD=.348). Means reflect mean item scores for each RCADS scale. 
Correlations among wave 1 RCADS scale scores for each sex separately are presented in Table 2. 
It is shown that all correlations were in a close range, almost similar across sexes, and generally above 
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.50 which can be regarded as high (Cohen, 1988). For both sexes the highest correlations were found 
between PD and OCD (r=.61 in boys and girls), and the lowest between SAD and OCD (boys r=.47; girls 
r=.51). 
 
Table 2. Correlations among wave 1 RCADS scale scores 
 Wave 1 RCADS scale 
Wave 1 RCADS scale GAD b/g SoPh b/g PD b/g OCD b/g 
SAD .52/.58 .52/.52 .51/.52 .47/.51 
GAD — .59/.54 .55/.54 .58/.58 
SoPh  — .56/.55 .54/.53 
PD   — .61/.61 
OCD    — 
Note. Correlations are presented for boys (b), girls (g) separately. 
 
Correlations between wave 1 and wave 2 RCADS scale scores can be found in Table 3. For instance, in 
boys, the correlation between wave 1 and wave 2 SAD scores was .30, whereas the correlations 
between wave 1 GAD, SoPh, and PD scores and wave 2 SAD scores were .27, .29, and .22 respectively. 
Hence, heterotypic correlations were almost as high as the homotypic correlation. In girls, a similar 
result was found for wave 2 SAD. Heterotypic correlations ranged between .27 and .29, whereas the 
homotypic correlation was .38. Similar relatively small discrepancies between homotypic and 
heterotypic correlations were found for wave 2 GAD, SoPh, and PD scores. 
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Table 3. Correlations between wave 1 and wave 2 RCADS scale scores 
 
Wave 1 RCADS scale 
Wave 2 RCADS scale 
SAD b/g GAD b/g SoPh b/g PD b/g OCD b/g 
SAD .30/.38 .23/.32 .35/.29 .28/.27 .21/.25 
GAD .27/.27 .34/.38 .29/.28 .22/.25 .23/.27 
SoPh .29/.29 .35/.29 .42/.41 .29/.28 .25/.25 
PD .22/.29 .25/.31 .24/.27 .32/.42 .25/.29 
OCD .23/.30 .25/.32 .28/.27 .27/.32 .31/.37 
Note. Correlations are presented for boys (b), girls (g) separately. 
 
The results of the regression analyses are presented in Tables 4 and 5. Analyses that were aimed at 
assessing specific homotypic continuity (Table 4) indicated that variances reflecting homotypic 
continuity were 2.3% for SAD, 3.6% for GAD, 3.7% for SoPh, 3.2% for PD, and .9% for OCD. Analyses 
aimed as specifically investigating heterotypic continuity revealed variances of 2.0% for SAD, 4.2% for 
GAD, 1.3% for SoPh, 2.3% for PD, and 2.7% for OCD (Table 5). 
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Table 4. Specific homotypic continuity (prediction by target scale). Prediction of wave 2 RCADS scale 
scores by wave 1 scale scores and sex 
 
Wave 2 RCADS scale 
SAD GAD SoPh PD OCD 
Wave 1 predictors R2/F change/p1 R2/F change/p1 R2/F change/p1 R2/F change/p1 R2/F change/p1 
Non-target scales (block 1) .119/69.68/.000 .150/91.19/.000 .132/78.35/.000 .126/74.19/.000 .106/61.22/.000 
Target scale (block 2) .050/123.57/.000 .023/58.06/.000 .069/178.54/.000 .037/90.39/.000 .025/59.20/.000 
Sex (block 3) .023/58.92/.000 .036/93.32/.000 .037/100.65/.000 .032/81.21/.000 .009/21.34/.000 
Target-scale*sex (block 4) .001/2.06/ns .002/5.12/.024 .000/.81/ns .009/23.81/.000 .002/5.38/.020 
 
Models for girls/boys separately in case of interaction target-scale*sex 
 Girls 
  Non-target scales (block 1) — .145/44.70/.000 — .128/38.75/.000 .109/32.82/.000 
  Target scale (block 2) — .024/31.06/.000 — .060/77.54/.000 .038/47.13/.000 
 Boys 
  Non-target scales (block 1) — .136/39.32/.000 — .107/29.72/.000 .089/24.41/.000 
  Target scale (block 2) — .018/20.85/.000 — .020/22.82/.000 .021/23.05/.000 
Note. Target-scale---Wave 1 RCADS scale identical to the wave 2 RCADS outcome scale in the 
regression model (prediction indicating specific homotypic continuity). Non-target scales---all other wave 1 
RCADS scales, not identical to the wave 2 RCADS outcome scale. R2---explained variance. 
 
In analyses aimed at homotypic continuity, some anxiety*sex interactions were significant. A marked sex 
difference was found for PD. Table 4 shows that homotypic continuity was much stronger for girls 
(homotypic R2=6.0%) than for boys (homotypic R2=2.0%). 
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Table 5. Specific heterotypic continuity (prediction by non-target scales). Prediction of wave 2 RCADS 
scale scores by wave 1 scale scores and sex 
 Wave 2 RCADS scale 
 SAD GAD SoPh PD OCD 
Wave 1 predictors R2/F change/p1 R2/F change/p1 R2/F change/p1 R2/F change/p1 R2/F chan  
Target scales (block 1) .391/373.39/.000 .375/337.53/.000 .436/483.57/.000 .380/347.98/.000 .337/263.4  
Non-target scale (block 2) .020/83.77/.000 .042/86.59/.000 .013/103.79/.000 .023/80.00/.000 .027/82.20  
Sex (block 3) .027/81.60/.000 .041/90.95/.000 .040/107.45/.000 .028/82.80/.000 .012/55.90  
Note. Target-scale---Wave 1 RCADS scale identical to the wave 2 RCADS outcome scale in the regression 
model. Non-target scales---all other wave 1 RCADS scales, not identical to the wave 2 RCADS outcome 
scale (prediction indicating specific heterotypic continuity). R2---explained variance. 
 
DISCUSSION 
 
The present study examined homotypic and heterotypic continuity of symptoms of separation anxiety 
disorder, generalized anxiety disorder, social phobia, panic disorder, and obsessive compulsive disorder 
in individuals from a community sample, who were assessed for the first time when they were aged 10 
to 12 years, and for the second time two years later. Variances reflecting homotypic continuity were 
roughly equal to those reflecting heterotypic continuity for OCD (2.5% versus 2.7%). Variances reflecting 
homotypic continuity were larger than for heterotypic continuity for SAD (5.0% versus 2.0%), SoPh (6.9% 
versus 1.3%), and PD (3.7% versus 2.3%), for PD especially in girls, and smaller for homotypic than for 
heterotypic continuity for GAD (2.3% versus 4.2%) (Tables 4 and 5). Applying cross-sectional research 
designs, previous studies found high comorbidity rates among different types of anxiety problems 
(Essau, Conradt, Petermann, 1999; Newman et al., 1996; Verduin, Kendall, 2003). The present study 
extended the knowledge about the taxonomy of anxiety problems in young adolescents with 
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longitudinal data. In accordance with previous cross-sectional work, SAD, GAD, SoPh, PD, and OCD 
symptoms appeared to be intertwined in a longitudinal fashion as well. However, considerable 
homotypic continuity was found as well. 
 
Separation anxiety 
For SAD, compared to heterotypic continuity, homotypic continuity was relatively strong. Previous 
studies indicated considerable comorbidity between SAD and the other anxiety problems, especially 
with SoPh (Compton, Nelson, March, 2000). In the present study comorbidity rates at wave 1 were high 
as well, not only with SoPh, but also with other types of anxiety. This suggests that SAD and the other 
anxiety problems may represent two sides of the same coin. However, homotypic continuity was 
stronger than heterotypic continuity, which supports the usefulness of SAD as a separate diagnostic 
construct. The distinction between SAD and other types of anxiety was further supported by another 
study, in which we conducted latent class analysis to assess the boundaries between SAD and SoPh in 
referred 8- to 11-year-olds (Ferdinand et al., 2006a). Four different classes of individuals were detected; 
those with (1) low SAD and SoPh item scores on a self-report questionnaire, (2) high SAD and high SoPh 
item scores, (3) high SAD and low SoPh scores, and (4) low SAD and high SoPh scores. This also 
supported the idea that, despite high comorbidity rates, SAD may at least partially represent a separate 
phenomenon, that, for instance, may be subject to specific etiological influences that differ from 
influences that affect the course of other anxiety problems. 
 
Generalized anxiety 
For GAD, homotypic continuity was relatively low. A previous study (Pine, Cohen, Brook, 2001) in 
adolescents from the general population indicated that separation anxiety disorder and social phobia in 
adolescents did not predict future generalized anxiety disorder. This suggested rather strong homotypic 
P a g e  | 41 
 
continuity of GAD. However, continuity of GAD was more heterotypic than in the study by Pine, Cohen 
and Brook (2001), because in our study, heterotypic continuity was also considerable. This contrast may 
be due to methodological issues such as differences in sample characteristics (Pine, Cohen and Brook 
investigated older adolescents), assessment procedures (Pine, Cohen and Brook applied standardized 
interviews instead of self-report questionnaires), or statistical approach (Pine, Cohen and Brook used 
categorical diagnostic samples whereas the present study used dimensional scale scores). Further, Pine, 
Cohen and Brook did not use a block design for their regression analyses, but included all predictors in a 
forward stepwise logistic regression analysis. So, in essence, they did not test if one predictor predicted 
future GAD, over and above the effect of other predictors. 
 
Social phobia 
Compared to heterotypic continuity, homotypic continuity of SoPh symptoms was relatively strong. 
Pine, Cohen and Brook (2001) found that SoPh, but also GAD, in adolescence predicted future SoPh, 
independently of other types of anxiety, whereas SAD did not. Remarkably, in their study, GAD was a 
better predictor of future SoPh than SoPh itself. The aforementioned methodological differences 
between the Pine et al. study versus the present study may explain differences between findings. 
 
Panic 
For PD, homotypic was relatively strong compared to heterotypic continuity. Analyses for boys and girls 
separately (Table 4) indicated that homotypic continuity was higher in girls than in boys. Previous 
studies already indicated that panic disorder tends to have a chronic course, in children as well as in 
adults (Biederman et al., 1997; Bruce et al., 2005). The prevalence of full blown panic disorder, and even 
of panic attacks, in adolescents is very low (Essau, Conradt, Petermann, 1999). The present study 
nevertheless suggests that in girls, the disorder may already begin with a chronic homotypic course at a 
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very young age which is in accordance with the higher prevalence in females versus males (Goodwin et 
al., 2005), and with studies that retrospectively investigated age at onset, and that often point to 
childhood or adolescence as a starting point (Sheehan, Sheehan, Minichiello, 1981). 
 
Obsessive compulsive disorder 
Comorbidity rates of OCD with other anxiety disorders are generally high (Heyman et al., 2001; Tukel et 
al., 2002), which was supported by the correlations among the wave 1 RCADS scale scores. The present 
study showed that homotypic and heterotypic continuity for OCD did not differ much. To our 
knowledge, previous studies that assessed homotypic continuity of OCD symptoms versus heterotypic 
continuity with other types of anxiety in young adolescents are not available, so we cannot compare our 
findings with previous work. Homotypic continuity was somewhat stronger in girls than in boys. This 
seems to suggest that, longitudinally, OCD symptoms in boys correlate differently with comorbid 
conditions than OCD symptoms in girls. Again, we were not able to find previous work on this topic. 
Future studies are needed to investigate if the differences between boys and girls we found can also be 
found in other samples, countries, and cultures. 
 
Practical implications 
In many studies, anxiety disorders are treated as one group of disorders (Barrett et al., 2001; Lipman, 
MacMillan, Boyle, 2001; MacMillan et al., 2001; Shortt, Barrett, Fox, 2001; Roza et al., 2003), and, even, 
some widely used assessment instruments do not contain scales that tap different anxiety dimensions 
(Achenbach, 1991a,b). Previous studies found considerable associations between different types of 
anxiety symptoms, which suggested the presence of one higher order factor (Nauta et al., 2004). Several 
studies with adults also found evidence for a higher order factor that explained the presence of different 
types of anxiety (Krueger, 1999; Vollebergh et al., 2001; Hettema et al., 2005). Given the magnitude of 
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heterotypic continuity in the present study, a higher order factor is likely to be present. However, the 
present study also showed that considerable homotypic continuity is present as well, occurring 
separately from a general propensity for high anxiety levels. This indicates that each type of anxiety 
problem may, at least partly, represent a distinct taxonomic construct. Homotypic continuity was found 
specifically for SAD, SoPh, and for PD in girls. This may indicate that SAD, SoPh, and PD represent 
diagnostic constructs that are at least partially distinct. Hence, in clinical practice, instruments are 
needed that measure different anxiety dimensions separately. Instruments that just assess on single 
anxiety dimension may not be sufficient. Further, the distinctions between different anxiety constructs 
indicate that, despite the evidence that similar treatment methods are generally efficacious for different 
types of anxiety problems, each type of anxiety might require a slightly different treatment approach, 
and development of specific treatment modules. 
 
Limitations 
The sample consisted of young adolescents only. For older adolescents, different homotypic and 
heterotypic continuities could apply. Furthermore, questionnaires were used instead of clinical 
interviews; information about the presence or absence of DSM-IV (American Psychiatric Association, 
1994) clinical diagnoses was not obtained. Even though RCADS symptom dimensions have proved to 
reflect corresponding DSM-IV anxiety disorders (Nauta et al., 2004), still, it may be the case that 
different results would have been obtained if DSM-IV diagnoses, that take account of the level of 
functional impairment, would have been used instead of RCADS scale scores. Since different informants 
may provide different information, this study would have been more valuable if information regarding 
symptoms of different types of anxiety would also have been gathered from parents or teachers. 
Unfortunately, such information was not available. 
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CONCLUSION 
 
In the present study’s sample of young adolescents from the Dutch general population, evidence for 
homotypic continuity was found for symptoms of separation anxiety and social anxiety, and for panic 
symptoms in girls, underscoring the usefulness of making distinctions between these different anxiety 
constructs. 
 
Footnote 
The erratum ((2008), Journal of Abnormal Child Psychology, 36 (3), 457) was integrated in this paper. 
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PART II 
Physiological stress activity in child general population samples 
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Chapter 3 
 
Perceived and physiological arousal during a stress task: can they differentiate between anxiety and 
depression? 
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ABSTRACT 
 
Background: Anxiety and depression might be two different valid constructs that often co-occur, or they 
could be different manifestations of the same underlying vulnerability. A theoretical framework to 
address this question is the tripartite model, by Clark and Watson, which hypothesizes that physiological 
hyperarousal (PH) is specific for anxiety. Knowledge about the relationship between PH, 
psychophysiological measures, perceived arousal, and anxiety would increase our understanding of the 
validity of the PH construct in this model. Our objective was to assess whether (a) hypothalamic 
pituitary–adrenocortical (HPA) axis functioning, and (b) perceived arousal before, during and after stress 
can differentiate anxious from depressive children. 
 
Methods: In a general population sample of 225 children aged 8-12 years, self-reported anxiety and 
depressive symptoms were assessed using the Multidimensional Anxiety Scale for Children (MASC) and 
the Children's Depression Inventory (CDI). Perceived arousal was assessed using a self-report 
questionnaire before, during and after a stress task. Basal and reactive HPA-axis functioning were used 
as indices for psychophysiological arousal. 
 
Results: Our data showed that the relation between perceived arousal and anxiety problems is stronger 
than the relation with depressive problems. Reactive HPA-axis functioning is reduced in children with 
depressive problems. 
 
Conclusions: Some evidence was found in support of the tripartite model. Our findings indicate that 
perceived arousal to a challenge might be a useful tool to assess the PH component of the tripartite 
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model. Reactive HPA-axis functioning might be able to differentiate between anxiety and depressive 
problems in children in a general population sample, but effect sizes are small and replication is needed. 
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INTRODUCTION 
 
Childhood anxiety and depressive symptoms have been associated with a range of negative outcomes 
(e.g. Weissman et al., 1999; Van Ameringen, Mancini, Farvolden, 2003; Bastiaansen et al., 2004), 
persistence is high (e.g. Ferdinand, Verhulst, 1995; Dunn, Goodyer, 2006; Colman et al., 2007), and 
children with an anxiety or depressive disorder have a greater chance of developing psychopathology 
later in life (e.g. Pine et al., 1998; Woodward, Fergusson, 2001; Aalto-Setala et al., 2002). Given these 
negative consequences, a better understanding of the causes and correlates of childhood anxiety and 
depression is imperative to improve treatment and prognosis for children affected by these disorders. 
An essential step forward for research in this field is to better define anxiety and depression in 
children. Much evidence has shown that anxiety and depressive symptoms in children and adolescents 
occur frequently and are often comorbid, with comorbidity rates ranging from 21 to 54% in population 
based studies (e.g. Essau, Conradt, Petermann, 2000; Costello et al., 2003; Ferdinand et al., 2005). 
Anxiety and depression might be two different valid constructs that often co-occur, or they could be 
different manifestations of the same underlying vulnerability. There are many models that have tried to 
disentangle these constructs. An interesting theoretical framework to address this question is the 
tripartite model, proposed by Clark and Watson (1991) and Watson et al. (1995a,b) in which symptoms 
of anxiety and depression are viewed along three dimensions. This model groups symptoms of 
depression and anxiety into 3 subtypes: negative affectivitiy (NA), a measure for general affective 
distress, positive affectivity (PA), a measure representing pleasurable engagement with the 
environment, and physiological hyperarousal (PH), a measure representing somatic tension and arousal, 
e.g. racing heart, sweaty palms and dry mouth. NA is associated with both anxiety and depression. A lack 
of PA, is hypothesized to be specifically associated with depression, while the third component, PH, is 
hypothesized to be specific for anxiety (Watson et al., 1995a,b). Research regarding the validity of the 
P a g e  | 55 
 
tripartite model in child and adolescent, clinical and general population samples also supports a three-
factor structure (e.g. Joiner, Catanzaro, Laurent, 1996; Chorpita, Daleiden, 2002; Turner, Barrett, 2003; 
Cannon, Weems, 2006). 
Nonetheless, earlier studies focusing on the validity of the tripartite model in child and 
adolescent populations were hampered by methodological problems, such as the use of subsets of 
items from existing anxiety and depression questionnaires to define the specific constructs. This leads to 
some difficulty with respect to validation: the most suitable validity criteria, for the three constructs in 
children and adolescents, were the same anxiety and depression scales from which the tripartite items 
were chosen (Chorpita, Daleiden, 2002). Additionally, the theory itself describes that PH is only related 
to anxiety disorders and not to depression. However, recent findings in child literature show moderate 
correlations between depression and PH measured by questionnaires (Brown, Chorpita, Barlow, 1998; 
Joiner et al., 1999; Chorpita, Daleiden, 2002). 
Another way of measuring PH could be the measurement of psychophysiological measures 
representing arousal (Laurent, Ettelson, 2001). Knowledge about the relationship between PH, 
psychophysiological measures, and anxiety would increase our understanding of the validity of the PH 
construct in the tripartite model. To our knowledge, so far only one study aimed at testing the validity of 
the PH component of the tripartite model against psychophysiological measures, i.e. heart rate (HR) and 
respiratory sinus arrythmia (RSA), representing arousal (Greaves-Lord et al., 2007a). Parent-reported 
anxiety was associated with low RSA in supine posture. This association was also found for self-reported 
anxiety problems, but only in boys. Self-reported depressive problems were associated with high RSA in 
supine posture in boys, pointing towards low arousal in depression. Self-reported depressive problems 
were also associated with high HR in standing posture, suggesting high arousal in depression. Thus, 
results remain inconclusive. 
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Besides autonomic nervous system (ANS) functioning, the hypothalamic–pituitary–
adrenocortical (HPA) axis is a major physiological stress response system. HPA-axis functioning has 
important effects on brain stem catecholaminergic input to the cortex through their effects on the locus 
coeruleus, a brain stem structure essential to the maintenance of arousal. Cortisol is the end product of 
the adrenal axis in humans. Abercrombie, Kalin and Davidson (2005) found that acute cortisol elevations 
cause heightened arousal ratings of objectively non-arousing stimuli in humans. Although these findings 
have to be interpreted carefully, because of the interference with the normal balance of hormones and 
the difficulties with the time parameters of acute versus long term arousal, they suggest that HPA-axis 
functioning can be seen as an indicator of PH. According to the tripartite model PH is specific for anxiety 
and not depression. This results in the hypothesis that HPA-axis functioning as a measure for PH can 
differentiate anxiety from depression. To our knowledge, no studies investigated the validation of the 
PH component of the tripartite model against HPA-axis functioning. 
Research regarding the association between HPA-axis functioning and depressive and anxiety 
symptoms in children is inconclusive. Studies that did find an altered HPA-axis functioning in anxious and 
depressed children, found this association mainly during sleep onset and at nighttime (Dahl et al., 1991; 
De Bellis et al., 1996; Goodyer et al., 2000; Feder et al., 2004; Forbes et al., 2006). Goodyer, Park and 
Herbert (2001) examined morning and evening cortisol among clinically depressed 8-16-year-old 
children followed over 72 weeks. Children with chronic depression had higher evening cortisol levels 
than children who recovered from their depression. Luby et al. (2003) found a stronger increase in 
cortisol levels in reaction to a separation stressor between depressed preschoolers and children with no 
psychiatric disorder. van West et al. (2008) found an elevated cortisol response to a psychosocial 
stressor in prepubertal subjects with social phobia as compared with healthy controls. In other studies 
no association was found (e.g. Gerra et al., 2000, Terleph et al., 2006; Greaves-Lord et al., 2007b). 
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Anxiety and depressive symptoms are highly comorbid, but most previous studies did not adjust 
for the effect of comorbidity on HPA-axis functioning. Only one study addressed comorbidity in children. 
Young, Abelson and Cameron (2004) found that only depressed children with a comorbid anxiety 
disorder showed an exaggerated adrenocorticotropic hormone (ACTH) response and a similar but non-
significant effect of a cortisol to a stressor. Subjects with pure mood or anxiety disorders showed normal 
ACTH and cortisol responses to a stressor. 
In sum, findings on the association between cortisol levels and anxiety or depressive problems in 
children are inconclusive. Further, studies assessing comorbid anxiety and depressive problems in 
relation to HPA-axis functioning are lacking. This leads to the question whether PH measured by 
physiological measures is really specific for anxiety. 
Another way of measuring arousal is the assessment of perceived arousal before, during and 
after a stress test. Previous studies suggest that high anxious subjects tend to perceive physiological 
sensations as more severe than non-anxious subjects (Sturges et al., 1998, Hoehn-Saric, McLeod, 2000; 
Richards, Bertram, 2000) sometimes even in the absence of an actual difference in physiological 
measures (Wilhelm, Gerlach, Roth, 2001; Edelmann, Baker, 2002). Our study is the first study to 
investigate the validation of the PH component of the tripartite model against perceived arousal in 
stressful (laboratory) situations. 
In the present study, we therefore hypothesize that PH measured by physiological measures 
represents both anxiety and depression. Further, based on the model, we would expect that only high 
anxious and comorbid children show an elevated perceived arousal to challenge. Thus, in a general 
population sample of children we examined whether (a) basal and reactive HPA-axis functioning, as a 
proxy for PH, and (b) perceived arousal before, during and after stress differentiate anxious from 
depressive children. 
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METHODS 
 
Participants 
This sample was drawn from a larger general population sample from the Dutch province of Zuid 
Holland (see “2003 sample” in Tick, Van der Ende, Verhulst, 2007). Of the 2,286 eligible respondents, 
1,710 (74.8%) parents of children aged 6-18-year olds participated in the study by Tick, Van der Ende 
and Verhulst (2007). From this sample, a sample of 508 8-12-year-olds living in municipalities relatively 
close to the city of Rotterdam was selected, to participate in a study investigating stress reactivity. All 8-
12-year-olds with scores on the internalizing and/or externalizing problem scales on the Child Behavior 
Checklist (CBCL; Achenbach, Rescorla, 2001) falling within the borderline or the clinical range were 
selected. This resulted in the selection of 140 children. Furthermore, 156 children aged 8-12 were 
randomly selected from the remaining 368 children, evenly distributed with regard to degree of 
urbanization, age and sex (see Figure 1). 
Exclusion criteria were: poor command of Dutch language, serious physical disease (e.g. cardiac, 
neurologic, respiratory disease), or receiving concurrent pharmacotherapy that could interfere with 
HPA-axis functioning. From this subsample three children were excluded because their parents did not 
speak the Dutch language. Of the remaining 293 eligible respondents, 231 (78.8%) participated. 
 
This article focuses on children in this age group because beyond the age of 12 years hormonal changes 
due to the onset of puberty might have an effect on HPA-axis functioning (Matchock, Dorn, Susman, 
2007) and this results in a less homogeneous sample. Furthermore, the stress test we used is not 
applicable below the age of 8 years. To examine possible selective attrition, a stepwise logistic 
regression analysis was performed with ‘participation yes or no’ as a dependent variable, and age, sex, 
socioeconomic status (SES) and the internalizing and externalizing problem scales on the CBCL as 
P a g e  | 59 
 
possible predictors. Sex, age and the externalizing and internalizing problem scales of the CBCL did not 
predict attrition. However, lower SES predicted attrition significantly (model χ2 = 8.621, d.f. = 2, p = 
.013). Cox and Snell R-square of the regression model was .029, which indicated that the effect of SES 
was small. Furthermore the level of psychopathology at the initial assessment, assessed with the 
externalizing and internalizing problem scales of the CBCL, was not associated with cooperation. 
From the 231 participants 6 (2.6%) refused to cooperate with the part of the study regarding 
physiological measures, 23 (10.0%) only gave permission to collect saliva at home and 202 (87.4%) gave 
permission for the complete procedure. 
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Figure 1. Sample selection 
Note. CBCL = Child Behavior Checklist 
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N=576, due to no 
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remaining sample
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selected at random; no 
borderline/clinical symptoms
N=296
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N=62, due to no parental 
permission to participate
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Procedure 
Participants were given written information with details about the objectives of the study, procedures 
and rights of the participant. A signed informed consent was obtained from each family. Prior to the 
physiological assessment, children were asked to fill in the Multidimensional Anxiety Scale for Children 
(MASC; March et al., 1997) and Children's Depression Inventory (CDI; Kovacs, 1992). Activity of the HPA 
system was assessed using salivary cortisol samples, which reflect the biologically active unbound 
fraction of serum cortisol (Gozansky et al., 2005), also in children (Shimada et al., 1995). When cortisol 
samples are examined two things have to be kept in mind; (1) measuring cortisol at a peak time (30 min 
after awakening- ‘cortisol awakening rise’ (CAR) (Rosmalen et al., 2005)) can give an indication of 
cortisol ‘reactivity’ and (2) cortisol levels have been found to react to stress, typically peaking about 20 
30 min following a stressor. Participants were instructed to collect saliva samples at home: (1) a first 
sample immediately after awakening in the morning (Cort1), when the child was still in bed, (2) a second 
sample 30 min later (Cort2), (3) a sample at 12:00 h (Cort3), and (4) a final sample at 20:00 h (Cort4). 
Participants were instructed to fill the tubes till a marker (at 500 μl). All samples were collected 
on a regular school day, stored in the freezer at home, and taken to the outpatient department 1 day 
later, when the physiological assessment took place. Children and parents received a written instruction 
with drawings and received another instruction by telephone the day before sampling to increase the 
reliability of cortisol sampling at home. Saliva samples were stored at −20 °C before analysis at the 
laboratory. Parents were asked to register general physical condition, activity levels (e.g. sports), 
consumption pattern (e.g. smoking, alcoholic beverages and caffeine intake), and medication use of the 
participants. 
The physiological assessment took place one day after saliva collection at home. Participants 
were seated comfortably in a light laboratory room where temperature and humidity levels were kept 
constant. All assessments took part in the afternoon (between 12 p.m. and 6.30 p.m.). Lunch was eaten 
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before assessment; the gap between lunch and baseline saliva samples was at least 1.5 h. After a rest 
period of 45 min, the session began with a baseline period of 10 min in which the participant was asked 
to sit still and relax. Subsequently, a stress test consisting of three subtasks; a mental arithmetic task 
(MAT) (4 min), a public speaking task (PST) (8 min speech preparation and 6 min public speaking) and a 
computer task (CT) (5 min) were administered. The public speaking task involved providing the child 
with a story scenario and then giving him/her 8 min to develop a story (Speech Preparation Period). 
Then the child had to deliver the speech for 6 min (Speech Period), this was followed by a computer task 
during 5 min. The story stem used was one in which the child was erroneously accused of stealing and 
had to describe to a “guard” why they were innocent. During the computer task children had to 
calculate by heart in how many steps they would be able to order four numbers from lowest through 
highest. They were told they had to act as quickly as possible and to make as little mistakes as possible. 
The public speaking task was videotaped and the participant was told that the computer task and the 
public speaking task were evaluated afterwards. Furthermore, for all tasks there was a time constraint. 
Both of these elements and the fact that the test combines a public speaking task with cognitive 
tasks are associated with the largest cortisol changes and the longest times to recovery in comparison 
with other stress tests (Dickerson, Kemeny, 2004). After accomplishment of the computer task the 
participant was asked to watch a movie during 25 min after sitting still and relaxing again for 5 min. This 
was implemented to allow participants to return to normal after the stressor. At the end of the baseline 
period, after each subtask of the stress test, and halfway and at the end of the recovery period, a 
questionnaire concerning physiological arousal was administered and saliva was collected (Cortisol 
samples 5–10 (Cort5–Cort10)) (see Figure 2). Sampling after each stress task was conducted in order to 
develop a cortisol profile during stress. 
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Figure 2. Cortisol sampling 
Note. Cort5 = cortisol at the end of the baseline period, Cort6 = cortisol after the mental arithmetic task (MAT), 
Cort7 = cortisol after the public speaking task (PST), Cort8 = cortisol after the computer task (CT), Cort9 = cortisol 
15 minutes after the stress task, Cort10 = cortisol 30 minutes after the stress task 
 
Measures 
Child behavior checklist 
The CBCL is a parent questionnaire for assessing problems in 4-18-year-olds. It contains 120 items on 
behavioral or emotional problems in the past 6 months. The response format is 0 = not true, 1 = 
somewhat or sometimes true, and 2 = very true or often true. The good reliability and validity of the 
original version of the CBCL (Achenbach, 1991) were confirmed for the Dutch translation (Verhulst, Van 
der Ende, Koot, 1996). Scores on two broad-band scales were computed. Scores on the Internalizing 
broad band scale are derived by summing scores on the ‘narrow-band’ scales ‘Withdrawn’, ‘Somatic 
Complaints’, and ‘Anxious/Depressed’, whereas scores on the Externalizing broad-band scale are 
computed by summing scores on the narrow-band scales ‘Delinquent Behavior’ and ‘Aggressive 
Behavior’. Scores on the Internalizing Problems and Externalizing Problems scales were used to include 
children. 
 
Multidimensional Anxiety Scale for Children 
The MASC is a 39-item self-report questionnaire that assesses anxiety symptoms concerning the last 2 
weeks in children and adolescents. Items are scored from 0 to 3 (0 = never true, 1 = rarely true, 2 = 
sometimes true, 3 = often true). The internal consistency (.90) and 1-month test–retest reliabilities (.87–
.90) (March et al., 1997) are very good. Cronbach's α in this study was .87. 
Baseline 
10 minutes
Cort5
MAT
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14 
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P a g e  | 64 
 
 
Children's Depression Inventory 
The CDI is a 27-item self-report questionnaire that assesses depressive symptoms concerning the last 2 
weeks in children and adolescents. Items are scored from 0 to 2 (0 = never true, 1 = sometimes true, 2 = 
always true). The internal consistency (.86) and 1-month test–retest reliabilities (.72) are adequate 
(Kovacs, 1981). Cronbach's α in this study was .84. 
 
Physiological Arousal Questionnaire (PAQ) 
The PAQ (Kallen, 2002) is a 7-item self-report questionnaire developed at our department for 
assessment of the perceived state of physiological arousal. The child is asked to indicate on a 9-point 
scale (0–8) to what extent he or she feels aroused: 0 = not at all to 8 = very much. Cronbach's α was .64 
(during baseline), .81 (during stress), .84 (during recovery). The specific items are shown in Table 1. The 
PAQ was administered at the end of the baseline period, after each subtask of the stress test, and after 
the recovery period. 
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Table 1. PAQ items 
1. Do you have warm or sweaty hands? 
2. Are you sweating? 
3. Do you feel your heart beating? 
4. Are you feeling hot or short of breath? 
5. Do you have a dry mouth? 
6. Do you have a tingling sensation in your face or hands? 
7. Are you nervous? 
 
Cortisol assessment 
An Enzyme-Linked Immuno Sorbent Assay (DRG Instruments GmbH, Marburg, Germany) was used to 
determine cortisol concentrations in 50 μl duplicate samples. The lower limit of detection was 1.12 
nmol/l, the intra-assay variation was 6.9% and the inter-assay variation was 8.6%. Of the samples 2.7% is 
missing due to insufficient saliva or due to intra-assay differences larger than 20%. Cortisol values that 
were above 3 SD of the mean were excluded (N=22) from the analysis in order to reduce the impact of 
outliers. 
In addition to the separate cortisol variables, we chose to use composite cortisol variables to 
analyze the diurnal and stress cortisol profile. To characterize the diurnal cortisol profile we calculated 
three composite measures according to Pruessner et al. (2003): cortisol awakening rise with respect to 
ground (CARg) and with respect to increase (CARi) and the area under the curve with respect to ground 
(AUCg) (Rosmalen et al., 2005). An area under the curve with respect to ground, such as CARg or AUCg, is 
a measure that represents the total amount of cortisol that is produced during a specific period and is 
calculated by computing the area between zero and the curve that is constituted by the respective 
cortisol levels (Pruessner et al., 2003). In the case of CARi, the distance from zero is ignored, thereby 
emphasizing changes over time (Pruessner et al., 2003). To characterize the cortisol profile during stress 
the area under the curve with respect to ground and increase (respectively AUCsg and AUCsi) were 
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calculated using cortisol samples representing baseline (Cort5 and Cort6), representing stress (Cort7, 
Cort8 and Cort9) and representing recovery (Cort10). For formulas see Appendix A. If one of the cortisol 
samples was missing, an area under the curve could not be calculated; therefore N=19 AUCsg and N=10 
AUCg were missing. 
 
Data analysis 
All statistical analyses were performed with SPSS 15.0. Item scores on the MASC, CDI and PAQ were 
summed to obtain total scores. As shown in Table 2, cortisol levels during stress were at their lowest at 
Cort6. Cortisol levels across participants reached their peak after the computer task, represented by 
Cort8, but probably reflect the cumulative response to all three components of the stressor and 
anticipation of stress due to the lag in cortisol response after stress exposure. Cort10 best reflects 
recovery values of cortisol. 
PAQ Total score, Cort4, Cort6, Cort 8, Cort 10, Body Mass Index (BMI) and CDI Total score were 
log transformed to normalize their distribution before statistical analyses. All of the not normally 
distributed measures, except for CDI Total score, Cort4 and PAQ Total score during recovery, were 
normally distributed after log-transformation. 
First, to investigate if the level of anxiety predicted basal HPA-axis functioning nine separate 
stepwise regression analyses were conducted. CARg, CARi, AUCg, AUCsg, AUCsi, Cort4, Cort6, Cort8 and 
Cort10 were entered in nine separate regression analyses as dependent variables. Age, gender and BMI 
might confound the cortisol-psychopathology relationship (e.g. see Rosmalen et al., 2005 for an 
overview). To control for possible effects of age, gender and BMI, these variables were first entered as a 
block into the model as independent variables. MASC Total score was entered in a second block as 
predictor. Nine similar regression analyses were conducted with the log-transformed CDI Total score as 
independent variable. 
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Table 2. Descriptives of anxiety, depression, perceived arousal, and cortisol measures 
Measures 
Mean (SD) 
Measures 
Mean (SD) 
MASC Total score   41.91 (13.91) Cort7 (nmol/l)   7.83 (3.21) 
CDI Total score     6.14 (5.33)   Cort8 (nmol/l)    8.56 (4.05) 
Cort1 (nmol/l)   14.89 (4.69) Cort9 (nmol/l)   8.08 (3.75) 
Cort2 (nmol/l)   17.83 (5.39) Cort10 (nmol/l)   7.85 (3.94) 
Cort3 (nmol/l)     8.59 (2.96)  AUCsg   7.28 (2.55) 
Cort4 (nmol/l)     6.50 (3.48) AUCsi   0.05 (1.74) 
CARg     8.18 (2.03) PAQ Total score (baseline)   6.78 (5.99) 
CARi     0.76 (1.47) PAQ Total score (after MAT)   8.95 (7.95) 
AUCg 116.77 (31.35) PAQ Total score (after PST) 11.30 (9.47) 
Cort5 (nmol/l)     7.88 (3.14) PAQ Total score (after CT)   8.03 (8.56) 
Cort6 (nmol/l)     7.46 (2.55) PAQ Total score (recovery)   5.96 (7.72) 
Note. SD = standard deviation, MASC = Multidimensional Anxiety Scale for Children, CDI = Children’s Depression 
Inventory, Cort1 = cortisol directly after awakening, Cort2 = cortisol half an hour after awakening, Cort3 = cortisol 
at 12.00 p.m., Cort4 = cortisol at 8.00 p.m., CARg = cortisol awakening rise with respect to ground, CARi = cortisol 
awakening rise with respect to increase, AUCg = area under the curve for Cort2-Cort4 with respect to ground, Cort5 
= cortisol at the end of the baseline period, Cort6 = cortisol after the mental arithmetic task (MAT), Cort7 = cortisol 
after the public speaking task (PST), Cort8 = cortisol after the computer task (CT), Cort9 = cortisol 15 minutes after 
the stress task, Cort10 = cortisol 30 minutes after the stress task, AUCsg= area under the curve for Cort5-Cort10 
with respect to ground, AUCsi= area under the curve for Cort5-Cort10 with respect to increase, PAQ = Perceived 
Arousal Questionnaire. 
 
Second, to investigate if the level of anxiety predicted perceived arousal, three separate stepwise 
regression analyses were conducted. PAQ Total score before, during and after the stress test were 
entered as dependent variables and the MASC Total score was entered as predictor. To control for 
possible effects of age and gender, these variables were first added to the model as independent 
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variables. Due to overlap between items of the MASC Physical Anxiety Scale and the PAQ, the 
correlation between the PAQ Total score was calculated. Furthermore the regression analyses were 
repeated for the MASC Total Score minus the scores on the MASC Phsycical Anxiety Scale. Three similar 
regression analyses were conducted with the log-transformed CDI Total score as independent variable. 
Third, three stepwise regression analyses were conducted with the PAQ Total score before, 
during and after the stress test as dependent variables. The first block consisted of age and gender, 
second the MASC Total score was added, third the log-transformed CDI Total score was added and 
finally the interaction term between the MASC Total score and the log-transformed CDI Total score was 
added. 
Finally, to investigate the relation between perceived and objective arousal, correlations 
between all cortisol and perceived arousal measures were calculated. For all analyses effect sizes are 
reported by R2,change. 
 
RESULTS 
 
Descriptives 
Two hundred and twenty-five children participated in the physiological part of the study (mean age 
10.06 years (SD 1.52), with 49.8% boys, and mean Body Mass Index (BMI) 18.11 (SD 3.24)). Mean scores 
and standard deviations of all the anxiety, depression, perceived arousal, and cortisol measures are 
presented in Table 2. The PST elicited the largest response in PAQ Total score. Therefore PAQ Total score 
after the PST was used as a measure of perceived arousal after stress, herein after referred to as PAQ 
stress. Correlations between MASC Total score and CDI Total score and perceived arousal measures 
after the different stress tasks were calculated. Perceived arousal elicited by the CT was most strongly 
correlated with both MASC Total score and CDI Total score (see Table 3). 
P a g e  | 69 
 
 
Table 3. Pearson’s correlations between perceived arousal measures after stress and anxiety and 
depression 
PAQ (log-transformed) MASC Total score CDI Total score 
MAT .34** .16* 
PST .32** .22** 
CT .38** .25** 
*= p<.05, **=p<.01, PAQ = Perceived Arousal Questionnaire, MAT = mental arithmetic task, PST = public speaking 
task, CT= computer task 
 
54 subjects had a negative value for CARi ranging from −.10 to −2.73. 91 subjects had a negative value 
for AUCsi ranging from −.02 to −4.13. We chose to include negative values in our analyses, because we 
examined the linear relation between physiological arousal and anxiety and depression using regression 
analyses. Subjects with a negative value of CARi had a significant (T = −2.64, p < .01) lower anxiety score 
(MASC Total score = 37.5) in comparison to children with positive values (MASC Total score = 43.2). This 
result was not significant anymore when corrected for age, sex and BMI, using stepwise binary logistic 
regressions. There was no significant difference in depression scores for CARi or AUCsi. 
 
Linear regressions 
There was no significant relation between any of the cortisol measures and MASC Total score. 
Furthermore, there was only one significant relation between log-transformed CDI Total score 
and any of the cortisol measures; a higher score on the CDI Total score resulted in a lower AUCsi. This 
suggests that children with higher rates of depression show a flattened response to stress. The results of 
the regression analyses for MASC Total score and log-transformed CDI Total score during baseline, after 
stress and during recovery are presented in Table 4.  
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Table 4. Predictive value of anxiety and depression regarding cortisol measures 
Predictors 
 
CARg CARi AUCg AUCsg 
β /R2 β /R2 β /R2 β /R2 
Gender, Age, BMI (first block) .23**;.-.02;-.11/.06* .18*;.13;-.11/.05* .16*;.12;-.15/.05* .05;.22**;-.18*/.06* 
MASC Total Score (second block) -.09/.01 .09/.01 -.01/.00 -.03/.00 
CDI Total Score (second block) .02/.00 .12/.01 .06/.01 -.07/.01 
Predictors AUCsi 
 
Cort6 
 
Cort8 
 
Cort10 
 
β /R2 
 
β /R2 
 
β /R2 
 
β /R2 
 
Gender, Age, BMI (first block) .20**;.06;-.16*/.06* -.01;.13;-.10/.02 .15*;.22**;-.20**/.08** .08;.03;-.12/.02 
MASC Total Score (second block) -.09/.01 -.01/.00 -.08/.01 -.08/.01 
CDI Total Score (second block) -.15/.02* -.02/.00 -.09/.01 -.12/.01# 
 
Note. β’s are standardized betas, uncorrected for age, BMI or gender. R2 change = explained variance for adding this step, MASC = Multidimensional Anxiety Scale 
for Children, CDI = Children’s Depression Inventory, Cort4 = cortisol at 8.00 p.m., CARg = cortisol awakening rise with respect to ground, CARi = cortisol 
awakening rise with respect to increase, AUCg = area under the curve for Cort2-Cort4 with respect to ground, Cort6 = cortisol after the mental arithmetic task 
(MAT), Cort8 = cortisol after the computer task (CT), Cort10 = cortisol 30 minutes after the stress task, AUCsg= area under the curve for Cort5-Cort10 with 
respect to ground, AUCsi= area under the curve for Cort5-Cort10 with respect to increase. # = p<.1, *= p<.05, **=p<.01. 
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Table 5. Predictive value of anxiety and depression regarding perceived arousal 
PAQ (log-transformed) 
Predictors Baseline Stress Recovery 
β /R2 β /R2 β /R2 
1. Age, gender -.07;.07/.01 .12;.08/.02 -.16*;.05/.03# 
2. MASC Total Score .35/.12** .33/.11** .37/.13** 
2. MASC Total Score, without PAS .28/.07** .28/.08** .29/.08** 
2. CDI Total Score .26/.07** .22/.05* .22/.05* 
 Baseline 
β /T 
Stress 
β /T 
Recovery 
β/T  
1. Age, gender -.07;.07/-1.03; 1.00 .12;.08/1.65; 1.07 -.16;.05/.-2.21*;.70 
2. MASC Total Score .35/5.07** .33/4.79** .37/5.37** 
Model statistics F change = 25.7, R2, change  = .12** F change = 23.0, R2 change = 
.11** 
F change = 28.84 , R2 change  = .13** 
3. MASC Total Score; CDI Total Score, .29;.13/3.74**; 1.76# .29; .09/3.71**; 1.22 .33;.08/4.31**;1.04 
Model statistics F change = 3.11, R2 change = .01# F change = 1.49, R2 change  = .01 F change = 1.08,  R2 change  = .01 
4. MASC Total Score; CDI Total Score; 
MASC Total Score * CDI Total Score 
.38;.24;-.17/2.0*; 1.13; -.53 .54;.37;-.46/2.79*;1.78#;-
1.43 
.54; .31;-.38/2.79*;1.47;-1.17 
Model statistics F change = .28, R2 change =  .00 F change = 2.06, R2 change =  .01 F change = 1.38,  R2 change =  .01 
Note. β’s are standardized betas, uncorrected for age or gender. R2, change = explained variance for adding this step. PAQ = Perceived Arousal Questionnaire, 
MASC = Multidimensional Anxiety Scale for Children, CDI = Children’s Depression Inventory, PAS = Physical Anxiety Scale. # = p<.1, *= p<.05, **=p<.01 
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The results of the regression analyses for MASC Total score, the MASC Total Score minus the scores on 
the MASC Physical Anxiety Scale, and log-transformed CDI Total score and log-transformed PAQ Total 
score during baseline, after stress and during recovery are presented in Table 5. All three of them 
predict perceived arousal during baseline, stress and recovery conditions. The regression analyses of 
MASC Total score and PAQ-score yields the strongest relation according to the effect sizes. When the 
items of the MASC Physical Anxiety Scale are subtracted from the Total score, the relation remains 
significant. 
Three stepwise regression analyses were conducted with the PAQ Total score before, during and 
after the stress test as dependent variables. The first block consisted of age and gender, second the 
MASC Total score was added, third the log-transformed CDI Total score was added and finally the 
interaction term between the MASC Total score and the log-transformed CDI Total score was added. The 
results are displayed in Table 5. This table shows that by adding the CDI Total score to the model, the 
model did not improve. When MASC and CDI Total score were simultaneously added to the model, only 
MASC Total Score remained significant. The effect size of adding this step is close to zero. 
To investigate the relation between perceived and objective arousal, correlations between all 
cortisol and perceived arousal measures were calculated. None of these correlations were significant, 
see Table 6. 
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Table 6. Pearson’s correlations between perceived and objective arousal measures 
PAQ 
(log-transformed) 
CARg CARi AUCg Cort4 AUCsg AUCsi Cort6 Cort8 Cort10 
Baseline  .01 .05 -.02 -.01 -.07 -.01 -.07 -.08 -.12 
Stress -.07 .09 -.01 .02 .08 .08 .07 .06 .02 
Recovery -.04 .06 -.07 -.05 -.06 .02 -.04 -.04 -.08 
PAQ = Perceived Arousal Questionnaire, Cort4 = cortisol at 8.00 p.m., CARg = cortisol awakening rise with respect 
to ground, CARi = cortisol awakening rise with respect to increase, AUCg = area under the curve for Cort2-Cort4 
with respect to ground, Cort6 = cortisol after the mental arithmetic task (MAT), Cort8 = cortisol after the computer 
task (CT), Cort10 = cortisol 30 minutes after the stress task, AUCsg= area under the curve for Cort5-Cort10 with 
respect to ground, AUCsi= area under the curve for Cort5-Cort10 with respect to increase. # = p<.1, *= p<.05, 
**=p<.01. 
 
We conducted a post hoc analysis to examine whether a group with clinical internalizing problems had 
the same relationship between anxiety and/or depression measures and perceived or objective arousal. 
These analyses showed that perceived and objective arousal have the same relation with anxiety and 
depression measures in children that exceed the borderline cut-off score for internalizing problems on 
the CBCL (N=54). 
 
DISCUSSION 
 
Principal findings 
PH as defined by the model of Clark and Watson is a concept based on anxiety and depression 
questionnaires. This concept is a rather virtual concept that has no quantifiable substrates; therefore it 
is difficult to assess the usefulness and significance of this model. Furthermore, the model by Clark and 
Watson is a model that is frequently cited with regard to the disentanglement of anxiety and depression 
as different constructs. In our opinion it is interesting, although complicated, to view our results with 
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respect to the tripartite model by Clark and Watson; it contributes to the discussion of how the model is 
constructed and why there are so many versions of it. This study attempted to quantify this concept by 
using two levels of arousal, a subjective and a physiological, in a specific situation (i.e. in basal conditions 
and during a stresstask) in order to make it more tangible and applicable. We examined whether, in a 
general population sample of children, basal and reactive HPA-axis functioning, as a proxy for PH, and 
perceived arousal before, during and after stress could differentiate anxious from depressive children. 
Overall, our results provide some evidence in support of the applicability of perceived arousal as 
a measure of PH, included in the tripartite model, to differentiate between anxiety and depressive 
problems in children in a general population sample. Perceived arousal is related to both anxiety and 
depressive problems. However, effect sizes for depressive problems are smaller than the effect sizes 
during baseline and recovery for anxiety problems. Furthermore, when anxiety and depressive problems 
are entered simultaneously, only anxiety problems predict perceived arousal. 
With respect to cortisol as a measure of perceived arousal, our results suggest that children with 
higher rates of depression have a flattened response to a stresstask. There was no relation between 
anxiety problems and any of the other cortisol measures. We can therefore state that our results 
provide some evidence that in a general population sample, reactive HPA-axis functioning can 
differentiate between anxiety and depressive problems in children. 
 
HPA-axis 
Greaves-Lord et al. (2007a) found some evidence for hyperarousal measured by psychophysiological 
measures, in both anxiety and depression. We could not replicate these results using indicators of HPA-
axis functioning instead of ANS functioning. One reason for the inconsistent findings could be the 
difference in age groups; the study of Greaves-Lord et al. (2007b) was conducted in a sample of young 
adolescents, whereas this study was conducted in a sample of school-aged children. 
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HPA-axis functioning was assessed during the day and in basal as well as in stress conditions. No 
relation with measures of anxiety problems was found. On the contrary, we found that children with 
higher rates of depression have a flattened response to stress. This result is in contrast with the findings 
of Luby et al. (2003) who found a stronger increase in cortisol levels in reaction to a separation stressor 
between depressed preschoolers and children with no psychiatric disorder. The effect size of our finding 
is very small, so our results have to be interpreted carefully. Furthermore, this finding could be the 
result of a type I error. Therefore replication in other samples is needed. An explanation for the lack of 
significant findings could be that alterations in HPA-axis functioning might only occur in children with a 
clinical anxiety or depressive disorder. In this general population sample the amount of subjects with 
clinical anxiety and depression was relatively low. One could hypothesize that only anxiety or depressive 
problems which interfere with daily life and exist for some time, have an effect on HPA-axis functioning. 
Or, alternatively, that altered HPA-axis functioning, as a preexisting trait, leads to a clinical anxiety or 
depressive disorder, but is not related to normal variation in levels of anxiety. 
 
Perceived arousal to a stressor 
In our study, perceived arousal to a real stressor was related to both anxiety and depressive problems. 
Our findings are not consistent with the tripartite model; PH is related to both anxiety and depression, 
although, PH shows a stronger association with anxiety than with depression. This is in line with recent 
findings in child and adult literature which show moderate correlations between depression and PH, 
when PH is measured using questionnaires (Brown, Chorpita, Barlow, 1998; Joiner et al., 1999; Chorpita, 
Daleiden, 2002). 
 
Limitations and strengths 
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This study is, to our knowledge, the first study to combine perceived arousal to challenge and HPA-axis 
functioning, as a measure for PH. Perceived arousal during a challenge is probably a more reliable 
marker for PH than items in questionnaires tapping arousal in daily life. 
The present study tested the validity of the PH component of the tripartite model in a general 
population sample. Therefore, in comparison to research in clinical samples, results can be generalized 
due to the lack of selection bias. However, originally, the tripartite model was developed with the use of 
data from a clinical sample (Clark, Watson, 1991). Clinical and general population samples might differ in 
impairment and severity and duration of symptoms. Therefore, the findings found in the present study 
cannot be generalized to clinical samples. This limitation is confirmed by the post-hoc analyses which 
show that exceeding the clinical cut-off score of internalizing problems on the CBCL moderates the 
relationship between perceived arousal and anxiety and depressive symptoms. Furthermore, relations 
that were not found in this study – for instance, the relation between HPA-axis functioning and anxiety 
problems- might be established in a clinical sample due to reasons mentioned above. Therefore 
replication in a clinical sample is needed. 
One could argue that there is an overlap between items from the PAQ and the MASC. However, 
the MASC assesses physical anxiety symptoms during the past two weeks and not in relation to an actual 
stressor. Furthermore, the relation between the MASC remains, even after deleting the items that 
assess physical anxiety symptoms. The PAQ is used as an instrument to assess the perceived arousal 
before, during and after a stressor and therefore measures a different construct; it does not measure 
anxiety symptoms, but it measures actual instantaneous arousal. 
In the present study, we used only the child as an informant to assess anxiety and depressive 
symptoms. One could argue that the use of multiple informants (e.g. parents or teachers) would lead to 
a more valid assessment of these symptoms (Grills, Ollendick, 2003; Comer, Kendall, 2004). However, 
multiple informant agreement is higher for externalizing than for internalizing problems; a possible 
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explanation for this phenomenon can be that internalizing problems tend to be inwardly focused upon 
the self (Grills, Ollendick, 2003). Therefore, self-report questionnaires are valid tools to assess 
internalizing problems in children and adolescents. 
Other demographic variables such as socioeconomic status, IQ and Tanner stage might have 
influenced cortisol values. These data are not available for our subjects. This is a limitation of the study. 
Previous studies showed inconsistent results regarding the association between cortisol levels 
and child anxiety or depressive problems. Studies that did find an altered HPA-axis functioning in 
anxious and depressed children, found this association mainly during sleep onset and at nighttime (Dahl 
et al., 1991; De Bellis et al., 1996; Goodyer et al., 2000; Feder et al., 2004; Forbes et al., 2006). In our 
study, we did not assess sleep-onset and nighttime cortisol levels. 
We assessed HPA-axis functioning by measuring the end product of this axis, cortisol. However, 
HPA-axis activity is regulated by multiple hormones and is a very complex system (Sapolsky, Romero, 
Munck, 2000; De Kloet, 2003; Herman et al., 2005). Hence, the measurement of only the end product is 
a relatively crude way to measure a possible altered functioning of this system. For instance, Young, 
Albelson and Cameron (2004), did find alterations in ACTH levels in depressed children with a comorbid 
anxiety disorder in response to a stressor, but not in cortisol levels. Thus, the lack of significant findings 
regarding cortisol in our study, does not necessarily mean that HPA-axis functioning is not altered in 
anxious or depressed subjects. These alterations might occur on different levels in the HPA-axis. 
 
CONCLUSION 
 
This study found some evidence in support of the tripartite model of Clark and Watson (1991). Together, 
our findings indicate that perceived arousal to a challenge might be a useful tool to assess the PH 
component of the tripartite model in a general population sample of school-aged children. HPA-axis 
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functioning measured by cortisol in stress conditions might differentiate between anxiety and 
depression, but this result is not very strong and needs replication in a general population sample. 
Future research is needed to replicate our findings in clinical samples. Findings might be 
different, when different measures for the assessment of HPA-axis functioning are used, such as evening 
and nighttime cortisol, or ACTH levels during stress or a Dexamethasone Suppression Test. Furthermore, 
studies that simultaneously assess HPA-axis and ANS functioning, as well as perceived arousal to a 
stressor, in different age groups, could contribute to a better differentiation of anxiety and depression in 
children and adolescents. Further research could also focus on measures of autonomic nervous system 
activity at rest and during stress, in addition to HPA-axis activity. 
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SUPPLEMENTARY MATERIAL 
 
Formulas 
The CARg  and CARi  were calculated using the following formulas: 
CARg = ((Cort1+Cort2) * timecort2-cort1)/2 
CARi = CARg – (Cort1 * timecort2-cort1). 
The formula to calculate AUCg was: 
AUCg = AUCcort2-cort3+AUCcort3-cort4 = ((Cort2+Cort3) * timecort3-cort2)/2 + ((Cort3+Cort4) * timecort4-cort3)/2 
The AUCsg  and AUCsi  were calculated using the following formulas: 
AUCsg = AUCcort6-cort5+AUCcort7-cort6+AUCcort8-cort7+AUCcort9-cort8+AUCcort10-cort9 
AUCsi = AUCsg -(Cort5 * timecort10-cort5) 
The AUCs were calculated in the same manner as the AUCs used in the formula for the AUCg. 
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Chapter 4 
Of fraidy-cats and wild tigers: a prospective study of infant autonomic functioning and child internalizing 
and externalizing problems 
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ABSTRACT 
 
Background: Variations in the autonomic nervous system and its proxies heart rate and heart rate 
variability have been implicated as possible biological markers of both internalizing and externalizing 
pathology in children. Most previous studies of autonomic arousal and problem behavior used a cross-
sectional study design or, in case of a longitudinal design, measured autonomic arousal later in life, 
increasing the possibility of reverse causality. We investigated the longitudinal associations between 
infant autonomic functioning and early childhood internalizing and externalizing problems. 
 
Methods: In infants of the Generation R Study, we measured resting mean heart rate and heart rate 
variability at 14 months. At 18 months and 6 years (N=464), child problem behavior was assessed with 
the Child Behavior Checklist. To investigate the association of infant heart rate and heart rate variability 
with change in childhood internalizing and externalizing problem behavior, we performed a series of 
regression analyses. 
 
Results: Autonomic functioning predicted internalizing problems at follow-up independently of 
externalizing problem behavior at follow-up, and vice versa. Lower infant heart rate was associated with 
less decrease of childhood externalizing problems, whereas higher infant heart rate was associated with 
a stronger increase of internalizing problems. Consistently, higher infant heart rate variability was 
associated with less decrease of childhood externalizing problems, whereas lower infant heart rate 
variability was associated with a stronger increase of internalizing problems. 
 
Conclusions: Our study shows that both infant heart rate and heart rate variability function as 
antagonistic predictors of childhood internalizing and externalizing problem behavior.  
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INTRODUCTION 
 
Mental health problems affect approximately 15% of preschool children aged 2 through 5 years (Egger, 
Angold, 2006; Skovgaard et al., 2007). Convergent evidence from prospective community studies shows 
that preschool problem behavior precedes later psychopathological problems (Basten et al., 2016). 
However, to some extent, many challenging or difficult behaviors in pre-school aged children are age-
appropriate and in keeping with normal development (Egger, Angold, 2006). This has made it difficult to 
discern age-appropriate behavior, reflecting normal development, from persistent pathological behavior 
and underlines the importance to identify early risk factors for later psychopathology. 
Internalizing and externalizing problems in childhood often co-occur (Fanti, Henrich, 2010) and 
show heterotypic stability (Basten et al., 2016). Prior research indicates that the development of 
externalizing and internalizing problems each have unique causes as well as shared causes (Mathiesen, 
Sanson, 2000). Biomarkers that increase one type of problem behavior and decrease the other, might 
remain undetected when internalizing and externalizing problems are not disentangled (Mathiesen et 
al., 2009). Therefore, developmental changes in internalizing and externalizing problems, as well as the 
co-occurrence of internalizing and externalizing problems, need to be considered in studying early risk 
factors for the continuity of problems among preschool children. 
Variations in the autonomic nervous system and its proxies heart rate and heart rate variability 
have been implicated as possible biological markers of both internalizing and externalizing pathology in 
children (Ortiz, Raine, 2004; Dietrich et al., 2007; Dierckx et al., 2014; Dieleman et al., 2015). Heart rate 
is controlled by the sympathetic and parasympathetic branches of the autonomic nervous system, while 
high frequency variation in heart rate (heart rate variability) is a proxy for the parasympathetic 
component of autonomic cardiac control. Low autonomic arousal shows an association with 
externalizing problems and behavioral disorders, whereas high autonomic arousal is associated with 
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internalizing problems and anxiety disorders (Ortiz, Raine, 2004; Dietrich et al., 2007; Dierckx et al., 
2014; Dieleman et al., 2015). Most previous studies that examined the association between autonomic 
arousal and problem behavior in children used a cross-sectional study design (Posthumus et al., 2009; El-
Sheikh, Hinnant, Erath, 2011) or, in case of a longitudinal design, measured autonomic beyond infancy 
(Hinnant, El-Sheikh, 2013; Hastings, Kahle, Nuselovici, 2014), which increases the possibility of reverse 
causality. Reverse causation refers to the situation in which the outcome precedes and causes the 
exposure instead of the other way around. Ideally potential risk factors for the development of serious 
problem behavior would be measured before the onset of such behaviors. 
A few studies investigated the longitudinal associations between infant autonomic functioning 
and later internalizing problems. Dierckx et al. (2014) showed a positive association between infant 
heart rate and anxiety symptoms at 3 years, whereas Baker et al. (2012) and Wagner et al. (2016) found 
no direct association between infant autonomic functioning and later internalizing problems. Studies 
investigating the association between infant autonomic functioning and externalizing problems showed 
no association (Van Hulle et al., 2000; Dierckx et al., 2014). However, the study by Dierckx et al. (2014) 
showed that lower infant resting heart rate predicted higher odds of lying at 3 years. They concluded 
that lower resting heart rate may be less an indicator of early childhood aggression than of fearless 
behavior. In these longitudinal studies examining infant autonomic functioning as a predictor for later 
problem behavior, most studies focused either on internalizing or externalizing problems, but few 
considered the co-occurrence of internalizing and externalizing problems. 
The current study was designed to examine the longitudinal associations between infant 
autonomic functioning and early childhood internalizing and externalizing problems simultaneously, in a 
large general population sample. We hypothesized that infant autonomic functioning (at 14 months) 
would differentially predict internalizing and externalizing problems at the age of 6, adjusting for these 
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internalizing and externalizing problems at baseline (at 18 months) respectively, reflecting a model of 
symptom change. 
 
METHODS 
 
Design and study population 
This study was conducted within the Focus cohort of the Generation R Study, a population-based 
prospective cohort from fetal life onwards (Tiemeier et al., 2012). All children were born between 
February 2003 and August 2005. The cohort consists of Dutch children and their parents and is ethnically 
homogeneous to rule out confounding and effect modification by ethnicity. 
Measurements of infant autonomic indices were added to the protocol of the examination 
round at age 14 months, while assessment was already ongoing. We obtained physiological 
measurements for 528 infants, as described previously (Dierckx et al., 2009). When the child was on 
average 5.9 years old, N=464 mothers rated the child’s emotional and behavioral problems (response 
rate of 87.9%). 
Written informed consent was obtained from all participants. The general design, all research 
aims and the specific measurements in the Generation R Study have been approved by the Medical 
Ethical Committee of the Erasmus Medical Center, Rotterdam. 
 
Measures 
Psychophysiological measurements 
Mothers and their infants were invited to our laboratory at 14 months after birth. Physiological 
measurements were performed by trained research assistants. We registered heart rate (HR) using a 
precordial, three pole ECG lead, sampled at 512 Hz. Furthermore, we monitored the breathing pattern 
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using a piëzo-electric transducer, recording expansion and contraction of the thorax. Signals were 
recorded using a Vitaport 3 digital recording system (Temec Inc, Kerkrade, the Netherlands). We 
recorded for 8 minutes, while the infant was at ease in its mothers lap. To help the infant relax, we 
played an episode of the Teletubbies© (BBC/Ragdoll Limited). Recordings did not start until signals had 
reached a stabilized steady-state. 
 
Power spectral analysis 
We analyzed the recorded data using custom made software. Irregular, slow breathing distributes the 
variation attributable to parasympathetic activity across the frequency spectrum. Hence, for each 
participant, we manually selected 100-180 seconds of the ECG, were breathing was most regular. R-top 
detection was conducted on the selected data window. Interbeat intervals were examined on the basis 
of the time between consecutive R-tops in the ECG. Interbeat intervals were used to calculate mean HR 
for the selected period. We performed spectral analysis using discrete Fourier transformation, based on 
non-equidistant sampling of the R-wave indices (Van Steenis, Tulen, Mulder, 1994). We calculated high 
frequency heart rate variability as a proxy for the parasympathetic component of autonomic cardiac 
control. As this indicator of autonomic cardiac control is dependent on respiratory frequency, which is 
much higher in infants, we adjusted the upper bound of the high frequency power band according to 
recommendations from literature (Bar-Haim, Marshall, Fox, 2000). We defined our high frequency 
power band between 0.15 Hz - 1.04 Hz. Time segments with more spectral power for respiration in the 
mid frequency band than in in high frequency band were discarded from heart rate variability analyses. 
This resulted in the removal of 2 subjects for the respective analyses. 
 
Maternal report of child behavior 
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We used the Child Behavior Checklist/1½–5 (CBCL), a parent questionnaire for assessing behavioral and 
emotional problems in children. This version was also chosen at follow-up because of the age range (5.1-
8.3 years). The CBCL has good reliability and validity (Achenbach, Rescorla, 2000). At follow-up, the 
mother rated the child’s emotional and behavioral problems over the preceding 2 months on a 3-point 
rating scale. Higher scores indicate more problems. For most of the children (N=433) CBCL 
questionnaires at 18 months of age were available to adjust for pre-existing problems at baseline. In the 
current study, we used the broadband Internalizing symptom score, the internalizing syndrome 
subscales Anxious/Depressed and Withdrawn, as well as the broadband Externalizing symptom score, 
and the externalizing syndrome subscales Aggressive Behavior and Attention Problems. 
 
Covariates 
Gender of the child, gestational age, weight at birth, age of the infant at physiological measurement, 
maternal age, smoking and drinking behavior during pregnancy, and level of highest completed 
education by the mother were studied as covariates, based on previous reports (Dierckx et al., 2014). 
Gestational age at birth and birth weight were obtained from community midwife and hospital registries 
at birth. Information on maternal smoking, maternal drinking, and highest completed education by the 
mother, were obtained during pregnancy by questionnaire. The Dutch Standard Classification of 
Education was used to define three categories of education: higher education phase 2 (university 
degree), higher education phase 1 (higher vocational training, Bachelor’s degree) and secondary 
education or lower. 
 
Statistical analyses 
The physiological variable heart rate variability was log-transformed to achieve a normal distribution. 
Box plots were used to identify outliers for heart rate and heart rate variability. This resulted in the 
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removal of one subject for the heart rate variability analyses. Pearson correlations were calculated to 
test the relations between predictor and outcome variables. Paired-samples T-tests were used to 
compare the mean scale and subscale scores of the CBCL at baseline with the mean scale and subscale 
scores of the CBCL at follow-up. 
To investigate the association of heart rate and heart rate variability with emotional or 
behavioral problems, we performed a series of regression analyses. All regression analyses were 
adjusted for maternal age, maternal smoking and drinking behavior during pregnancy, maternal highest 
completed education, child gender, gestational age, weight at birth and age at physiological 
measurement. In these analyses, we assessed multicollinearity by examining tolerance and the variance 
inflation factor. None of our analyses showed a tolerance below .2 or a variance inflation factor above 
2.5. 
First, we performed separate linear regression analyses with heart rate as the independent 
variable and the Internalizing symptom score, the Anxious/depressed problem score, or the Withdrawn 
problem score at follow-up as dependent variables. In this model of symptom change, we adjusted the 
analyses for the baseline Internalizing symptom score. 
Second, we repeated these analyses with the Externalizing symptom score, the Aggressive 
Behavior symptom score, and the Attention Problems score at follow-up as dependent variables 
corrected for the baseline Externalizing symptom score. 
Third, we tested the specificity of infant heart rate and heart rate variability as predictors for the 
Internalizing symptom score or subscale scores and the Externalizing symptom score or subscale scores 
at follow-up, respectively, by mutually adjusting the broadband scales. 
Fourth, we tested the robustness of significant results of the observed associations using logistic 
regressions. To this aim, we dichotomized follow-up CBCL scores at the 80th percentile score for each 
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scale as a cut-off to classify children as having problems, in line with previous publications of this cohort 
(e.g. Velders et al. (2011)). 
For the linear regression analyses effect sizes are reported as delta R squared, with .01 defined 
as a small effect size, .09 as a medium effect size and .25 as a large effect size (Cohen, 1988). All analyses 
were performed using SPSS 21.0 for Windows. 
 
Multiple imputation 
Multiple imputation was used to account for missing values in covariates and the CBCL at 18 months. 
Missing values in psychophysiological measures and the CBCL at follow-up were not imputed. Missing 
values ranged from 0% for gender to 7.3 % for the baseline Internalizing symptom score. Descriptives of 
original, non-imputed, data are presented in Table 1. To impute the missing values we included all 
covariates, psychophysiological measures and outcome measures as predictors in the multiple 
imputation models. The presented data are pooled estimates from 30 imputed datasets. 
 
Non-response analysis 
Children with missing data on the CBCL at follow-up (N=64) were compared with children for whom 
these data were available (N=464). Data was more frequently missing in children with a lower 
gestational age at birth (p<.001), a lower weight at birth (p<.001), whose mothers were younger (p<.01), 
and whose mothers were of lower education (p<.01). 
 
RESULTS 
 
Sample characteristics 
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Table 1 presents the baseline characteristics and child behavior scale scores at follow-up. The scores on 
the CBCL at baseline differed from the scores at 6 years: on average, internalizing scale scores of the 
CBCL increased, whereas externalizing scale scores decreased. The percentage of children with a CBCL 
subscale score in the clinical range varied from .5 to 2.3 %, as expected in a population based study. An 
overview of the correlations between predictor and outcome variables is presented in Supplementary 
Table 1. 
 
The relation of infant physiology with internalizing problems during follow-up 
Table 2 presents the longitudinal associations of infant resting heart rate and heart rate variability with 
the child CBCL Internalizing symptom score and the subscale scores at follow-up. In a fully adjusted 
model, we observed a positive association of infant heart rate with the child Internalizing symptom 
score at follow-up, which given the baseline adjustment, we interpret as change. A higher infant heart 
rate was associated with a stronger increase in Internalizing symptom and Anxious/depressed problem 
scores during follow-up. In addition, we observed a negative longitudinal association of infant heart rate 
variability with the child Anxious/depressed problem score. A lower infant heart rate variability was 
associated with a stronger increase of Anxious/depressed problem scores during follow-up. There was 
no longitudinal association between infant heart rate or heart rate variability and the Withdrawn 
problem score during follow-up. 
To facilitate clinical interpretation, we also modelled our outcome dichotomously. The logistic 
regression analyses were consistent and indicate that our results were not caused by a skewed 
distribution of the outcome measures. 
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Table 1. Characteristics of the study population 
 Original, non-imputed data 
 N Mean (SD)a 
Maternal education 461 3.97 (.99) 
 Secondary education or lower (%)  33.9 
 Higher education, phase 1 (%)  27.1 
 Higher education, phase 2 (%)  39.0 
Maternal age at intake, years (SD) 464 32.0 (3.7) 
Maternal smoking during pregnancy 436 1.32 (.67) 
 Never smoked during pregnancy (%)  79.8 
 Smoked until pregnancy was known (%)  8.5 
 Continued smoking in pregnancy (%)  11.7 
Maternal alcohol during pregnancy 432 2.26 (.89) 
 Never used alcohol in pregnancy (%)  30.3 
 Used alcohol until pregnancy was known (%)  13.7 
 Alcohol use continued in pregnancy (%)  56.0 
Child gender, male (%) 464 50% 
Weight at birth, grams  464 3542 (528) 
Gestational age at birth, weeks  464 40.1 (1.7) 
Age child at physiological assessment, months  458 14.5 (.6) 
Age child at follow-up, months  464 71.2 (3.1) 
Heart rate, bpm  464 124.0 (10.7) 
High frequency heart rate variability, ms2  461 2.86 (.42) 
CBCL Internalizing symptom score at baseline  430 3.96 (3.3) 
CBCL Anxious/depressed problem score at baseline 432 .83 (1.0) 
CBCL Withdrawn problem score at baseline 433 .52 (.78) 
CBCL Externalizing symptom score at baseline 432 9.81 (6.4) 
CBCL Aggressive behavior symptom score at baseline 432 7.89 (5.1) 
CBCL Attention Problem score at baseline 433 1.92 (1.8) 
CBCL Internalizing symptom score at follow-up  464 4.74 (4.5)*** 
CBCL Anxious/depressed problem score at follow-up 464 1.11 (1.4)*** 
CBCL Withdrawn problem score at follow-up 464 .97 (1.2)*** 
CBCL Externalizing symptom score at follow-up 464 6.55 (5.9)*** 
CBCL Aggressive behavior symptom score at follow-up 464 5.97 (4.9)*** 
CBCL Attention Problem score at follow-up 463 1.36 (1.6)*** 
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Note. a=presented are mean and standard deviation, unless otherwise indicated, SD= standard deviation, ***= CBCL 
score at follow up differed from the same score at baseline with p<.001. 
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Table 2. Infant mean heart rate and heart rate variability as predictors of internalizing behavior during follow-up reported by the mother 
 
Note. Beta=standardized Beta, B= unstandardized Beta, 95%CI= 95% confidence interval for B, R2 change= R2 for adding heart rate or heart rate variability to the 
model. R2 change is based on original complete cases. All analyses were corrected for internalizing behavior at baseline, gestational age, weight at birth, age at 
physiological measurement, gender, maternal age at birth, maternal smoking and alcohol consumption during pregnancy, and maternal education. 
  Internalizing symptom score   Anxious/depressed problem score   Withdrawn problem score 
 Beta B 95% CI R2change p  Beta B 95% CI R2 change p  Beta B 95% CI R2 change p 
Heart rate (N=464) .10 .046 .01, .08 .012 .011  .14 .021 .01, .03 .024 .000  .04 .005 -.005, .02 .002 .32 
Heart rate variability (N=461) -.05 -.55 -1.46, .37 .005 .24  -.10 -.39 -.68, -.11 .017 .007  -.03 -.09 -.34, .16 .001 .50 
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The relation of infant physiology with externalizing problems during follow-up 
Table 3 presents the longitudinal associations of infant resting heart rate and heart rate variability with 
the child CBCL broadband Externalizing symptom score and the subscale scores. Overall, there were no 
clear associations between infant heart rate and heart rate variability and change of the externalizing 
problems during follow-up, although heart rate variability showed a positive longitudinal association 
with the Attention Problem score during follow-up. 
 
The relation of infant physiology with internalizing and externalizing problems during follow-
up, mutually adjusted 
We tested the specificity of infant heart rate and heart rate variability as predictors for the Internalizing 
symptom score or subscale scores and the Externalizing symptom score or subscale scores at follow-up, 
respectively, by mutually adjusting the broadband scales (Table 4). The addition of the broadband 
Externalizing symptom score to the fully adjusted model clearly strengthened the longitudinal 
associations of infant heart rate and heart rate variability with change of child Internalizing symptom 
and Anxious/depressed problem scores. 
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Table 3. Infant mean heart rate and heart rate variability as predictors of externalizing behavior during follow-up reported by the mother 
 
 
Note. Beta=standardized Beta, B= unstandardized Beta, 95%CI= 95% confidence interval for B, R2 change= R2 for adding heart rate or heart rate variability to the 
model. R2 change is based on original complete cases. All analyses were corrected for externalizing behavior at baseline, gestational age, weight at birth, age at 
physiological measurement, gender, maternal age at birth, maternal smoking and alcohol consumption during pregnancy, and maternal education. #=analyses 
with attentional problems as outcome variable had N=463 for heart rate analyses and N=460 for heart rate variability analyses. 
  Externalizing symptom score   Aggressive Behavior symptom score   Attention Problem score# 
 Beta B 95% CI R2 change p  Beta B 95% CI R2 change p  Beta B 95% CI R2 change p 
Heart rate (N=464) -.02 -.011 -.06, .04 .002 .65  -.01 -.004 -.04, .04 .001 .84  -.05 -.007 -.02, 006 .004 .27 
Heart rate variability (N=461) .08 1.16 -.03, 2.36 .006 .057  .06 .79 -.21, 1.78 .005 .12  .10 .38 .05, .70 .006 .024 
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Also, clear longitudinal associations of infant heart rate and heart rate variability with the Externalizing 
symptom and subscale scores emerged when accounting for the concurrent level of internalizing 
symptoms. Lower infant heart rate was associated with a less strong decrease of the child Externalizing 
symptom, Aggressive Behavior and Attention Problem scores at follow-up. Similarly, higher infant heart 
rate variability was associated with a less strong decrease of child Externalizing symptom, Aggressive 
Behavior and Attention Problem scores at follow-up. The logistic regression analyses showed consistent 
associations. The results of these analyses are presented in Supplementary Table 2. 
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Table 4. Infant mean heart rate and heart rate variability as predictors of internalizing and externalizing behavior during follow-up reported by 
the mother, mutually adjusted 
 
Note. Beta=standardized Beta, B= unstandardized Beta, 95%CI= 95% confidence interval for B, R2 change= R2 for adding heart rate or heart rate variability to the 
model. R2 change is based on original complete cases. All analyses were corrected for in-or externalizing behavior at baseline, gestational age, weight at birth, age 
at physiological measurement, gender, maternal age at birth, maternal smoking and alcohol consumption during pregnancy, and maternal education. The 
analyses were additionally adjuted for externalizing behavior at 6 years when the broadband Internalizing symptom score and the internalizing subscale scores 
were entered as outcome, and additionally adjusted for internalizing behavior at 6 years when the broadband Externalizing symptom score and the 
externalizing subscale scores were entered as outcome. #=analyses with attentional problems as outcome variable had N=463 for heart rate analyses and 
N=460 for heart rate variability analyses. 
 
 
 
  Internalizing symptom score   Anxious/depressed problem score   Withdrawn pro   
 Beta  B 95% CI R2 change p  Beta B 95% CI R2 change p  Beta B 95% CI    
Heart rate (N=464) .12 .053 .03, .08 .019 .000  .15 .022 .01, .03 .031 .000  .06 .006 -.002, .02   
Heart rate variability (N=461) -.09 -1.12 -1.84, -.39 .015 .003  -.13 -.51 -.77, -.24 .028 .000  -.07 -.20 -.43, .02   
  Externalizing symptom score   Aggressive Behavior symptom score   Attention Prob   
 Beta B 95% CI R2 change p  Beta B 95% CI R2 change p  Beta B 95% CI    
Heart rate (N=464) -.09 -.049 -.09, -.01 .011 .013  -.08 -.036 -.07, -.004 .009 .026  -.09 -.013 -.025, -.001   
Heart rate variability (N=461) .11 1.67 .70, 2.64 .016 .001  .10 1.22 .42, 2.01 .014 .003  .12 .46 .15, .76   
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Principal findings 
In this large general population cohort, lower infant heart rate was associated with a less strong 
decrease of childhood externalizing problems, whereas higher infant heart rate was associated with a 
stronger increase of internalizing problems. Moreover, heart rate variability results were consistent. 
Our study emphasizes the importance of using a longitudinal design over a developmental 
sensitive period when studying early risk factors for the continuity of problems among preschool 
children. The mutual adjustment for internalizing and externalizing problems in our analyses created 
statistically homogeneous phenotypes, which enabled us to study the specificity of autonomic arousal as 
a predictor for change of internalizing or externalizing problems at follow-up in a large non-
homogeneous general population sample of children in which co-occurrence of internalizing and 
externalizing problems was high. 
Previous studies suggest that low heart rate may be a static genetically determined marker for 
later antisocial behavior (Ortiz, Raine, 2004). Our study suggests that both infant resting heart rate and 
heart rate variability are vulnerability factors for the later development of problem behavior. One could 
hypothesize that both ends of the extremes, namely physiological under- and overarousal, predisposes 
individuals to behavior to create homeostasis. Homeostatic mechanisms may lead underaroused 
individuals to engage in stimulation seeking or risky behaviors, while overaroused individuals avoid 
situations that are perceived as threatening or fearful as means of bringing their autonomic activity to 
more desirable optimal levels. 
In a previous study in this sample a higher heart rate in infants predicted a higher 
Anxious/depressed problem score at the age of 3 years, but there was no association with the 
Aggressive Behavior problem score or the Attention Problem score at 18 months or 3 years (Dierckx et 
al., 2011; Dierckx et al., 2014). Explanations for the differences in results compared to the current study 
might lie in the developmental pathways of internalizing and externalizing problems. First, externalizing 
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problems tend to decrease beyond toddler age, while pure internalizing problems have a low prevalence 
at toddler age, but become more prevalent with increasing age (Gilliom, Shaw, 2004). Using latent 
profile analysis, the study by Basten et al. (2016) showed that a profile with predominantly internalizing 
problems was only discernible at 6 years, while at earlier ages internalizing problems were less 
prevalent, mild and typically accompanied by at least mild levels of externalizing problems. In contrast, a 
profile characterized by moderate externalizing problems and emotionally-reactive behavior was visible 
at all ages, but the prevalence of this profile was higher in infancy than in early childhood. Therefore, 
higher scores for externalizing problems are less common and arguably more deviant with increasing 
age. One could hypothesize that low autonomic arousal is a marker for more deviant externalizing 
problems that become more apparent in childhood. Second, at a younger age, externalizing behavior is 
most often reactive, triggered on impulse and by strong emotions, while proactive, planned aggression, 
which is often accompanied by low levels of emotional reactivity, develops later in life (Dierckx et al., 
2014). In a cross-sectional study in school-aged children an increased resting heart rate variability was 
associated with pro-active aggression (Scarpa, Haden, Tanaka, 2010). Possibly, low autonomic arousal is 
a marker of pro-active, planned aggression which develops later in life and showed no association with 
the highly prevalent emotional reactive externalizing behavior seen infants and toddlers, while high 
autonomic arousal is a marker of early and persistent internalizing problems. 
Interestingly, although part of the Internalizing problem scale of the CBCL/1½–5, the child 
Withdrawn problem score was not longitudinally associated with infant resting heart rate or heart rate 
variability. The Withdrawn problem score predicts not only internalizing problem behavior, but has 
consistently been associated with autism spectrum problems (Ooi et al., 2014) and consists of items that 
measure unresponsive and withdrawn behavior (Achenbach, Rescorla, 2000). Possibly, this type of 
behavior is not specifically predicted by autonomic under- or overarousal. 
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Strengths and limitations 
This study has several methodological advances including the longitudinal design, the large population 
based sample, and the consideration of the co-occurrence of internalizing and externalizing problems in 
our statistical analyses. The measurement of autonomic functioning in infancy before the longitudinal 
assessment of internalizing and externalizing problems correcting for baseline decreases the possibility 
of reverse causation. 
Some methodological issues need to be discussed. First, in the present study we used only 
maternal report for the assessment of problem behavior. However, a recent study by Ivanova et al. 
(2010) showed that parents are sufficiently capable of objectively rating their children’s problem 
behavior using the CBCL/1½–5. In addition, although the outcome parameters were assessed with 
parent-report measures, all predictors were objective biological measures, hence there is no risk of 
shared method variance bias. Second, the Generation R Focus Cohort is ethnically homogeneous to rule 
out confounding and effect modification by ethnicity, which as a consequence limits the generalizability 
of our results to other ethnic populations. Third, although the participation rate in the present study was 
high (78%), there is a possibility of selection bias as the non-respondents had younger mothers, and 
mothers with a lower level of education. Finally, although our results show a consistent pattern of 
associations in the hypothesized directions based on previous literature, which makes the possibility of 
false positive results less plausible, given the number of performed statistical analyses the possibility of 
false positive results should be considered. 
 
CONCLUSIONS 
 
The present study suggests that low autonomic arousal is a marker for the development of more 
deviant, externalizing problems during childhood and shows less association with the highly prevalent 
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emotional reactive externalizing behavior seen in infants and toddlers, while high autonomic arousal 
might be a marker of early and persistent internalizing problems. Future studies may benefit from 
measures of externalizing problems that discern proactive, planned aggression and low emotional 
reactivity from more impulsive, reactive aggression accompanied by high levels of emotional reactivity. 
In conclusion, our study shows that both infant heart rate and heart rate variability function as 
antagonistic predictors of early childhood internalizing and externalizing problems. In studying early risk 
factors for the continuity of problems among preschool children, we emphasize the importance of 
considering developmental changes in and the co-occurrence of internalizing and externalizing 
problems, because biomarkers that increase one type of problem behavior and decrease the other, such 
as autonomic functioning, might remain undetected when internalizing and externalizing problems are 
not disentangled. 
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SUPPLEMENTARY MATERIAL 
Supplementary Table 1. Pearson’s correlations between predictor and outcome variables 
 
Variables                                        N=464 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15.   
    
1.Maternal age at intake                  
2.Maternal education  .24**                 
3.Maternal smoking during pregnancy  .02 -.18**                
4.Maternal alcohol use during pregnancy  .22**  .28**  .04               
5.Child gender  .04  .03 -.03 -.04              
6. Age child at physiological assessment  .02  .12* -.05  .14** -.01             
7.Gestational age at birth  .04  .11*  .03  .10* -.05  .04            
8.Weight at birth  .01  .04 -.09 -.00 -.09* -.02  .56**           
9.Heart rate  .06 -.01  .01  .05  .02 -.06 -.08 -.09          
10.Heart rate variability  .00 -.02  .01 -.03  .07  .04  .03  .04 -.66**         
11.CBCL Internalizing baseline -.05  .00  .04  .06 -.03  .01 -.05  .02  .00 -.03        
12.CBCL Externalizing baseline -.10* -.03  .06  .07 -.18** -.02 -.03  .01 -.03 .00 .56**       
    
13.CBCL Internalizing follow-up -.14** -.04  .06 -.06 -.10*  .02 -.05 -.05  .10* -.07 .35** .30**      
14.CBCL Anxious/depressed follow-up -.15** -.05  .07 -.07 -.02  .02 -.09 -.06  .15** -.12** .36** .25** .80**     
15.CBCL Withdrawn follow-up -.09 -.05  .01 -.04 -.15**  .04 -.08 -.09*  .04 -.05 .26** .21** .69** .47**    
16.CBCL Externalizing follow-up -.10* -.08  .06  .00 -.18**  .03 -.07 -.01 -.03 .07 .21** .34** .63** .42** .48**   
17.CBCL Aggressive Behavior follow-up -.07 -.04  .05  .01 -.14**  .03 -.06  .01 -.02 .06 .21** .34** .63** .42** .47**   
18.CBCL Attention Problems follow-up -.16** -.15**  .07 -.02 -.22**  .00 -.09* -.05 -.06 .09 .12** .21** .38** .26** .35**   
Note. Pearson’s correlations are calculated with imputed data,* p<.05, **p<.01 (2-tailed). 
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Supplementary Table 2. Infant mean heart rate and heart rate variability as predictors of dichotomized 80th percentile scores of internalizing 
and externalizing behavior during follow-up reported by the mother, mutually adjusted 
 
 
 
 
Note. OR= Odd’s ratio, 95%CI= 95% confidence interval for OR. Predictors are standardized to facilitate the interpretation of the odd’s ratios. OR’s represent 
the odds of having a broadband In-/Externalizing symptom score or internalizing/externalizing subscale score in the highest 20th percentile when the predictor 
changes by a standard deviation. An OR of less than one indicates a negative association of the predictor with their odds of having a broadband In-
/Externalizing symptom score or internalizing/externalizing subscale score in the highest 20th percentile. An OR of more than one indicates a positive 
association of the predictor with their odds of having a broadband In-/Externalizing symptom score or internalizing/externalizing subscale score in the highest 
20th percentile. To facilitate the interpretation of the odd’s ratios, z-scores were calculated for continuous predictors. All analyses were corrected for in-or 
externalizing behavior at baseline, gestational age, weight at birth, age at physiological measurement, gender, maternal age at birth, maternal smoking and 
alcohol consumption during pregnancy, and maternal education. The analyses were additionally adjusted for externalizing behavior at 5 years when the 
broadband Internalizing scale and the subscales were entered as outcome, and additionally adjusted for internalizing behavior at 5 years when the broadband 
Externalizing scale and the subscales were entered as outcome. 
 
 Internalizing problems  Anxious/depressed problems  Withdrawn problems 
 OR 95% CI p  OR 95% CI p  OR 95% CI p 
Heart rate (N=464) 1.83 1.37, 2.44 .000  1.90 1.42, 2.54 .000  .94 .74; 1.19 .61 
Heart rate variability (N=461) .52 .39, .70 .000  .51 .38, .69 .000  .88 .70, 1.11 .27 
 Externalizing problems  Aggressive Behavior problems  Attention Problems 
 OR 95% CI p  OR 95% CI p  OR 95% CI p 
Heart rate (N=464) .65 .48, .89 .007  .74 .55, .99 .046  .78 .60, 1.01 .065 
Heart rate variability (N=461) 1.72 1.28, 2.33 .000  1.34 1.02, 1.77 .039  1.40 1.09, 1.80 .009 
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PART III 
Physiological stress activity in children with an anxiety disorder 
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Chapter 5 
Alterations in HPA-axis and autonomic nervous system functioning in childhood anxiety disorders point 
to a chronic stress hypothesis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dieleman, G.C., Huizink ,A.C., Tulen, J.H., Utens, E.M., Creemers, H.E., Van der Ende, J., & Verhulst, F.C. 
(2015). 
Psychoneuroendocrinology, 51, 135-150. 
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ABSTRACT 
 
Background: It is of debate whether or not childhood anxiety disorders (AD) can be captured by one 
taxonomic construct. This study examined whether perceived arousal (PA), autonomic nervous system 
(ANS) and hypothalamic-pituitary-adrenal (HPA) axis measures can distinguish children with different 
primary diagnoses of clinical anxiety disorders (AD) from each other, and from a general population 
reference group (GP). 
 
Methods: The study sample consisted of 152 AD children (comparing separation anxiety disorder, 
generalized anxiety disorder, social phobia and specific phobia), aged 8- to 12 years, and 225 same-aged 
reference children. HPA-axis functioning was measured by a diurnal cortisol profile. ANS functioning was 
measured by continuous measures of skin conductance level in rest and during a mental arithmetic task 
and high frequency heart rate variability in rest. PA was assessed by a questionnaire. 
 
Results: The AD sample showed lower high frequency heart rate variability during rest, heightened 
anticipatory PA, higher basal and reactive skin conductance levels and lower basal HPA-axis functioning 
compared to the GP sample. The existence of 3 or more clinical disorders, i.e. a high clinical ‘load’, was 
associated with lower basal HPA-axis functioning, higher skin conductance level and lower posttest PA. 
Specific phobia could be discerned from social phobia and separation anxiety disorder on higher skin 
conductance level. 
 
Conclusions: Our findings indicated that children with AD have specific psychophysiological 
characteristics, which resemble the psychophysiological characteristics of chronic stress. A high 
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clinical‘load’ is associated with an altered ANS and HPA-axis functioning. Overall, ANS and HPA-axis 
functioning relate to AD in general, accept for specific phobia. 
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INTRODUCTION 
 
Anxiety disorders (AD) are among the most prevalent psychiatric disorders in children and adolescents 
(e.g. Costello, Egger, Angold, 2005). They are associated with impaired functioning, such as school 
dropout, social isolation, alcoholism, and suicide attempts, and an increased risk for developing other 
psychiatric disorders (Bittner et al., 2007). Hence, research into causes and correlates of childhood 
anxiety disorders is imperative to improve treatment and prognosis for children affected by these 
disorders. 
A complicating issue is whether distinctions between separate anxiety disorders in children can 
be made. High comorbidity rates between AD have been reported (e.g. Beesdo, Knappe, Pine, 2009). 
This underlines the hypothesis of one taxonomic construct capturing childhood anxiety disorders. 
However, substantial heterogeneity exists in the age of onset of specific anxiety disorders (Beesdo et al., 
2010), providing, in terms of taxonomy, an indicator to separate different types of anxiety disorders 
(Beesdo, Knappe, Pine, 2009). Furthermore, age is also related to the clinical ‘load’; i.e. the number of 
anxiety disorders increases with age. Anxiety load is significantly associated with poorer outcome 
(Woodward, Fergusson, 2001). One could argue that the causes and correlates of a high anxiety ‘load’ 
may differ from those of a low anxiety ‘load’. 
One way to test the taxonomic construct of AD is to study the physiological correlates of 
childhood anxiety disorders, i.e., the activity of the hypothalamic-pituitary-adrenal (HPA) axis and the 
autonomic nervous system (ANS), two major physiological stress systems. During non-stress conditions 
the HPA-axis shows a diurnal pattern of cortisol secretion, with peak levels approximately 30 minutes 
after waking up and a subsequent decline during the day (Wust et al., 2000). Glucocorticoids can act 
both to augment and suppress sympathetically mediated changes in e.g. cardiovascular function, 
metabolism, and immune function. Normally, activation of these stress systems leads to behavioral and 
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physical adaptive changes that improve an organism’s ability to survive. However, children with an 
anxiety disorder may perceive the world as full of stressors that demand endless vigilance and coping, 
with no possibility to relax and to regard things as safe (Sapolsky, 2002). It can be hypothesized that 
these children function under conditions of persistent stress, with an excessive and prolonged stress 
system activation. This would result in increased and prolonged production of hypothalamic 
corticotropin releasing factor (CRF), cortisol and catecholamines (Pervanidou, 2008), which, in turn, 
could result in hypoactivation of the HPA-axis, as a compensatory down-regulation (Charmandari, 
Tsigos, Chrousos, 2005). 
Studies regarding the association between anxiety disorders and basal HPA-axis functioning in 
children are scarce and findings are inconclusive. Forbes et al. (2006) found higher peri-sleep-onset 
cortisol levels in children with an anxiety disorder compared to children with a depression or healthy 
control children, whereas Feder et al. (2004) found that anxious children exhibited significantly lower 
nighttime cortisol levels and a delayed rise in cortisol during the nighttime when compared to depressed 
and healthy children. In other studies no association was found (e.g. Terleph et al., 2006; Greaves-Lord 
et al., 2007; Dieleman et al., 2010). However, Greaves-Lord et al. (2007) reported that young 
adolescents with persistent anxiety problems had higher morning cortisol levels and a higher awakening 
response. 
Several problems may have contributed to the inconsistency of these findings. The groups under 
study were dissimilar in methods of sampling, age, developmental status, and diagnostic status. Some 
studies used general population samples (e.g. Greaves-Lord et al., 2007), whereas others focused on 
clinical groups (e.g. Forbes et al., 2006), which are likely to display major differences in symptom 
severity and comorbidity. Next to that, differences in functioning of the HPA-axis could depend on the 
stage of the disorder (Pervanidou, 2008). 
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Overall, research on ANS functioning in children with anxiety problems shows an increased 
activity of the sympathetic nervous system (e.g. Dietrich et al., 2007; Schmitz et al., 2011; Kossowsky et 
al., 2012) and a decrease of parasympathetic control (e.g. Schmitz et al., 2011). Furthermore, previous 
studies suggest that high anxious adults have an increased perception of physiological sensations (e.g. 
Hoehn-Saric, McLeod, 2000), i.e. increased perceived arousal, sometimes even in the absence of an 
actual difference in physiological measures (e.g. Edelmann, Baker, 2002). 
At present, it is still unclear as to what extent ANS or HPA-axis activity relate to anxiety in 
general, or whether they are specific correlates of the different types of anxiety disorders. Few studies 
have compared the endocrine and autonomic profiles between different pediatric anxiety disorders, and 
if so the focus was on one specific anxiety disorder with a disorder-specific stimulus (i.e. Kossowsky et 
al., 2012). To our knowledge this is the first study to test whether anxiety load is associated with altered 
HPA-axis and ANS functioning. 
The present study’s aim was to test whether HPA-axis (basal), ANS (basal and reactive) and 
perceived arousal (PA) measures can distinguish children (N=154) aged 8-12 years with different primary 
diagnoses (separation anxiety disorder (SAD), generalized anxiety disorder (GAD), social phobia (SoPh) 
and/or specific phobia (SpPh)) of clinical anxiety disorders (AD) from each other, and from a same-aged 
general population reference group (GP) (N=225). We hypothesized that children in the clinical anxiety 
sample show 1) elevated sympathetic and lowered parasympathetic activity compared to the general 
population sample. 2) Furthermore, we expected a pattern of hypoactivation of basal HPA-axis 
functioning, considering the severity and chronicity of perceived stress in a clinical AD sample, when 
compared to a general population reference group. 3) Within the AD sample we hypothesized that there 
would be no difference in activity of both ANS and HPA-axis between different types of anxiety 
disorders, because of the known high rates of comorbidity in childhood anxiety disorders. 4) Finally, we 
hypothesized that children with a high anxiety load in the clinical sample show hypoactivation of basal 
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HPA-axis functioning, have higher sympathetic functioning and lower parasympathetic functioning, and 
higher perceived arousal in rest and stress conditions when compared to children with a low anxiety 
load. 
 
METHODS 
 
Participants 
Eligible for participation in the clinical anxiety disorder group (AD) were N=152 children aged 8 to 12 
years diagnosed with a primary diagnosis of separation anxiety disorder (SAD; N=57), generalized 
anxiety disorder (GAD; N=47), social phobia (SoPh; N=29) or specific phobia (SpPh; N=19), who had been 
referred to the outpatient clinic of the department of Child and Adolescent Psychiatry of either Erasmus 
MC in Rotterdam or Curium-LUMC in Leiden, The Netherlands. All children were diagnosed with the 
Anxiety Disorders Interview Schedule for DSM-IV (ADIS-C; Silverman, Albano, 1996). 
The general population (GP) sample, consisting of 202 participants aged 8 to 12 years, was 
drawn from a larger general population sample study (Tick, Van der Ende, Verhulst, 2007). Study 
characteristics of the 2 groups are presented in Tables 1 and 2. All children were diagnosed with the 
Diagnostic Interview Schedule for Children-Parent version (DISC-P; Shaffer, Fisher, Lucas, 1998). 
Exclusion criteria for both the AD and GP group were: IQ < 85, poor command of the Dutch 
language, serious physical disease, pervasive developmental disorder, selective mutism, schizophrenia 
or other psychotic disorders, pharmacotherapy that could interfere with HPA-axis or ANS functioning or 
pharmacotherapy aimed at treating anxiety or depressive symptoms. Methylphenidate treatment in 
children with ADHD was discontinued the day before and on the day of measurements (AD N=7, GP 
N=6) because methylphenidate treatment can increase heart rate and blood pressure (Ballard et al., 
1976). 
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The Committees for Medical Ethics of Erasmus MC and LUMC approved the study. 
 
Procedure 
Parents and participants signed informed consent before participation. Prior to the physiological 
assessment, parents and children completed psychological questionnaires. To assess the diurnal cortisol 
profile, participants collected 4 saliva samples at home by filling tubes till a marker (at 500 µl): (1) a first 
sample immediately after awakening in the morning (Cort1), when the child was still in bed, (2) 30 
minutes later (Cort2), (3) at 12h (Cort3), and (4) at 20h (Cort4). All samples were collected on a single 
regular school day, stored in the freezer at home, and taken to the assessment at the outpatient 
department one day later. Parents were asked to register general physical condition, activity levels, 
consumption pattern, and medication use of their child. 
 The physiological assessment took place in the hospital between 12h and 1830h. Participants 
were seated comfortably in a laboratory room where temperature and humidity levels were kept 
constant. Lunch was eaten before the assessment; the gap between lunch and baseline saliva samples 
was at least 1.5 h. After an acclimatization period of 45 minutes, the session began with a baseline 
period of 10 minutes in which the participant was asked to sit still and relax. Subsequently, a mental 
arithmetic task (MAT) was administered. At the end of the baseline period and after the MAT, a 
questionnaire concerning physiological arousal (PAQ) was administered. A cortisol sample was collected 
after the baseline period (Cort5), to have a second basal cortisol measure next to the diurnal profile on a 
different day. 
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Figure 1 Procedure 
Note. Cort1-Cort2-Cort3-Cort4-Cort5 = Cortisol sample 1-5, SCL= Skin conductance level, MAT=Mental arithmetic 
task. 
 
Measures 
Assessment of diagnostic status and symptom severity 
Anxiety Disorders Interview Schedule for DSM-IV (AD-group) 
ADIS-C (Silverman, Saavedra, Pina, 2001) is a semi-structured interview to assess DSM-IV AD in 7- to 17-
year-olds. A trained psychologist conducted the interview with the child and parents separately. To 
obtain a diagnosis, both a symptom count of DSM-IV symptom criteria, as well as level of impairment 
according to the parent, child, and interviewer, are taken into account. 
 
Diagnostic Interview Schedule for Children-Parent version (GP group) 
The DISC-IV- P/C is a highly structured respondent-based psychiatric interview to assess DSM-IV 
disorders found in children. The DISC-IV-P showed good inter-rater and test-retest reliability (Shaffer, 
Fisher, Lucas, 1998; Shaffer et al., 2000). Last year’s diagnoses were calculated according to the DISC-IV-
P diagnostic algorithm. 
 
Child Behavior Checklist 
Day1 Regular school day Day2 Physiological assessment
Baseline 
10 minutes
Cort5
MAT
4 minutes
Cort1
Heart rate, respiratory rate, SCL
Cort4Cort2 Cort3
Wake-up
30 minutes 
after 
wake-up
12.00h 20.00h
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The CBCL is a parent questionnaire for assessing problems in 4- to 18-year-olds. It contains 120 items on 
behavioral or emotional problems during the past 6 months. The response format is 0 = not true, 1 = 
somewhat or sometimes true, and 2 = very true or often true. The good reliability and validity of the 
original version of the CBCL (Achenbach, Rescorla, 2001) were confirmed for the Dutch translation 
(Verhulst, Van der Ende, 2013). Scores on two broad-band scales were computed: Internalizing and 
Externalizing. 
 
Multidimensional Anxiety Scale for Children 
The MASC is a 39-item self-report questionnaire that assesses anxiety symptoms concerning the last two 
weeks in children. Items were scored from 0 to 3 (0 = never true, 1 = rarely true, 2 = sometimes true, 3 = 
often true). The internal consistency (.93) and test-retest reliabilities (.81) are very good (March et al., 
1997; Liber, 2008). 
 
Children’s Depression Inventory 
The CDI is a 27-item self-report questionnaire that assesses depressive symptoms concerning the last 
two weeks in children. Items are scored from 0 to 2 (0 = never true, 1 = sometimes true, 2 = always 
true). The internal consistency (.82) (Liber, 2008) and 1-month test-retest reliabilities (.72) are adequate 
(Kovacs, 1981). 
 
Stress task 
The Mental Arithmetic Task was applied as a standardized laboratory stress task to induce measurable 
physiological changes (Kirschbaum, Pirke, Hellhammer, 1993). The MAT lasted 4 min, during which the 
child was asked to subtract numbers as quickly and accurately as possible. If the child made a mistake or 
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did not respond, he or she was required to start all over again. Dependent on the child’s age, the child 
was asked to subtract 7 from 100 (<12 years), or 23 from 1021 (≥12 years), and so on. 
 
Physiological and hormonal measures 
Cortisol assessment 
The laboratory that analyzed our cortisol samples switched from solid-phase radioimmunoassay (RIA, 
Diagnostic Products Corporation, Los Angeles) to Enzyme-Linked Immuno Sorbent Assay (ELISA, DRG-
kits, Marburg, Germany) during data collection. Thirty-one cortisol samples were analyzed by both RIA 
and ELISA. Correlation between both assays was high (R=.994878). The slope was not equal to 1 so the 
concentrations in the DRG standards were adjusted by the laboratory to guarantee equal results. 
Cortisol samples of eighty-three children of the AD sample were analyzed by solid-phase 
radioimmunoassay (Kallen et al., 2008). An Enzyme-Linked Immuno Sorbent Assay (DRG Instruments 
GmbH, Marburg, Germany) was used to determine cortisol concentrations in 50 μl duplicate samples for 
the rest of the samples. For technical specifics see (Dieleman et al., 2010). Cortisol values that were 
above 3 SD of the mean were excluded from the analysis to reduce the impact of outliers. 
In addition to the separate cortisol variables, we used composite cortisol variables to analyze the diurnal 
profile. We calculated three composite measures according to Pruessner et al. (2003): cortisol 
awakening rise with respect to ground (CARg), with respect to increase (CARi) and the area under the 
curve with respect to ground (AUCg). The CARg and CARi were calculated using the following formulas: 
CARg = ((Cort1+Cort2) * timecort2-cort1)/2, CARi = CARg – (Cort1 * timecort2-cort1). The formula to calculate 
AUCg was: AUCg = AUCcort2-cort3+AUCcort3-cort4 = ((Cort2+Cort3) * timecort3-cort2)/2 + ((Cort3+Cort4) * time 
timecort4-cort3)/2. If one of the cortisol samples was missing, an area under the curve could not be 
calculated. Therefore for the GP group, N=13 CARg (6.4%), N=13 CARi (6.4 %) and N=25 AUCg (12.4%), for 
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the AD group, N=17 CARg (11.0%), N=21 CARi (13.6%) and N=16 AUCg (10.4%), were missing and 
excluded for those specific analyses. 
 
Autonomic measures 
During the experiment, continuous measurements were made of heart rate (Stratakis, Chrousos, 1995), 
respiration rate (RESP) and skin conductance level (SCL). HR was recorded using a 3-lead ECG, sampled 
at 512 Hz. SCL was used as a measure of the sympathetic function of the ANS and was assessed using 
two adhesive disposable active Ag/AgCl electrodes attached to the volar surfaces of the medial 
phalanges of the index and ring fingers of the non-dominant hand. SCL was sampled at 8 Hz, and stored 
in μS. RESP was measured using an inductive plethysmography method (belts containing a magnetic coil, 
Respitrace™, TEMEC Respiratory Inductive Plethysmography system; TEMEC Instruments B.V., Kerkrade, 
The Netherlands), sampled at 8 Hz. 
 
Physiological Arousal Questionnaire 
The PAQ is a 7-item self-report questionnaire developed at our department for assessment of the 
perceived state of physiological arousal. The child was asked to indicate on a 9-point scale (0-8) to what 
extent he or she felt aroused: 0 = not at all to 8 = very much. Cronbach’s alpha was .64 (during baseline), 
.81 (during stress). For a description in detail see Dieleman et al. (2010). 
 
Analysis of physiological data 
HRV during rest 
A customised software program calculated the interbeat intervals (IBI’s) of the ECG using R-top 
detection, resulting in IBI time series during rest (3 min period of stationary signal; minutes 7-10 of 
resting period). These time series were inspected and artifacts were removed. 
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The IBI time series during the 3 min period of rest was further subjected to a discrete Fourier transform, 
based on non-equidistant sampling of the R-wave incidences (CARSPAN program, Groningen, The 
Netherlands (Mulder et al., 1988; Van steenis, Tulen, Mulder, 1994), to yield power spectra of the 
rhythmic oscillations over a frequency range of 0.02–0.50 Hz, with a resolution of 0.01 Hz. For each time 
segment, the power was calculated for the high-frequency band (HF: 0.14-0.50 Hz), in addition to mean 
HR and respiration rate. HF HR variability is a commonly used proxy for the vagal component of 
autonomic cardiac control. Because the HF of HR variability is strongly correlated with respiratory sinus 
arrhythmia (Kamath, Fallen, 1993), respiratory frequency was monitored separately to control for this 
effect. Time segments with more spectral power for respiration in the MF band than in the HF band 
were discarded from HF HR variability analyses. This resulted in the removal of the observations of 3 
children from the GP group and 1 from the AD group. HF HR variability was not calculated during the 
MAT because of breathing irregularities as a consequence of speaking. 
 
Data Analysis 
All statistical analyses were performed with SPSS 20.0. For descriptive purposes, means and standard 
deviations were calculated based on untransformed variables. For further analyses, measures of SCL, 
Cort1-5, HF HR variability, perceived arousal, CDI Total score and scores on the internalizing and 
externalizing scales of the CBCL were log-transformed to approach a normal distribution. Subsequently, 
stress responses in perceived arousal and SCL were calculated as the level during the MAT minus the 
pretest level for each of these measures. Age, gender and BMI might confound the cortisol-
psychopathology relationship (e.g. see Rosmalen et al. (2005) for an overview). To control for possible 
effects of age, gender and BMI, these variables were entered as covariates. Effect sizes are reported as 
partial Eta squared, with .01 defined as a small effect size, .06 as a medium effect size and .14 as a large 
effect size (Cohen, 1988). 
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First, we investigated whether there was a difference between the AD and GP group in HPA-axis 
functioning using four two-way between groups ANCOVAs with sex and group as factors and age and 
BMI as covariates. The dependent variables were CARg, CARi, AUCg and Cort5 (after the baseline period). 
These analyses were repeated with the addition of the externalizing scale of the CBCL and the CDI Total 
score as covariates to control for the effects of comorbid behavior problems and depressive symptoms. 
Subsequently, a two-way MANCOVA with group and sex as factors, BMI and age as covariates, and 
Cort1-4 as dependent variables was conducted. 
Further, to analyze if there was a difference between the GP and AD group in autonomic 
functioning levels during rest, group differences in pretest levels (PAQ, HF HR variability and SCL) and in 
difference scores between pre- to post/during test levels (PAQ and SCL) corrected for pretest levels, 
were analyzed using ANCOVAs. All analyses were adjusted for age, gender, and BMI. These analyses 
were repeated with the addition of the externalizing scale of the CBCL and the CDI Total score as 
covariates to control for the effects of comorbid behavior problems and depressive symptoms. 
Third, to investigate if ‘anxiety load’ was associated with HPA-axis functioning and autonomic 
functioning, the AD group was subsequently divided into three groups: a group with one anxiety 
disorder, a group with two anxiety disorders and a group with three or more anxiety disorders. The 
analyses as described above for the comparison AD versus GP group were repeated for the comparison 
between the three groups with a different anxiety load. Posthoc comparisons tests were used to explore 
which of the three groups were significantly different from each other. 
Fourth, to investigate if ‘clinical load’, which takes comorbidity (Depression, Dysthymic disorder, 
ADHD, ODD and CD) into account as well, was associated with HPA-axis functioning and autonomic 
functioning, the AD group was subsequently divided into three groups: a group with one clinical 
disorder, a group with two clinical disorders and a group with three or more clinical disorders. The 
analyses as described above for the comparison AD versus GP group were repeated for the comparison 
P a g e  | 127 
 
between the three groups with a different clinical load. Posthoc comparisons tests were used to explore 
which of the three groups were significantly different from each other. 
Finally, in order to investigate whether different anxiety disorders have different endocrine or 
autonomic profiles the AD group was divided into four groups. Groups were based on the anxiety 
diagnosis with the highest severity score on the ADIS-C according to the clinician. This resulted in groups 
with, respectively, a main diagnosis of SAD, GAD, SoPh and SpPh. The analyses as described above for 
the comparison AD versus GP group were repeated for the comparison between the four groups with a 
different anxiety disorder. Posthoc comparisons tests were used to explore which of the four groups 
were significantly different from each other. 
 
  
P a g e  | 128 
 
RESULTS 
 
Table 1. Sample characteristics of AD and GP sample and comorbidity 
Diagnoses 
AD 
Main diagnosis ADIS-C /Count 
anxiety diagnosis ADIS-C 
N (% of total sample)/N 
GP 
Count anxiety diagnosis DISC-P 
N (% of total sample) 
GAD 47 (30.5)/75 0 (0) 
SoPh 29 (18.8)/49 2 (1.0) 
SAD 57 (37.0)/46 2 (1.0) 
SpPh 19 (12.3)/48 25 (12.4) 
PD - - 
OCD - - 
PTSD - - 
 
Other diagnosis ADIS-C 
 N (% of total sample) 
Other diagnosis DISC-P 
N (%) 
ADHD 15 (9.7) 17 (8.4) 
ODD 10 (6.5) 15 (7.4) 
CD 3 (1.9) 1 (0.5) 
DD 2 (1.3) - 
DysD 8 (5.2) - 
Note. GP = general population sample, AD = clinical anxiety disorder sample, SD = standard deviation, BMI = Body Mass Index, 
CBCLintern = Internalizing scale of Childhood Behavior Checklist, CBCLextern = Externalizing scale of Childhood Behavior Checklist, 
MASC = Multidimensional Anxiety Scale for Children, CDI = Children’s Depression Inventory, ADIS-C= Anxiety Disorders 
Interview Schedule for DSM-IV, DISC-P= Diagnostic Interview Schedule for Children-Parent version, GAD = generalized anxiety 
Measures 
AD (N=152) 
Mean (SD) 
GP (N=200) 
Mean (SD) 
Age 10.2 (1.5) 10.1 (1.5) 
Gender (♀, ♂) 46.8%, 53.2% 50%, 50% 
BMI 17.9 (4.9) 18.1 (3.2) 
CBCLintern*** 20.6 (9.0) 7.3 (5.8) 
CBCLextern*** 11.4 (7.9) 5.9 (5.9) 
MASC Total score*** 51.37 (17.72) 42.08 (14.09) 
CDI Total score*** 9.61 (7.04) 6.41 (5.49) 
No medication in last two 
months# 60.4% 73.8% 
Time of awakening 7.15 (0.5) 7.03 (0.85) 
Percentage menarche 7.1% of girls 5.9% of girls 
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disorder, SoPh = social phobia, SAD = separation anxiety disorder, SpPh = specific phobia, PD = panic disorder, OCD = obsessive 
compulsive disorder, PTSD = posttraumatic stress disorder, ADHD = attention deficit hyperkinetic disorder, ODD = oppositional 
defiant disorder, CD = conduct disorder, DD = depressive disorder, DysD = dysthymic disorder. *= p<.05, **=p<.01, ***=p<.001. 
# For specification of medication use in the last two months see supplementary Figure 1. 
 
Sample characteristics (see Tables 1-3) 
Scores on the internalizing and externalizing scale of the CBCL, the CDI Total score and MASC Total score 
were significantly higher in the AD group compared to the GP group. Correlations between psychiatric 
and physiological measures are presented in Tables 2 and 3. MASC Total score is significantly negatively 
correlated with CARi; high levels on the MASC Total score are associated with a low CARi in the AD 
group. 
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Table 2. Pearson correlations between physiologic and psychiatric measures in the anxiety disorder group 
 MASC 
total 
Score  
CDI 
total 
score 
CBCL 
internalizing 
scale 
CBCL 
externalizing 
scale 
CARg CARi AUCg HF HR SCL 
baseline 
SCL 
during 
test 
MASC Total Score  1 .419** .191** .002 -.01 -.189* -.025 -.066 -.095 -.036 
CDI Total score   1 .297** .235** -.026 -.137 -.074 -.103 -.020  .034 
CBCL internalizing scale    1 .498**  .086  .016 -.078 -.043 -.004  .041 
CBCL externalizing scale     1  .048 -.052 -.160 -.060  .124  .172* 
CARg       1  .164  .400** -.012  .064  .071 
CARi        1  .149 -.032 -.043  .006 
AUCg         1  .071 -.146 -.142 
HF HR          1 -.100 -.127 
SCL baseline          1  .923** 
SCL during test            1 
Note. CBCL internalizing = Internalizing scale of Childhood Behavior Checklist, CBCL externalzing = Externalizing scale of Childhood Behavior Checklist, MASC = 
Multidimensional Anxiety Scale for Children, CDI = Children’s Depression Inventory, CARg = cortisol awakening rise with respect to ground, CARi = cortisol 
awakening rise with respect to increase, AUCg = area under the curve for Cort2-Cort4 with respect to ground, SCL = skin conductance level, HF HR= high 
frequency heart rate variability,*= p<.05, **=p<.01. 
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Table 3. Pearson correlations between physiologic and psychiatric measures in the general population group 
 MASC 
total 
Score  
CDI 
total 
score 
CBCL 
internalizing 
scale 
CBCL 
externalizing 
scale 
CARg CARi AUCg HF HR SCL 
baseline 
SCL 
during 
test 
MASC Total Score  1 .468** .412** .223** -.03 -.123 -.015 -.012  .024 -.052 
CDI Total score   1 .469** .429** -.010  .109  .070  .055 -.012 -.022 
CBCL internalizing scale    1 .545**  .053  .097  .118 -.023 -.113 -.096 
CBCL externalizing scale     1 -.042  .126 -.038 -.038  .003  .011 
CARg      1  .096  .574** -.063 -.056 -.103 
CARi        1  .207**  .002  .065 -.009 
AUCg         1  .033 -.095 -.031 
HF HR          1 -.088 -.058 
SCL baseline        ¤    1  .836** 
SCL during test            1 
Note. CBCL internalizing = Internalizing scale of Childhood Behavior Checklist, CBCL externalzing = Externalizing scale of Childhood Behavior Checklist, MASC = Multidimensional 
Anxiety Scale for Children, CDI = Children’s Depression Inventory, CARg = cortisol awakening rise with respect to ground, CARi = cortisol awakening rise with respect to increase, 
AUCg = area under the curve for Cort2-Cort4 with respect to ground, SCL = skin conductance level, HF HR= high frequency heart rate variability,*= p<.05, **=p<.01 
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Daytime cortisol measures (see Table 4) 
Both the AD and GP group included several subjects with negative values for CARi (GP: 24.8%, AD 
21.4%). There were no differences in cortisol awakening measures between both groups. CARg was 
lower for boys (mean=7.66, SD=2.12) compared to girls (mean=8.46, SD=2.21) (F=7.31(1, 288), p<.01, 
partial Eta squared=.025 (small)). 
For AUCg, there was a highly significant between groups difference (see Figure 2). The difference 
in AUCg between the AD group and the GP group was determined by lower values of Cort3 and Cort4 
(see Table 4) for the AD group. The same pattern was seen for baseline cortisol levels preceding the 
stress task. These results remained significant after correcting for externalizing behavior and depressive 
symptoms. Effect sizes varied between medium to large effects (partial Eta squared .11-.25). 
To check that our significant results were not due to medication effects, we did a secondary 
analysis only for children that did not use any medication. Results indicated that our findings were not 
influenced by the use of medication. 
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Figure 2. Cortisol diurnal profile 
Note. GP = general population group, AD = anxiety disorder group, Cort1 = cortisol directly after awakening, Cort2 
= cortisol half an hour after awakening, Cort3 = cortisol at 12.00 p.m., Cort4 = cortisol at 8.00 p.m. 
 
Baseline and stress response measures of perceived arousal and autonomic functioning 
The MAT elicited a significant increase in PAQ Total score in the GP group (T= 5.66, p<.001), thus 
reflecting a perceived physiological stress response. At pretest, the AD group had significantly higher 
levels of perceived arousal and SCL, and lower levels of HF HR variability when compared to controls 
(see Table 4). During the stress task, AD children had a higher difference in SCL when compared to 
controls. SCL during stress was significantly higher in the AD group (see Figure 3). These results 
remained significant after correcting for externalizing and depressive symptoms. Effect sizes varied 
between .01-.16, with medium to large effects for SCL and small effects for perceived arousal and HF HR 
variability. 
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Table 4. Means, as well as group differences in baseline HPA measures and in baseline and reactive autonomic and perceived arousal measures 
  
AD group 
Mean (SD-N) 
GP group 
Mean (SD-N) 
Group differences# 
((M)ANCOVA'S//partial 
Eta squared) 
Group differences## 
((M)ANCOVA'S//partial Eta 
squared) 
Group differences###  
((M)ANCOVA'S//partial 
Eta squared) Variable 
CARi .84 (1.90-117) .69 (1.44-184) ns ns ns 
CARg 7.86 (2.44-116) 8.11 (2.04-184) ns ns ns 
AUCg 87.7 (28.9-111) 119.1 (31.7-172) F(1,277) = 67.95***//.20 F(1,271) = 48.34***//.15 F(1, 268)=57.49*** 
Cort1-4   F(1,274) = 22.88***//.25 F(1,268) = 15.73***//.19 F(1,265) = 19.06***//.22 
Cort1(nmol/l) 13.95 (5.14) 14.91 (4.84) ns ns ns 
Cort2(nmol/l) 17.91 (6.58) 17.52 (5.26) ns ns ns 
Cort3(nmol/l) 5.67 (2.73) 8.73 (2.95) F(1,274) = 56.62***//.17 F(1,271) = 36.15***//.12 F(1,268) = 44.31***//.14 
Cort4(nmol/l) 3.07 (3.00) 6.37 (2.82) F(1,274) = 85.95***//.24 F(1,271) = 59.20***//.18 F(1,268) = 72.28***//.21 
Cort5(nmol/l) 5.74 (4.24-120) 7.76 (2.56-191) F(1,305) = 46.02***//.13 F(1,298) = 36.86***//.11 F(1,295) = 37.33***//.11 
PAQ pretest .88 (.34-146) .76 (.35-198) F(1,339) = 9.01**//.03 F(1,332) = 6.82*//.02 ns 
PAQ posttest .92 (.33-147) .87 (.36-199) ns ns ns 
PAQ diff .04 (.23-145) .11 (.28-198) ns ns ns 
SCL (μS) baseline .54 (.26-121) .39 (.16-193) F(1,308) = 37.26***//.11 F(1,301) = 31.40***//.09 F(1,301) = 31.40***//.09 
SCL (μS) during test .67 (.27-120) .48 (.15-189) F (1,303)=55.0***//.15 F (1,296)=43.68***//.13 F (1,294)=48.06***//.14 
SCL (μS) diff .13 (.10-119) .09 (.09-189) F(1,301)=17.46***//.06 F(1,294)=12.62***//.04 F(1,292)=14.15***//.05 
HF HR 3.40 (0.42-119) 3.57 (0.42-192) F(1,305) = 10.78**//.03 F(1,298) = 7.11**//.02 F(1,298) = 10.24**//.03 
 
Note. SD = standard deviation, GP = general population group, AD = anxiety disorder group, Cort1 = cortisol directly after awakening, Cort2 = cortisol half an 
hour after awakening, Cort3 = cortisol at 12.00 p.m., Cort4 = cortisol at 8.00 p.m., Cort5 = cortisol during baseline, CARg = cortisol awakening rise with respect 
to ground, CARi = cortisol awakening rise with respect to increase, AUCg = area under the curve for Cort2-Cort4 with respect to ground. SCL = skin conductance 
level, HF HR= high frequency heart rate variability, PAQ = Perceived Arousal Questionnaire. #covariates: age, sex, bmi. ## covariates: age, sex, bmi, CBCL 
externalizing behavior, ### covariates: age, sex, bmi, CDI Total score. *= p<.05, **=p<.01, ***=p<.001. 
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To check that our significant results were not due to medication effects, we did a secondary analysis 
only for children that did not use any medication. Results indicated that our findings were not 
influenced by the use of medication. 
 
Comorbidity 
As shown in Table 5 comorbidity rates are high; 55.3% had a single clinical anxiety disorder, 30.9% had 
two clinical anxiety disorders, 11.8% had three clinical anxiety disorders and 2.0% had four clinical 
anxiety disorders. In the group with a main diagnosis of SAD the proportion of children with three or 
more clinical anxiety disorders was relatively high. SpPh is more often a comorbid than a main diagnosis, 
whereas SAD is more often a main than a comorbid diagnosis. One third of children with a main 
diagnosis of SoPh have a comorbid diagnosis of GAD. 
 
 
Figure 3. Skin conductance levels, baseline and during test 
Note. GP = general population group, AD = anxiety disorder group, Cort1 = cortisol directly after awakening, SCL = 
skin conductance level. 
 
Anxiety ‘load’ versus daytime cortisol, autonomic measures and perceived arousal 
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For AUCg, there was a non-significant trend between groups. Means show that this trend is a 
consequence of the difference between the groups with one and two clinical anxiety disorders as 
compared to the group with three or more clinical anxiety disorders. Further analyses showed that there 
was no difference in Cort3 and a trend in Cort4. Mean scores in Cort3 and Cort4 showed the same 
pattern as AUCg between groups. Results are presented in table 6. There were no significant between 
groups differences for CARg, CARi, Cort1, Cort2 and Cort5. 
Regarding ANS functioning significant group differences were found in pretest and test levels of 
SCL. Posthoc analyses revealed that the group with the most clinical anxiety disorders had significantly 
higher pre- and posttest SCLs than the group with one or two anxiety disorders. These results remained 
significant after correcting for externalizing and depressive symptoms. There were no significant 
between group differences for the SCL stress response and HF HR variability. 
Pre- and posttest perceived arousal was significantly different between groups. The group with 
3 or more clinical anxiety disorders had lower pre- and posttest PAQ-scores in comparison with the 
groups with one and two anxiety disorders. These results remained significant after correcting for 
externalizing behavior. When the results were corrected for depressive symptoms, only posttest PAQ 
remained significantly different between groups. There was no significant between group difference for 
the PAQ stress response. 
For all significant results described above overall effect sizes were medium and varied between 
.05-.10. 
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Table 5. Cross tabulation of main diagnosis and comorbid disorders 
 
Note. GAD = generalized anxiety disorder, SoPh = social phobia, SAD = separation anxiety disorder, SpPh = specific phobia 
  
 Comorbid diagnoses N(% per main anxiety diagnosis) 
SAD SoPh SpPh GAD ADHD ODD CD DYS DD 
Total comorbid 
diagnoses per main 
anxiety diagnosis 
Main diagnosis 
SAD=57 - 13(22.8) 15(26.3) 14(24.6) 8(14.0) 5(8.8) 1(1.8) 1(1.8) 2(3.5) 59 
SoPh=29 3 (10.3) - 2(6.9) 9(31.0) 1(3.4) 1(3.4) 0(0) 3(10.3) 0(0) 19 
SpPh=19 5(26.3) 2(10.5) - 5(26.3) 2(10.5) 2(10.5) 1(5.3)  0(0) 0(0) 17 
GAD=47 5(10.6) 6(12.8) 12(25.5) - 4(8.5) 2(4.3) 1(2.1) 4(8.5) 0(0) 34 
Count of comorbid diagnosis  13 21 29 28 15 10 3 8 2 129 
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Table 6. Daytime cortisol, ANS measures and perceived arousal versus ‘anxiety load’ 
 
Variable 
Single clinical 
anxiety disorder 
Mean (SD-n) 
Two clinical 
anxiety 
disorders 
Mean (SD-n) 
Three or more 
clinical anxiety 
disorders 
Mean (SD-n) 
     
Group differences# 
(ANCOVA'S //partial Eta 
squared) 
Group differences## 
(ANCOVA'S//partial Eta 
squared) 
Group differences### 
(ANCOVA'S//partial Eta 
squared) 
AUCg 89.52(31.63-62) 92.17 (24.54-33) 71.45(21.09-16) ns, trend   
Cort3 .83 (.20-68) .84 (.15-37) .72 (.18-17) ns   
Cort4 .56 (.32-65) .54 (.31-37) .38 (.24-17) ns, trend   
SCL (μS) baseline .48(.22-62) .55 (.27-36) .67(.26-23) F(2,113)= 4.53*//.07 F(2,108) = 3.27*//.06 F(2,106) = 4.76**//.08 
SCL (μS) during test .61 (.24-61) .66 (.27-37) .83 (.29-22) F (2,112)= 5.07**//.08 F (2,107)= 3.49*//.06 F (2,105)= 4.74*//.08 
PAQ pretest .89 (.31-70) .93 (.30-36) .72 (.49-17) F (2,115)= 4.05*//.07 F (2,110)= 4.90**//.08 ns, trend 
PAQ posttest .96 (.29-72) .94 (.32-35) .70 (43-17) F (2,116)= 5.73**//.07 F (2,111)= 5.80**//.10 F (2,108)= 5.52**//.09 
Note. SD = standard deviation, GP = general population group, AD = anxiety disorder group, AUCg = area under the curve for Cort2-Cort4 with respect to 
ground, Cort3 = cortisol at 12.00 p.m., Cort4 = cortisol at 8.00 p.m., SCL = skin conductance level, PAQ = Perceived Arousal Questionnaire. All variables, except 
AUCg, were log-transformed. #covariates: age, sex, bmi. ## covariates: age, sex, bmi, CBCL externalizing behavior, ### covariates: age, sex, bmi, CDI Total score. *= 
p<.05, **=p<.01. 
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Clinical ‘load’ versus daytime cortisol, autonomic measures and perceived arousal 
For AUCg, there was a significant between groups difference. Post hoc analyses showed that the 
difference in AUCg between the groups was determined by the difference between the groups with one 
and two clinical disorders as compared to the group with three or more clinical disorders. Thus, the 
group with the most clinical disorders had a significantly lower AUCg. Further analyses showed that the 
difference was determined by lower values of Cort3, Cort4 showed a trend. The results remained 
significant for AUCg and Cort3 after correcting for externalizing behavior. Only the results for AUCg 
remained significant after correction for depressive symptoms. Significant results are presented in table 
7. There were no significant between groups differences for CARg, CARi, Cort1, Cort2 and Cort5. 
Regarding ANS functioning significant group differences were found in pretest and test levels of 
SCL. Posthoc analyses revealed that the group with the most clinical anxiety disorders had significantly 
higher pre- and posttest SCLs than the group with one or two anxiety disorders. These results remained 
significant after correcting for externalizing and depressive symptoms. There were no significant 
between group differences for the SCL stress response and HF HR variability. 
Posttest perceived arousal was significantly different between groups. The group with 3 or more 
clinical anxiety disorders had a lower posttest PAQ-score in comparison with the group with only one 
anxiety disorder. Although children with two clinical anxiety disorders had rather similar scores on 
posttest PAQ as the group with one anxiety disorder, there was no significant difference with the group 
with 3 or more disorders, which may be due to a lack of power. These results remained significant after 
correcting for externalizing behavior. There was no significant between group difference for pretest PAQ 
or the PAQ stress response. 
For all significant results described above overall effect sizes were medium and varied between 
.05-.10. 
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Table 7. Daytime cortisol, ANS measures and perceived arousal versus ‘clinical load’ 
 
Note. SD = standard deviation, GP = general population group, AD = anxiety disorder group, AUCg = area under the curve for Cort2-Cort4 with respect to 
ground, Cort3 = cortisol at 12.00 p.m., Cort4 = cortisol at 8.00 p.m., SCL = skin conductance level, PAQ = Perceived Arousal Questionnaire. All variables, except 
AUCg, were log-transformed. #covariates: age, sex, bmi. ## covariates: age, sex, bmi, CBCL externalizing behavior, ### covariates: age, sex, bmi, CDI Total score. *= 
p<.05, **= p<.01. 
 
 
Variable 
Single clinical 
disorder 
Mean (SD-n) 
Two clinical 
disorders 
Mean (SD-n) 
Three or more 
clinical disorders 
Mean (SD-n) 
     
Group differences# 
(ANCOVA'S //partial Eta 
squared) 
Group differences## 
(ANCOVA'S//partial Eta 
squared) 
Group differences### 
(ANCOVA'S//partial Eta 
squared) 
AUCg 
87.82(28.01-54) 97.72 (30.33-35) 71.49(21.70-22) F (2, 103) = 5.42**//.10 F (2,99) = 5.05**//.09 F (2,99) = 4.37*//.08 
Cort3 
.82 (.19-59) .86 (.16-39) .73 (.18-24) F (2, 115) = 3.93*//.07 F (2, 110) = 3.53*//.06 ns, trend 
Cort4 
.55 (.33-57) .57 (.30-38) .40 (.24-24) ns, trend   
SCL (μS) baseline 
.48(.22-62) .55 (.27-36) .67(.26-23) F(2,113) = 4.53*//.07 F(2,108) = 3.27*//.06 F(2,106) = 4.76**//.08 
SCL (μS) during test 
.61 (.24-61) .66 (.27-37) .83 (.29-22) F (2,112) = 5.07**//.08 F (2,107) = 3.49*//.06 F (2,105) = 4.74*//.08 
PAQ pretest 
.88 (.32-62) .95 (.30-38) .76 (.43-23) ns   
PAQ posttest 
.95 (.31-63) .95 (.32-38) .76 (.39-23) F (2,116)= 3.51*//.06 F (2,111)= 3.49*//.06 F (2,108)= 3.32*//.06 
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Type of main anxiety diagnosis versus daytime cortisol, autonomic measures and perceived 
arousal 
As presented in Table 8, significant group differences were found in pretest and test levels of SCL. 
Posthoc analyses revealed that children with a main diagnosis of SpPh showed higher SCL’s compared to 
the SAD and the SoPh-groups. Effect sizes were medium and varied between .11-.13. These results 
remained significant after correcting for externalizing and depressive symptoms. GAD was not 
significantly different from SpPH. There was no significant between-groups difference for any of the 
cortisol measures, perceived arousal or HF HR variability. 
Children in the AD group with a main diagnosis of SpPh differed from children in the GP group 
with a diagnosis of SpPh (DISC-IV- P/C (N=25)) on several measures. Children with SpPh from the AD 
group have higher CBCLextern scores (AD mean = 1.06 (sd =.27), GP mean = .78 (sd =.35) T = 3.32, df 54, 
p<.01), lower AUCg (AD mean = 82.24 (sd = 28.17), GP mean = 106.17 (sd = 31.8) T = -2.90, df 51, p<.01), 
higher baseline SCL (AD mean = .69 (sd = .25), GP mean = .42 (sd = .16) T = 4.77, df 52, p<.001) and 
higher during test SCL (AD mean = .83 (sd = .25), GP mean = .51 (sd = .17) T = 5.45, df 52, p<.001). These 
results are in line with the general differences between the GP and the AD group. Thus the elevated 
levels of SCL’s of SpPh are specific for clinical SpPh. 
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Table 8. ANS measures versus type of anxiety disorder 
 
Note. SD = standard deviation, SCL = skin conductance level, All variables were log-transformed. #covariates: age, sex, bmi. ## covariates: age, sex, bmi, CBCL 
externalizing behavior, ### covariates: age, sex, bmi, CDI Total score. *= p<.05, **= p<.01. 
 
 
 
Variable 
Separation 
anxiety 
disorder 
Mean (SD-n) 
Social 
anxiety 
disorder 
Mean (SD-n) 
Generalized 
anxiety 
disorder 
Mean (SD-n) 
Specific 
phobia 
Mean (SD-n) 
 
Group differences# 
(ANCOVA'S//partial eta 
squared) 
 
Group differences## 
(ANCOVA'S//partial eta 
squared) 
Group differences### 
(ANCOVA'S//partial 
eta squared) 
SCL (μS) baseline .50 (.20-46) .48 (.21-22) .53(.29-36) .75(.26-17) F(3,111) = 4.36**//.11 F(3,105) = 3.96**//.11 F(3,104) = 4.49**//.12 
SCL (μS) during test .62 (.19-46) .58 (.24-22) .68(.31-35) .89 (.29-17) F (3,110)= 5.31**//.13 F (3,104)= 5.23**//.13 F(3,103) = 5.91**//.15 
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DISCUSSION 
 
Our results show that children with a clinical anxiety disorder have a pattern of hypoactivation of basal 
HPA-axis functioning, elevated sympathetic, and lowered parasympathetic activity compared to a 
general population sample. Anxiety ‘load’, as a marker of severity, is associated with differences in 
functioning ANS. A high anxiety ‘load’ in the clinical sample is associated with higher sympathetic 
functioning in comparison to children with a low anxiety ‘load’. There is no relationship between anxiety 
‘load’ and parasympathetic functioning. Results for children with a high anxiety ‘load’ show a trend 
towards hypoactivation of basal HPA-axis functioning. In contrast with our expectations, children with a 
high anxiety ‘load’ have lower posttest perceived arousal in comparison with children with a low anxiety 
‘load’. When adding comorbid disorders to the ‘load’, the same pattern is seen. Moreover, a high clinical 
‘load’ is associated with hypoactivation of basal HPA-axis functioning in comparison to children with a 
low clinical ‘load’ even after correcting for depressive and externalizing symptoms. Although we did not 
expect a difference in functioning of ANS or HPA-axis between the different types of anxiety disorders, 
our results show that children with a main diagnosis of specific phobia can be discerned from children 
with a social phobia and separation anxiety disorder on higher sympathetic functioning during basal and 
stress conditions, even in the presence of high comorbidity rates, although comorbidity rates were 
comparable to or even lower than other studies (e.g. Kendall et al., 2010). 
 
Anxiety ‘load’ 
Our results are in support of the hypothesis that a child with a clinical disorder functions under chronic 
stressful conditions, with concomitant changes in the activity of both the stress systems. This notion is 
further underlined by the finding that a high clinical ‘load’ in the clinical sample was associated with 
lower basal HPA-axis functioning and higher sympathetic functioning in comparison to children with only 
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one or two clinical anxiety disorders, after correcting for externalizing and depressive symptoms. The 
analyses for anxiety ‘load’ show the same pattern, but show only a trend in the results for HPA-axis 
functioning which may be due to a lack of power. Our findings might indicate that there are already 
biological underpinnings of the ‘load’ of anxiety disorders in childhood, which might be predictive of 
adverse outcomes later in life. The ‘load’ of anxiety disorders during adolescence has been associated 
with later risks of anxiety disorders, major depression, substance dependence, suicidal behavior and 
other adverse outcomes, such as educational underachievement and early parenthood (Woodward, 
Fergusson, 2001). 
 
Specificity of psychophysiological correlates 
Our study underlines the hypothesis that basal ANS and HPA-axis functioning relate to anxiety disorders 
in general, and only heightened sympathetic (re)activity is a specific correlate for specific phobia. Other 
lines of research also support the idea of specific phobia as a specific taxonomic entity. In a population-
based twin registry, lifetime diagnoses for six anxiety disorders (generalized anxiety disorder, panic 
disorder, agoraphobia, social phobia, animal phobia, and situational phobia) were obtained during 
personal interviews (Hettema et al., 2005). The authors concluded that genetic factors predispose to 
two broad groups of disorders dichotomized as panic-generalized-agoraphobic anxiety versus the 
specific phobias. Social phobia was regarded as an intermediate as it was influenced by both genetic 
factors. Further evidence for specific phobia as a specific taxonomic entity comes from longitudinal 
studies: specific phobia exclusively predicts specific phobia from childhood or adolescence to adulthood 
(e.g. Pine et al., 1998). In other words: there is strong evidence for longitudinal specificity of specific 
phobia. The psychophysiological correlates of clinical specific phobia in our study, confirm the existing 
genetic and longitudinal evidence for specific phobia as a separate taxonomic construct. The lack of 
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specificity of psychophysiological correlates for the other anxiety disorders is in line with the findings of 
Hettema et al. (2005). 
 
Daytime cortisol 
One of the most robust and striking results of our study is the low diurnal cortisol profile at noon and in 
the evening in children with AD. The same difference is seen in pretest cortisol levels, with lower levels 
of cortisol preceding the MAT. Within the AD group the severity of the disorder, or the clinical ‘load’, 
resulted in an even lower diurnal cortisol profile at noon and a trend for a lower diurnal cortisol profile 
in the evening. At least two causal pathways leading to hypocortisolism in clinical anxiety disorders are 
conceivable. 
We propose that chronic and pathological anxiety problems, interfering with daily life and 
leading to a clinical anxiety disorder, have a different effect on physiological functioning than 
temporarily heightened, subclinical anxiety symptoms. In subclinical anxiety, the first symptoms of 
exacerbated worrying, fear and anxiety might lead to an initial increase in adrenocortical activity, i.e. 
hypercortisolism. When anxiety symptoms become clinical and persist, compensatory mechanisms 
become activated and gradually result in an attenuation of cortisol secretion, i.e. hypocortisolism. A 
recent study by Steudte et al. (2011) found evidence in support of this theory. The authors found lower 
concentrations of cortisol in hair in adults with GAD. Cortisol in hair reflects cortisol secretion over a 
prolonged period of time. This suggests that under naturalistic conditions GAD in adults is associated 
with hypocortisolism. Other evidence in support of this theory comes from animal studies. Herman et al. 
(2005) state that chronic stress leads to two mechanisms in animals. First, facilitation: a new stressor 
leads to a stronger increase in cortisol in chronically stressed animals compared to non-stressed animals, 
and second, habituation: a chronic stressor in chronically stressed animals leads to a progressive 
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decrease in cortisol. Our results are in line with the habituation hypothesis of chronic stress in animal 
research. 
Alternatively, altered physiological functioning, as a vulnerability factor, could influence the 
expression of clinical anxiety disorders, but is not related to normal variation in levels of anxiety. 
Following this line of reasoning, moderate changes in HPA-axis functioning might be adaptive, whereas 
large alterations in physiological functioning may mark dysregulated emotions. Studies in support of this 
theory showed that cortisol administration reduced fear reports in patients with social phobia (Soravia 
et al., 2006) and that cortisol responses to psychosocial stress were inversely related to subsequent 
anxiety ratings (Schlotz et al., 2008). 
 
Autonomic measures 
Although effect sizes varied, our study confirms previous findings in studies with children with anxiety 
symptoms regarding autonomic functioning: AD children show heightened sympathetic functioning in 
rest and stress (SCL as a proxy for sympathetic ANS) and lower parasympathetic functioning in rest (HF 
HR variability as a proxy for parasympathetic ANS) compared to controls. With respect to sympathetic 
ANS functioning there seems to be a dose-response effect; children with a high anxiety ‘load’ exhibit 
even higher levels of sympathetic activity in comparison with children with a low anxiety ‘load’. 
Interestingly, in studies finding evidence of low cortisol in association with PTSD or PTSD risk, there was 
also evidence of greater sympathetic arousal as reflected by catecholamine levels (Radley et al., 2011). 
Possibly, hypocortisolism in non-stressful conditions due to ‘habituation’ in children with a clinical 
anxiety disorder (i.e. a chronic stressor leads to a progressive decrease in cortisol) alters the ability of 
the HPA-axis to restore homeostasis following exposure to stress, resulting in increased sympathetic 
activation. 
 
P a g e  | 147 
 
Perceived arousal 
Previous studies suggest that high anxious subjects tend to perceive physiological sensations as more 
severe than non-anxious subjects (Hoehn-Saric, McLeod, 2000), sometimes even in the absence of an 
actual difference in physiological measures (Edelmann, Baker, 2002). In our study, the perceived arousal 
during rest in children with an AD compared to controls was higher. Apparently, anticipatory anxiety in 
children with an AD is high and has reached a plateau even before the stress task begins. This finding is 
supported by a recent study in healthy adults, relating neuroticism to exaggerated anticipatory anxiety 
experience (Drabant et al., 2011). 
In contrast with these findings is the result that within the AD group children with a high anxiety 
‘load’ experienced less perceived arousal in comparison with children with a low anxiety ‘load’. There 
are several possible explanations: 1) children with a high anxiety ‘load’ are alexithymic and can not 
register their own perceived arousal, 2) children actively direct their attention away from threatening 
bodily sensations and nervous feelings, or 3) children with a high anxiety ‘load’ already have a 
continuous plateau level of arousal which they rate as not deviant from normal. This last hypothesis 
could be in line with the general hypothesis that children with a high anxiety ‘load’ function under 
chronic stress conditions. 
 
Limitations 
Several limitations of our study need to be taken into consideration. First, the availability of only one 
cortisol diurnal profile can be seen as a limitation. Rotenberg et al. (2012) show that the cortisol 
awakening response requires at least 3 weekdays of sampling to yield a stable estimate. However, a 
review by Golden et al. (2011) states that the use of sampling multiple salivary cortisol measures across 
the diurnal curve (including awakening cortisol), likely reflects chronic cortisol burden and has the 
highest reliability of all cortisol measures (r = 0.63-0.84). 
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Second, sampling compliance was based on child-reported time of saliva collection combined 
with parent-initiated times on a daily log sheet. Use of electronically monitored timing would improve 
the precision and accuracy of sample timing, as well as the ability to screen for potentially invalid 
samples. Furthermore, our participants had lunch on the day of the assessment. Although lunch was 
eaten before the assessment and the gap between lunch and baseline saliva samples was at least 1.5 h, 
it might still have had an effect on pretest cortisol levels (Rotenberg et al., 2012). Other variables such as 
socioeconomic status and Tanner stage might have influenced cortisol values, although in a sample of 8 
to 12 year olds the influence of Tanner stage will be limited. These data are not available for our 
subjects. This is a limitation of the study. 
Another notable weakness of the current study is the lack of heart rate variability measures and 
cortisol measures during stress. The MAT is a cognitive task that compared to a public 
speaking/cognitive task combination is less capable of eliciting a substantial cortisol stress response 
(Kirschbaum, Pirke, Hellhammer, 1993; Dickerson, Kemeny, 2004). Furthermore, it is a task in which 
speech limits the possibility to control HF HR variability for respiratory frequency, therefore, HF HR 
variability was not analyzed during the MAT. 
Comorbidity rates and the distribution of main anxiety diagnoses in this sample will exert its 
effects on the functioning of both stress systems. This is also applicable for the method of sampling and 
age, although we tried to minimize variation in developmental status through the inclusion of only 
children below 13 years. Considering these limitations, results regarding our sample cannot be directly 
extrapolated to other clinical samples. Nonetheless, selecting samples in which no comorbidity exists 
represent an artificial reality not found in most clinical settings. 
 
CONCLUSION 
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Our findings indicate that children with an anxiety disorder can be distinguished on several 
psychophysiological characteristics from healthy children. The results underline the hypothesis that ANS 
and HPA-axis functioning relate to anxiety disorders in general, and only heightened sympathetic 
(re)acitivity is a specific correlate for specific phobia, which confirms the existing genetic and 
longitudinal evidence for specific phobia as separate taxonomic construct. Furthermore, our study found 
some evidence in support of the hypothesis that a child with a clinical anxiety disorder functions under 
chronic stressful conditions, with concomitant changes in the activity of both the stress systems. This 
notion is underlined by the finding that a high clinical ‘load’ in the clinical sample was associated with an 
even further deviation of basal HPA-axis functioning and sympathetic functioning. This might indicate 
that there are already biological underpinnings of the ‘load’ of anxiety disorders in childhood, which 
might be predictive of adverse outcomes later in life. 
Future research is needed to replicate our findings in other clinical samples. Furthermore, the 
cross-sectional character of this study makes it difficult to draw conclusions regarding the causality of 
deviations in HPA-axis and ANS functioning in children with an AD, therefore longitudinal studies in 
children in which the course and severity of anxiety symptoms and disorders are related to basal and 
reactive HPA and ANS functioning are needed. 
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Figure 1. Medication use during last two months 
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Chapter 6 
Persistence of anxiety disorders and concomitant changes in cortisol 
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ABSTRACT 
 
In a clinical sample of 116 children and adolescents we studied the relation between the course of an 
anxiety disorder during treatment and the concomitant changes in cortisol levels. Assessments at 
baseline, after three months, and at one-year follow-up were performed with the Anxiety Disorders 
Interview Schedule. When we compared cortisol levels at baseline and one-year follow-up, persistence 
of the anxiety disorder was associated with both increased daytime cortisol production (F = 3.2, 
p = 0.04) and a trend towards a decreased cortisol morning rise (F = 2.4, p = 0.09). At one-year follow-up 
daytime cortisol production was lowest in the early remitters (109.7 ± 29.2 h mmol/l), higher in the late 
remitters (121.0 ± 40.0 h mmol/l) and highest in the non-remitters (131.1 ± 48.9 h mmol/l). Early 
remitters had the highest cortisol morning rise (1.1 ± 1.5 h mmol/l), followed by the late remitters 
(0.8 ± 1.8 h mmol/l), the non-remitters had the lowest cortisol morning rise (0.07 ± 1.7 h mmol/l). 
Persistence of an anxiety disorder may thus lead to changes in HPA-axis functioning, underscoring the 
importance adequate treatment of anxiety disorders. 
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INTRODUCTION 
 
The relation between HPA-axis functioning and internalising problems has been examined repeatedly. In 
patients with major depression, higher basal cortisol levels, and in patients with posttraumatic stress 
disorder, lower cortisol levels are consistent findings, although exceptions have also been reported 
(Goenjian et al., 1996; Bonne et al., 2003, Bremner et al., 2003, Goenjian et al., 2003; Burke et al., 
2005a; Lopez-Duran, Kovacs, George, 2009). In comparison, studies investigating cortisol levels in 
patients with other anxiety disorders are less common. Research on panic disorder yielded conflicting 
results. Some authors reported increased HPA-axis activity (Wedekind et al., 2000; Vreeburg et al., 
2010), whereas others showed normal HPA-axis activity (Gurguis, Mefford, Uhde, 1991). Recently, 
Mantella et al. (2008) reported increased basal cortisol levels in patients with a generalised anxiety 
disorder. 
Even fewer studies have investigated the association between anxiety problems and cortisol 
levels in children and adolescents. Kagan, Reznick and Snidman (1987) found that basal cortisol levels 
were higher in inhibited than in uninhibited young children. Two studies reported similarly increased 
HPA-activity in anxious children and adolescents. Granger, Weisz and Kauneckis (1994) showed that 
social anxiety in children and adolescents referred to an outpatient clinic was associated with a more 
pronounced increase in salivary cortisol concentrations after exposure to a mild stressor. In a study 
conducted by Feder et al. (2004), children with an anxiety disorder had lower nighttime cortisol levels 
and a steeper rise of cortisol concentrations after awakening, compared to depressed and healthy 
control children. 
However, several other studies could not demonstrate an association between anxiety problems 
and cortisol levels. Martel et al. (1999) did not find differences in basal cortisol levels between social 
phobic adolescent girls and matched controls. A study comparing adolescents with an anxiety disorder 
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and healthy controls showed no difference in cortisol response induced by a public speaking task (Gerra 
et al., 2000). 
A numbers of problems and caveats may have contributed to the inconsistency of findings. The 
groups under study where dissimilar. Some studies were conducted in the general population, whereas 
others focused on clinical groups, which are likely to display important differences in symptom severity. 
Moreover, most of these studies did not adjust for comorbid symptoms of major depression. As 
symptoms of major depression are closely associated with anxiety symptoms and have been associated 
with alterations in HPA-axis activity, they can confound the association under study. Most studies 
performed were small and hence underpowered to detect subtle differences between groups. 
In addition, some authors have suggested that the inconsistent findings may be due to changes 
in HPA-axis functioning during the course of the disorder (Greaves-Lord et al., 2007). Gunnar and 
Vazquez (2001) posited that, although stressful events provoke frequent elevations in cortisol at first, 
these elevations would eventually lead to downregulation of the HPA-axis. On the other hand, 
elevations in cortisol levels that persist across time could also tune HPA-axis activity to a higher level 
(Sapolsky, Krey, McEwen, 1986). A recent study by Greaves-Lord et al. (2007) favoured the second 
hypothesis. They demonstrated in a large general population sample of young preadolescents that only 
persistent, and not current anxiety problems were associated with high basal cortisol levels. The 
developing HPA-axis of children and adolescents may be especially vulnerable to such stress-induced 
changes. This could be indicative of progressing damage or atrophy to elements of the HPA-axis. 
Permanent HPA-axis dysfunctioning in early life has repeatedly been linked to chronicity and recurrence 
of affective disorders and affective symptoms (Flory et al., 2009; Nicolson et al., 2010). Persistence of an 
anxiety disorder in childhood could have life-long consequences for the neuroendocrine 
system/health/well-being, underscoring the need for prospective, longitudinal research. 
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Moreover, the chronic and pathological anxiety experienced by children and adolescents in a clinical 
population is more severe than the anxiety reported by study participants from the general population, 
hence it may have a greater impact on the developing HPA-axis and impair its future functioning. 
In a clinical sample of 116 children and adolescents aged between 8 and 16 years we studied the 
relation between the trajectory of an anxiety disorder during treatment and the concomitant change in 
cortisol levels. Although the findings in literature are inconsistent, most research to date seems to 
indicate high cortisol levels in individuals with an anxiety disorder, other than PTSD, when compared to 
normal controls. Hence, we postulate that levels of cortisol in patients in remission are lower than in 
non-remitted patients. In addition, we hypothesise that persistence of the anxiety disorder is associated 
with further alteration of HPA-axis functioning. We expect levels of cortisol at follow-up to be higher 
than at baseline, especially in the non-remitters group. 
 
METHODS 
 
Participants 
Participants had been referred to the outpatient clinic of the department of Child and Adolescent 
Psychiatry of either the Erasmus Medical Center in Rotterdam or Leiden University Medical Center – 
Curium. All consecutive referrals to these departments were assessed with the Anxiety Disorders 
Interview Schedule for DSM-IV-Child Version (ADIS-C). Children and adolescents with a primary diagnosis 
of generalised anxiety disorder, separation anxiety disorder, social phobia or specific phobia were 
eligible for inclusion. Exclusion criteria were: current medication for an anxiety disorder or current 
corticoid medication, co-morbid pervasive development disorder, obsessive compulsive disorder, post 
traumatic stress disorder, substance use, and an IQ score below 85 on the Wechsler Intelligence Scale 
for Children-Revised (WISC-R). 
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A standardised stepped-care cognitive behavioural therapy program for childhood anxiety disorders was 
used, consisting of two phases. Phase one consisted of the FRIENDS program (Barrett, Lowry-Webster, 
Holmes, 2000), which comprises psycho-education, relaxation and breathing exercises, exposure, 
problem solving skills training, social support training, and cognitive restructuring. FRIENDS 
encompassed 10 child sessions and 4 separate parent sessions. Children, who were not successfully 
treated after phase one as determined by ADIS-C at three months follow-up, received a supplementary 
phase. Phase two consisted of 10 sessions, in which parents and child participated together in each 
session. Parents were more actively involved in phase two. The skills learned during phase one were 
elaborated (cognitive restructuring, exposure and long-term relapse control). 
In total, 184 children and adolescents aged 8–16 years participated in the study. 60 participants 
were diagnosed with a separation anxiety disorder as the primary diagnosis, 56 with a generalised 
anxiety disorder, 45 with a social phobia and 23 with a specific phobia. 55 participants had more than 
one anxiety disorder. Three participants were diagnosed with a co-morbid depression, eight with co-
morbid dysthymia. Of the 184 participants, 42 participants did not participate at follow-up due to 
logistic and practical reasons, cortisol samples for 26 participants where lost due to a failure of the lab 
storage refrigerator. The Medical Ethical Committees of the Erasmus MC in Rotterdam and the Leiden 
University Medical Centre in Leiden approved the protocol. All parents and each adolescent provided 
written consent. 
 
Diagnostic assessment 
The Anxiety Disorders Interview Schedule for DSM-IV (ADIS-C) is a semi-structured interview aimed at 
assessment of DSM-IV anxiety disorders in children and adolescents. The interview was conducted by a 
trained post-doctoral psychologist and supervised master-level students with the patient and the 
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parents separately. A diagnosis is based both on a symptom count of DSM-IV symptom criteria, and on 
the level of impairment according to the parent, the patient, and the interviewer. The ADIS-C showed 
good to excellent interrater reliability, with Kappa for the different diagnoses ranging from 0.63 to 80 for 
the child interview, and 0.65 to 0.88 for the parent interview. The combined interview showed excellent 
reliability, with Kappa ranging from 0.80 to 0.92. In addition test-retest reliability was excellent, with 
intraclass correlation coefficients ranging from 0.78 to 0.95 for the child interview and from 0.81 to 0.96 
for the parent interview (Siebelink, Treffers, 2000; Silverman, Saavedra, Pina, 2001). 
 
Questionnaires 
Information on self-reported anxiety was obtained by administering the Dutch version of the 
Multidimensional Anxiety Scale for Children (MASC). The MASC is a self-report measure of general 
anxiety in children and includes 39 items. The internal reliability was excellent with internal reliability 
coefficients ranging from 0.62 to 0.85 for the subscales and to 0.90 for the total scale. Test–retest 
reliability was excellent as well, with an intraclass correlation coefficient for the total scale of 0.93 with a 
retest after three months (March et al., 1997). 
Information on self-reported depression was obtained by means of the Dutch version of the 
Children's Depression Inventory (CDI). The CDI is a 27-item scale suited for monitoring changes in a 
child's mood (March et al., 1997). Good reliability (Cronbach's alpha between 0.81 and 0.87) and good 
test–retest reliability (Intraclass correlation coefficient = 0.80) has been reported (Kovacs, 1985). 
To supplement the child report, we used the Child Behaviour Checklist (CBCL), a parent 
questionnaire for assessing psychiatric problems in children. At baseline, the mother rated the child's 
emotional and behavioural problems over the preceding 2 months on a 3-point scale. As a measure of 
depression severity we used the DSM affective scale to minimise collinearity with anxiety symptoms. 
This scale was developed by Achenbach in 2003 to represent the DSM category of major depressive and 
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dysthymic disorders. The DSM oriented scales have good reliability (Cronbach's alpha = 0.82) and good 
test-retest reliability (Intraclass correlation coefficient = 0.88) (Achenbach, Dumenci, Rescorla, 2003). 
 
Cortisol assessment 
Participants were asked to collect saliva samples at home. Participants and their parents were briefed 
on how to sample the saliva by one of the research staff. In addition they were given detailed written 
instructions. Four samples were collected. (1) Immediately after awakening in the morning, when the 
child was still in bed, (2) 30 min later, (3) at 12.00 h, and (4) at 20:00 h. The time of awakening was 
recorded on the first saliva tube. Children were asked not to eat 0.5 h before sampling, and to refrain 
from consuming dairy products 1 h before sampling. All samples were collected on a regular school day, 
stored in the freezer at home, and brought along to the clinic a day later. Saliva samples were stored at 
−20 °C until analysis. Cortisol concentrations were determined in duplicate 20 ml samples by solid-phase 
radioimmunoassay with iodinated cortisol (Coat-A-Count, Diagnostic Products Corporation, LA, USA). 
The lower limit of detection was 1 nmol/l, the intra-assay variation was 6.9% and the inter-assay 
variation was 8.6%. 
We employed two measures that are commonly used to summarise aspects of the diurnal 
pattern of cortisol: morning rise and daytime cortisol secretion. Total daytime cortisol secretion was 
calculated as the area under the curve (AUC) for samples 1, 3 and 4 with respect to the ground, 
according to Pruessner et al. (2003). While cortisol daytime AUC is a reliable index of unstimulated HPA-
axis activity is, waking up in the morning is a potent stressor. Hence, cortisol morning rise levels can 
provide additional information on the reactivity of the HPA-axis (Wust et al., 2000), which must 
otherwise be gleaned from stimulation tests with either CRH/ACTH or under influence of a stressor in a 
laboratory setting. The morning rise was calculated as the area under the curve with regard to the 
increase for samples 1 and 2 (Edwards et al., 2001). 
P a g e  | 163 
 
 
Procedure 
Cortisol saliva samples were collected at baseline and one year later. 
The ADIS-C, MASC and CDI were administered to the children and their parents at three time 
points, namely at baseline, after three months and at one-year follow-up. Interviewers were blind to 
pre-treatment diagnoses, disease trajectory, and cortisol levels. 
 
Statistical analysis 
First we performed a non-response analysis. We compared age, sex, depression and anxiety scores of 
the 116 participants for whom cortisol samples where available both at baseline and one year later to 
the 68 participants for whom insufficient data was available. We used t-tests for normally distributed 
variables, for non-normal distributed continuous variables Mann–Whitney U-tests and for dichotomous 
variables Chi Square tests. 
The participants fell into three groups. This categorisation was determined prior to the start of 
data collection and has been described in an earlier publication based on this sample (Legerstee et al., 
2010). As shown in Figure 1, the groups were based on the trajectories of the anxiety disorders as 
assessed by ADIS-C: (1) early remitters: those participants who no longer suffered from any anxiety 
disorder after three months (N=40), (2) late remitters: those participants who had no anxiety disorder at 
one-year follow up (N=48), (3) non-remitters: those participants who still fulfilled the criteria for an 
anxiety disorder at one-year follow up (N=28). We compared these three groups on gender, weight and 
baseline anxiety and depression severity using Chi Square tests and ANOVA with Tukey's correction 
where appropriate. 
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In a preliminary analysis, we determined whether the severity of the anxiety disorder, as 
measured by the MASC, was associated with cortisol levels at baseline or follow up. We employed linear 
regressions, corrected for age and sex. 
In our main analysis, we tested the hypothesis, that persistence of an anxiety disorder is 
associated with changes in cortisol levels between baseline and follow-up. We used mixed model 
analysis to determine whether levels of cortisol changed between baseline and one-year follow-up. We 
tested whether any such change was related to the course of the anxiety disorder by means of an 
interaction term between time and remission status. The analysis was corrected for age, sex, and 
depression severity both at baseline and at one-year follow up. 
We employed ANCOVA's to illustrate the findings of the mixed model. We show to what extent 
cortisol levels at baseline were related to the subsequent course of the anxiety disorder. We corrected 
for age, sex and depression severity at baseline. Similarly, we show to what extent early, late or non-
remitters had different cortisol levels at one-year follow-up. We corrected for age, sex, baseline cortisol 
levels, and depression severity at baseline and one-year follow-up. Significant findings were further 
explored by contrasting the early remitters group against the late and non-remitters. 
All statistical analyses were carried out using the Statistical Package for the Social Sciences 13.0 
for Windows (SPSS Inc.). 
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Figure 1. Study overview 
  
BASELINE 
N = 116
Measurement of cortisol
Assessment of psychopathology using ADIS, MASC and CDI 
Friends program
THREE MONTH FOLLOW UP
Assessment of psychopathology using ADIS, MASC and CDI 
Remission
N = 40
No remission
N = 76
ONE YEAR FOLLOW UP
Measurement of cortisol
Assessment of psychopathology using ADIS, MASC and CDI 
Early remitters
N = 40
Anxiety disorder in
remission at three 
months.
Late remitters
N = 48
Anxiety disorder in
remission at one 
year follow-up
Non-remitters
N = 28
Anxiety disorder 
still present.
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RESULTS 
 
The non-response analysis showed that the participants, who were included in the analysis, had a similar 
boy/girl ratio (χ2 = 0.65, df = 1, p = 0.5) and age range (U = 2391.5, p = 0.9), as well as similar baseline 
depression (U = 2290.5, p = 0.4 for child report, U = 2361.5, p = 0.8 for maternal report) and anxiety 
scores (t = −0.99, df = 176, p = 0.36) to participants for whom insufficient data was available. 
In Table 1, we show the baseline characteristics for the children and adolescents according to 
the trajectory of their anxiety disorder. There was no difference between the groups in boy/girl ratio (χ2 
= 3.85, df = 2, p = 0.14) or age-range (F = 0.43, df = 2.155, p = 0.7). Baseline anxiety scores showed a 
trend for a difference between the groups (F = 2.46, df = 2.152, p = 0.07). However, pair wise 
comparisons showed no significant differences between the groups. Child reported depressive 
symptoms differed between the groups (F = 8.13, df = 2.147, p < 0.001). There were lower depressive 
symptoms in the early remission group versus the late (p < 0.001) and non-remission (p < 0.065) groups. 
A similar pattern was found for maternally reported child depressive symptoms (F = 6.69, df = 2.155, p = 
0.001. Again, there were lower depressive symptoms in the early remission group when compared to 
the non-remission group (p = 0.001), however the difference between the early and late remission 
groups was not significant. 
Anxiety levels were not associated with concomitant cortisol AUC levels either at baseline (B = 
0.08, 95% CI −0.16, 0.48, p = 0.3) or at follow up (B = 0.13, 95% CI −0.21, 0.98, p = 0.2). Similarly, anxiety 
levels were not associated with concomitant cortisol morning rise levels at baseline (B = −0.02, 95% CI 
−0.02, 0.02, p = 0.8) or at follow up (B = −0.01, 95% CI −0.04, 0.01, p = 0.3). 
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Table 1. Baseline characteristics of the study population 
 Early remitters 
(reference group) 
N=40 
Late remitters 
 
N=48 
Non-remitters 
 
N=28 
Age at intake in years (SD) 11.1 (2.1) 10.9 (2.2) 10.5 (2.5) 
Female % 42 46 57 
Anxiety symptom severity (SD) 40.0 (12.8) 45.7 (17.4)   43.7 (17.7) 
Depression symptom severity (SD) 5.2 (3.7) 10.6 (7.5) *   8.9 (6.5) * 
* Significant difference with reference group at p<0.05. 
 
Cortisol morning rise 
First, we present the results of the multilevel analysis, which focuses on changes in cortisol from 
baseline to one-year follow up. Overall, cortisol morning rise did not differ between baseline and one-
year follow-up (F = 0.5, df = 247, p = 0.5). However, inspection of Figure 2b shows that cortisol morning 
rise increased in early and late remitters, whereas it decreased in non-remitters. Indeed, there was a 
trend for the interaction between remission category and time (F = 2.4, df = 247, p = 0.09).We 
conducted further analyses to illustrate these findings. The trajectory of the anxiety disorder was not 
associated with baseline cortisol morning rise (F = 0.3, df = 2.142, p = 0.7). Early remitters (mean 1.0, 
95% CI 0.5; 1.4 h * mmol/l) had similar cortisol morning rise levels at baseline as late remitters (mean 
0.8, 95% CI 0.3; 1.2 h * mmol/l) and non-remitters (mean 1.0, 95% CI 0.4; 1.6 h * mmol/l). 
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As shown in Figure 2b, at one-year follow up, the trajectory of the anxiety disorder was associated with 
cortisol morning rise (F = 4.3, df = 2, 100, p = 0.01). Early remitters had the highest cortisol morning rise 
(mean 1.3, 95% CI 0.7; 1.8 h*mmol/l, reference group), followed by the late remitters (mean 0.8, 95% CI 
0.3; 1.3 h * mmol/l, p = 0.2), the non-remitters had the lowest cortisol morning rise (mean −0.2, 95% CI 
−1.0; 0.6 h * mmol/l, p = 0.004). 
 
Daytime AUC cortisol 
Again, we first describe findings from our multilevel analysis. As shown in Figure 2c, the overall daytime 
AUC increased from baseline to one-year follow-up, but this increase did not reach statistical 
significance (F = 2.5, df = 249, p = 0.08). More importantly however, the increase in cortisol levels was 
dependent on the trajectory of the anxiety disorder (remission category × time, F = 3.2, df = 249, p = 
0.04). 
As a next step, we conducted post hoc analyses to illustrate the significant interaction effect 
observed in the multilevel analysis. As expected, at baseline, daytime AUC cortisol did not differ (F = 0.1, 
df = 2.141, p = 0.9) between the early remitters (mean 85.8, 95% CI 76.8; 94.8 h * mmol/l), late remitters 
(mean 88.6, 95% CI 79.7; 97.5 h * mmol/l) and non-remitters (mean 86.4, 95% CI 74.0; 98.7 h * mmol/l). 
In contrast, daytime AUC levels at follow up differed significantly across the groups (F = 3.37, df 
= 2, 100, p = 0.04), accounting for the interaction effect. It was lowest in the early remitters (mean 
108.7, 95% CI 95.6; 121.8 h * mmol/l, reference group), higher in the late remitters (mean 120.5, 95% CI 
108.6; 132.5 h * mmol/l, p = 0.2) and highest in the non-remitters (mean 138.5, 95% CI 120.7; 156.2 h * 
mmol/l, p = 0.01). 
 
DISCUSSION 
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The present study investigated associations between the trajectory of an anxiety disorder and the 
concurrent changes in cortisol levels in a clinical sample of children and adolescents. 
There was an increase in daytime AUC cortisol between baseline and follow-up, which was 
dependent on the trajectory of the anxiety disorder. This increase was most pronounced for non-
remitters, intermediate in late remitters and less obvious in early remitters. At one year follow up, AUC 
cortisol was highest in non-remitters, followed by late remitters and was the lowest in early remitters. 
Overall, cortisol morning rise did not differ significantly between baseline and follow-up. 
However, there was a trend for cortisol morning rise to increase in early and late remitters, whereas it 
decreased in non-remitters. At one-year follow-up, this corresponded with significant differences 
between the groups, with lowest cortisol morning rise in non-remitters, followed by late remitters and 
the highest cortisol morning rise in non-remitters. Again, late remitters formed an intermediate group, 
consistent with a dose–response effect; the longer participants were anxious the more pronounced the 
changes in cortisol. 
In children and adolescents, research focussing on the relation between anxiety and the HPA-
axis has mainly been cross-sectional in nature. For daytime cortisol levels, our findings at one-year 
follow-up, which demonstrate higher cortisol levels in non-remitters versus late and early remitters, are 
consistent with results from literature which generally describes heightened daytime cortisol levels in 
relation to anxiety (Kagan, Reznick, Snidman, 1987). 
Studies describing cortisol morning rise in relation to anxiety in children are rare. A number of 
studies, especially in adults, have shown an increased cortisol morning rise is related to anxiety or stress 
(Kunz-Ebrecht et al., 2004; Vreeburg et al., 2010). In contrast, some studies seem to indicate a blunted 
morning rise. Feder et al. (2004) showed that anxious children exhibited a delayed nocturnal rise before 
reaching similar peak levels of cortisol near the time of awakening. Some authors have suggested that a 
blunted cortisol response measure, such as a the cortisol morning rise, can be due to a ceiling effect due 
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to already elevated basal cortisol levels (Martín del Campo et al., 2000; Burke et al., 2005b). This is 
largely in line with our own results. 
Although straightforward, the cross-sectional approach has limited our understanding of the 
temporal interplay between anxiety and HPA-axis functioning, which may have contributed to the lack 
of agreement among the different studies. 
In two recent studies, Greaves-Lord et al. (2007) have tried to address this issue. In the first 
study, they investigated a large general population sample of preadolescents. They showed that 
individuals with high prevalent anxiety levels only showed elevated morning cortisol levels and an 
elevated cortisol morning rise if they had a history of anxiety problems earlier in life. Unfortunately, the 
history of anxiety problems was determined retrospectively, which may have lead to a recall bias. 
In their second study, Greaves-Lord et al. took a prospective approach. They observed that 
cortisol levels in adolescents from the general population where not associated with anxiety problems at 
baseline and did not predict anxiety problems two years later. These results seem to contradict earlier 
research by Smider et al. (2002), who found that higher mean daytime cortisol levels at age 4.5 
predicted internalizing problems at age 6. Again, this may be due to differences in study population or 
cortisol measure used. 
Prospective studies in a clinical setting have two advantages over studies in a general population 
sample. First, as anxiety symptoms are bound to be more pronounced in a clinical group, associated 
changes in HPA-axis functioning may also be more pronounced, and thus easier to detect. Second, one 
can study the association of treatment induced changes in anxiety with the concomitant pattern of 
cortisol levels. 
Previously, Tafet et al. (2005) compared a group of 20 adults who received cognitive therapy for 
generalised anxiety disorder with 8 adults untreated for their generalised anxiety disorder. They found 
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that in the treated group only, plasma cortisol measured at 16 h was lower after treatment than at 
baseline. Plasma cortisol in the untreated group remained stable (Tafet et al., 2005). 
Our results of increased daytime cortisol levels in late and non-responders seem to be at odds 
with Tafet et al.’s findings. However, differences in population studied i.e. adults versus children and 
adolescents, cortisol measure i.e. one time point plasma cortisol versus three time point salivary cortisol 
in our study, and length of the study, i.e. 24 weeks versus 1 year make the two studies difficult to 
compare. Most importantly, Tafet et al. (2005) did not differentiate between treatment responders and 
non-responders, which makes it impossible to determine whether cortisol varies over time depending 
on treatment success. 
Our study differs from previous work in that it has a prospective, longitudinal design and is set in 
a clinical sample consisting of children and adolescents. In addition to the benefits of a prospective and 
longitudinal design, research in children and adolescents is able to study the anxiety disorder while it is 
still developing. It allowed us to show changes in cortisol functioning during the course of the anxiety 
disorder. We will now discuss several possible explanations for our results. 
First, individuals with higher daytime cortisol and/or lower control morning rise may represent a 
subgroup that is more difficult to treat successfully and hence takes longer to reach remission. Our 
results cannot easily be reconciled with this explanation, as we could not demonstrate an association 
between baseline cortisol levels and subsequent remission status. 
Second, our observations may be due to the non-remitter group having the most severe 
symptoms, either at baseline or at one year follow up. Early remitters showed a non-significant trend 
towards lower anxiety scores at baseline as compared to late remitters and non-remitters. However, 
neither at baseline nor at follow up, was anxiety severity associated with cortisol levels. 
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Third, depression severity was higher in the late and non-remitter groups. This may have 
confounded the associations. However, we addressed this by correcting for depression severity in all our 
analyses. 
Fourth, our study design did not allow us to contrast the changes in cortisol levels during 
treatment for anxiety to changes in cortisol levels occurring as part of normal development in a one-year 
period. Hence, we cannot rule out that normal age-related changes underlie part of the observed 
changes in cortisol levels. However, the differences between early, late and non-remitters cannot be 
explained easily by such age-related changes as these are, most likely, very similar in all three groups. 
Finally, the changes in cortisol levels could reflect chronic stress associated with the presence of 
an anxiety disorder. The dose–response pattern, i.e. the level of change in cortisol was related to the 
course of the anxiety disorder, strongly supports this interpretation. Indeed, there are biological studies 
in animals and humans that suggest a potential underlying mechanism for our findings. Prolonged or 
repeated stress-induced elevations in cortisol levels result in atrophy of hippocampal neurons and loss 
of synapses (Magarinos, McEwen, 1995). Damage to or atrophy of the hippocampus affects the 
glucocorticoid feedback inhibition of CRH secretion and leads to higher CRH and daytime cortisol 
concentrations (Schloesser, Manji, Martinowich, 2009). In addition, such atrophy or damage has been 
associated with a lowered or even absent cortisol morning rise (Buchanan et al., 2004; Pruessner et al., 
2007). 
The longitudinal relationship between anxiety disorders and symptoms and HPA-axis functioning 
should be a focus for further research. Clinical research should follow cases and age and sex matched 
controls prospectively over time to relate HPA-axis changes during the course of the illness to HPA-axis 
changes during the course of normal development. In addition, while studies of placebo-treated patient 
controls are ethically questionable, comparison of different treatment modalities in relation to HPA-axis 
functioning can shed light on the effect of specific treatments on HPA-axis functioning. Finally, further 
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longitudinal, research in the general population is needed to elucidate the relation between HPA-axis 
functioning and the development of anxiety symptoms and ultimately the incidence of anxiety 
disorders. 
Several methodological aspects must also be discussed. The absence of a non-treated control 
group with an anxiety disorder makes it impossible to evaluate the effect of the cognitive behavioural 
therapy on cortisol levels in this study. Unfortunately, ethical considerations prohibit withholding 
treatment for a prolonged period of time. Further, the study was conducted in a university hospital 
setting, hence referral biases may have limited the generalisability of the study sample. Primarily, our 
results can most easily be generalised to severely affected, young patients. Because our study was not 
performed under laboratory conditions, it was not possible to closely monitor adherence to the testing 
protocol and to assess the participant's sleeping pattern, this may have affected the reliability of the 
cortisol measurements. 
Finally, our study did not assess pubertal status, which is an important determinant of cortisol 
levels. Should pubertal status be related to remission status as well, this could lead to confounding. 
However, because we have a broad age range and adjusted for age, this is not very likely. 
 
CONCLUSIONS 
 
This is the first prospective study demonstrating specific changes in cortisol levels in relation to the 
trajectory of an anxiety disorder in a relatively large, clinical sample. Our findings seem to indicate that 
persistence of an anxiety disorder leads to changes in HPA-axis functioning, underscoring the 
importance of early detection and adequate treatment of anxiety disorders. 
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Chapter 7 
Stress reactivity predicts symptom improvement in children with anxiety disorders 
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ABSTRACT 
 
Background: We examined the longitudinal associations of autonomic nervous system (ANS) and 
hypothalamic-pituitary-adrenal (HPA) axis rest and reactivity measures with anxiety and depressive 
symptoms at one-year follow-up in children with anxiety disorders. 
 
Methods: In a clinical sample of 152 children with a primary DSM-IV anxiety disorder, aged 8 to 12 
years, anxiety and depressive symptoms were assessed with the Multidimensional Anxiety Scale for 
Children and the Children’s Depression Inventory at pre-treatment baseline and one year later, after 
treatment with cognitive behavioral therapy. At baseline, children participated in a 70 minutes stress 
task. Salivary cortisol was measured directly prior to and 20 minutes post stress task. Skin conductance 
level (SCL), heart rate and high frequency heart rate variability (HRV) were continuously measured 
during rest and the stress task. To investigate if rest or reactivity measures predicted anxiety and 
depressive symptoms at one-year follow-up, linear regression analyses were conducted for rest and 
reactivity measures of SCL, heart rate, HRV and cortisol separately. 
 
Results: Higher SCL reactivity predicted less decrease of anxiety symptoms at one-year follow-up. 
Cortisol reactivity showed a weak association with depressive symptoms at one-year follow-up: lower 
cortisol reactivity predicted less decrease in depressive symptoms. 
 
Limitations: Only self-reported anxiety and depressive symptoms were used. However, all predictors 
were objective biological measures, hence there is no risk of shared method variance bias. 
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Conclusions: These findings suggest that pre-treatment HPA and ANS responsiveness to stress are 
predictive biomarkers for a lack of symptom improvement in children with a clinical anxiety disorder. 
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INTRODUCTION 
 
Anxiety disorders are among the most prevalent types of psychiatric disorders experienced by children 
and adolescents (Verhulst et al., 1997; Bittner et al., 2007), with separation anxiety disorder, specific 
phobia, social phobia, and generalized anxiety disorder being the most frequent childhood anxiety 
disorders (Beesdo-Baum, Knappe, 2012). Childhood anxiety has been associated with a range of 
negative outcomes, including academic underachievement, drug dependency, and an increased risk for 
developing other psychiatric disorders (Woodward, Fergusson, 2001; Bittner et al., 2007). 
Cognitive behavioral therapy (CBT) is the treatment of choice for children with an anxiety 
disorder, with a remission rate of 59% following treatment (James et al., 2013). A 7 to 19 year follow-up 
study of the long-term outcomes of treated childhood anxiety disorders showed that patients with a 
poorer response to CBT, had higher rates of panic disorder, substance abuse and dependency in 
adulthood than the successfully treated controls (Benjamin et al., 2013). It is, therefore, important to 
identify predictors of symptom improvement in treated children with an anxiety disorder. 
Several studies tried to gain insight into clinical predictors of treatment outcome in children with 
anxiety disorders. Some studies reported that higher anxiety severity predicts a less favorable outcome 
(Compton et al., 2014; Hudson et al., 2013; Last, Hansen, Franco, 1998; Liber et al., 2010). A few studies 
showed that children with comorbid mood disorders are more likely to retain their primary anxiety 
disorder following treatment (Hudson et al., 2013; Liber et al., 2010). Various studies examined the role 
of parental characteristics as predictors of treatment outcome in children, but an inconsistent pattern of 
findings resulted (Legerstee et al., 2008; Hudson et al., 2013; Compton et al., 2014). Because clinical 
characteristics are weak or inconsistent indicators of response to CBT, there is an increasing interest in 
identifying biomarkers to predict differential treatment response (Lester, Eley, 2013). 
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Physiological stress response systems have been implicated as possible important biological 
state markers for childhood anxiety. It can be hypothesized that children with an anxiety disorder 
function under conditions of persistent stress, with an excessive and prolonged stress system activation 
(Dieleman et al., 2015). Alterations in the autonomic nervous system (ANS) have been associated with 
anxiety disorders in children; children with an anxiety disorder show a pattern of heightened activity of 
the sympathetic nervous system (Schmitz et al., 2011; Kossowsky et al., 2012; Dieleman et al., 2015) and 
diminished parasympathetic control (Schmitz et al., 2011; Dieleman et al., 2015), although some studies 
failed to show this difference (Kossowsky et al., 2012; Kristensen et al., 2014). Another major 
physiological stress response system is the hypothalamic-pituitary-adrenal (HPA) axis. Glucocorticoids 
can act both to augment and suppress autonomic mediated changes. Cross-sectional studies related 
HPA axis functioning to childhood anxiety disorders, but provided inconsistent findings (Feder et al., 
2004; Forbes et al., 2006; Krämer et al., 2012; Dietrich et al., 2013; Dieleman et al., 2015). This may 
reflect the variable methods of sampling, resting state versus stress paradigms, differences in age, 
developmental status, and diagnostic status of the study populations. Furthermore, differences in 
functioning of the HPA axis could depend on the chronicity or the severity of the disorder (Pervanidou, 
2008; Dieleman et al., 2015). 
Despite the evidence of altered pre-treatment HPA axis and autonomic functioning in anxiety-
disordered children, studies that have assessed stress physiology as a predictor of therapy outcome in 
childhood anxiety disorders are lacking. This study aims to investigate the longitudinal association of 
stress physiology at pre-treatment baseline with anxiety and depressive symptoms at one-year follow-
up in a clinical sample of anxiety disordered children treated with CBT. We hypothesize that anxiety-
disordered children with a stronger autonomic stress response, i.e. heightened activity of the 
sympathetic and diminished activity of the parasympathetic nervous system, show persistence of 
anxiety symptoms one year later. Also, we explore the longitudinal association between cortisol levels 
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and anxiety symptoms at one-year follow-up, but formulate no specific hypothesis, given the 
inconsistent results of previous studies. Furthermore, since comorbid depressive symptoms have been 
associated with a less favorable treatment outcome in children with anxiety disorders (Liber et al., 2010; 
Hudson et al., 2013) and in previous work we observed that cortisol reactivity was specifically associated 
with depressive symptoms (Dieleman et al., 2010), we will also explore the longitudinal association of 
stress physiology with depressive symptoms. 
 
METHODS 
 
Participants 
This study included 152 children, aged 8 to 12 years, referred to the outpatient clinic of the Department 
of Child and Adolescent Psychiatry of Erasmus Medical Center in Rotterdam or the University Medical 
Center in Leiden, The Netherlands. These hospitals serve as secondary or tertiary referral centers of 
South-West Netherlands. Children had a primary diagnosis of separation anxiety disorder (N=57), 
generalized anxiety disorder (N=47), social phobia (N=29) or specific phobia (N=19). All children were 
diagnosed with the Anxiety Disorders Interview Schedule for DSM-IV (Silverman, Albano, 1996). 
Exclusion criteria were: IQ < 85, poor command of the Dutch language, serious somatic disease, autism 
spectrum disorder, selective mutism, psychotic disorders, pharmacotherapy that could interfere with 
HPA axis or ANS functioning. 
 
Methylphenidate treatment in children with comorbid attention deficit hyperactivity disorder was 
discontinued the day before physiological measurements (N=7), because methylphenidate treatment 
can increase heart rate and blood pressure (Ballard et al., 1976). Children on medication for an anxiety 
disorder were withdrawn from medication, if possible, or otherwise excluded. For children with 
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comorbid attention deficit hyperactivity disorder, the dosage of medication was kept constant during 
the study as a constant dosage of medication for attention deficit hyperactivity disorder was considered 
unlikely to confound treatment effects. The Committees for Medical Ethics of Erasmus Medical Center 
and Leiden University Medical Center approved the study. 
 
 
 
Figure 1. Procedure 
Note. MAT= mental arithmetic task, SCI= social competence interview, Cort=cortisol. Cort following stress: cortisol 
levels in response to stress typically peak about 20 to 30 minutes following a stressor. 
 
Procedure 
Parents and participants signed informed consent before participation. Parents and children completed 
psychological questionnaires and a diagnostic interview before the physiological tests at the pre-
treatment baseline and at one-year follow-up. 
Physiological assessments took place in the hospital between 12.00h and 18.30h, because 
variation of cortisol levels is least in the afternoon (Wust et al., 2000). After an acclimatization period of 
45 minutes, the session began with a resting period of 10 minutes. Subsequently, a mental arithmetic 
task and, after another resting period of 10 minutes, a social competence interview were administered. 
Saliva collection took place after resting period 1 (cortisol during rest) and 20 minutes after the social 
competence interview (cortisol following stress), because cortisol levels typically peak 20 to 30 minutes 
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after stress. Figure 1 presents the temporal sequence of measures. Parents were asked to report general 
physical condition, dietary pattern and medication use of their child. For more information on 
medication use, see Appendix 1. 
 
Measures 
The Anxiety Disorders Interview Schedule for Children DSM-IV (ADIS-C) is a semi-structured interview to 
assess DSM-IV anxiety disorders in 7- to 17-year-olds (Silverman, Saavedra, Pina, 2001). A trained 
psychologist conducted the interview with the child and parents separately at pre-treatment, post-
treatment and one-year follow-up. To obtain a diagnosis, both a count of DSM-IV symptom criteria, as 
well as the level of impairment according to the parent, child, and interviewer, were taken into account. 
The parent and the child were asked to indicate on a 9-point scale (i.e., 0-8) to what extent the 
symptoms interfered with the child's daily life. Subsequently, the interviewer gave an interference rating 
(Clinician Severity Rating (CSR)), on the same 9-point scale, for the child and parent interview, 
separately. If the CSR was 4 or higher, a diagnosis was assigned. The anxiety disorder with the highest 
CSR was regarded as the primary anxiety disorder. Interviewers who administered the ADIS-C at follow-
up were blind to pre-treatment diagnoses, disease trajectory, and physiological measures. 
 
The Multidimensional Anxiety Scale for Children (MASC) is a 39-item self-report questionnaire (March et 
al., 1997), administered at pre-treatment, post-treatment and one-year follow-up, assessing anxiety 
symptoms during the last two weeks in children and adolescents. Items are scored from 0 to 3 (0 = never 
true, 1 = rarely true, 2 = sometimes true, 3 = often true). The internal consistency (.93) and one-month 
test-retest reliabilities (.81) of the Dutch translation are good (Liber et al., 2008). 
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The Children’s Depression Inventory (CDI) is an age-appropriate 27-item self-report 
questionnaire (Kovacs, 1992), administered at pre-treatment, post-treatment and one-year follow-up, 
assessing depressive symptoms in the last two weeks in children and adolescents. Items are scored from 
0 to 2 (0 = never true, 1 = sometimes true, 2 = always true). The Dutch translation showed good internal 
consistency for the total score (.82) (Liber et al., 2008), 1-month test-retest reliabilities (.72) are 
acceptable (Kovacs, 1981). 
 
Treatment 
All children participated in a standardized stepped-care CBT program for childhood anxiety disorders, 
consisting of two phases (van der Leeden et al., 2011). In the first phase, children were treated with the 
FRIENDS program, an evidence-based treatment program for anxiety disorders (Barrett, Lowry-Webster, 
Turner, 2000), which encompassed 10 child sessions and 4 separate parent sessions. The FRIENDS 
program comprised psychoeducation, relaxation and breathing exercises, exposure, problem-solving 
skills training, social support training and cognitive restructuring exercises (Shortt, Barrett, Fox, 2001; 
Liber et al., 2008). Parent sessions comprised mainly psychoeducation. All children that were not 
successfully treated in the first phase, as determined by ADIS-C at three months follow-up, received 
supplementary CBT. The second phase consisted of 10 manualized sessions, in which parents and child 
participated together in each session. See Figure 2 for the study design. Consequently, the change of 
symptoms predicted by the physiological measures reflect both the variation in natural course of 
symptoms and the effect of structured and standardized treatment all children received. 
The present study is an extension of the data collection described by Liber et al. (2008) with an 
additional 25 children. Liber et al. (2008) studied the effects of individual versus group CBT in children 
up to 12 years of age, who attended primary school. The additional 25 children comprised 6 children 
who attended primary school but could not be randomized, because they refused assignment to group 
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treatment (N=2), were absent at the start of the group (N=1), or were treated at an affiliated outpatient 
clinic near to home (N=3). The other 19 children, aged 12-13 years, attended the first grade of secondary 
school and received individual therapy because of practical reasons (time schedules differed between 
the different secondary schools). To summarize, all additional 25 children received individual treatment 
with the FRIENDS program. The efficacy of group CBT did not differ from the efficacy of individual CBT in 
children up to 12 years of age (Liber et al., 2008). 
Adherence was carefully checked as part of the treatment integrity measures. All therapy 
sessions were videotaped; a random selection of 30% of the tapes of individual sessions and all tapes of 
the group sessions were checked for adherence. Twenty-two therapists conducted the therapy sessions; 
seventeen were licensed psychologists and 5 were psychologists in the last year of their training who 
worked under close supervision of a licensed psychologist. Therapists at each institute met weekly to 
discuss the treatment and were supervised by two experienced licensed cognitive behavioral therapists. 
See Liber et al. (2008) and Van der Leeden et al. (2011) for more detailed information on treatment 
adherence and integrity. 
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Figure 2. Flowchart 
Note. CBT= cognitive behavioural therapy. 
 
Stress tasks 
The mental arithmetic task is a standardized laboratory stress task to induce measurable physiological 
changes (Kirschbaum, Pirke, Hellhammer, 1993). The mental arithmetic task lasted 4 minutes, during 
which the child was asked to subtract numbers as quickly and accurately as possible. If the child made a 
mistake or did not respond, he or she was required to start all over again. Dependent on the child’s age, 
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the child was asked to subtract 7 from 100 (<12 years), or 23 from 1021 (≥12 years), and to continue this 
subtraction till no further subtraction was possible. 
The social competence interview (Ewart, Kolodner, 1991) is a standardized stress task that 
impacts ambulatory blood pressure in adolescents (Ewart, Kolodner, 1993; Ewart, Jorgensen, Kolodner, 
1998). For this study, we used a revised version of the social competence interview, in which a stressful 
situation related to the primary anxiety diagnosis was discussed in detail with the patient. In a pilot 
study of the original social competence interview (N=8), most participants chose a topic unrelated to 
their anxiety disorder suggesting avoidance. To elicit a more pronounced physiological reaction the 
interview topic was adapted. During minutes 14-20 of the social competence interview the participant 
was asked to imagine, without speaking, that he or she was in that stressful situation again and to re-
experience the feelings and thoughts. 
 
Physiological and hormonal measures 
Cortisol assessment 
Cortisol samples were assessed with solid-phase radioimmunoassay (RIA, Diagnostic Products 
Corporation, Los Angeles; N=83) and Enzyme-Linked Immuno Sorbent Assay (ELISA, DRG-kits, Marburg, 
Germany; N=69) as the laboratory changed the standard technique during data collection. To test for 
possible effects of measurement thirty-one cortisol samples were analyzed by both RIA and ELISA. 
Correlation between both assays was high (R=.99). The slope was not equal to 1, therefore the 
concentrations in the DRG standards were adjusted by the laboratory to obtain comparable results. 
Cortisol values above 3 SD of the mean were excluded from the analysis to reduce the impact of 
outliers. 
 
Autonomic measures 
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During the experiment, continuous measurements were made of heart rate, respiration rate and skin 
conductance level (SCL) in order to assess ANS activity. For technical specifics see Dieleman et al. (2015). 
 
Analysis of physiological data 
A customised software program calculated the interbeat intervals of the ECG using R-top detection, 
resulting in interbeat interval time series during rest (minutes 7-10 of the first resting period; a 3 
minutes stationary period) and stress (minutes 17-20 of the re-experiencing part of the social 
competence interview; a period without speaking and regular breathing). Interbeat interval time series 
were transformed to heart rate series. We conducted spectral analysis of these intervals using discrete 
Fourier transformation (Van Steenis, Tulen, Mulder, 1994). For each time segment, we calculated mean 
heart rate and high frequency heart rate variability (HRV; 0.14-0.50 Hz), the last parameter as a proxy 
for the parasympathetic component of autonomic cardiac control. Because HRV is strongly correlated 
with respiratory sinus arrhythmia (Kamath, Fallen, 1993), respiratory frequency was monitored and 
controlled for. Time segments with more spectral power for respiration in the mid frequency band than 
in the high frequency band were discarded from HRV analyses. This resulted in the removal of 1 subject 
for the respective analyses. Mean SCL levels were computed during rest and stress periods as 
parameters reflecting sympathetic ANS activity. 
 
Data analysis 
Measures of depressive symptoms, SCL, cortisol and HRV were log-transformed to approach a normal 
distribution. Means of heart rate, HRV and SCL were defined for two periods: minutes 7-10 of the first 
resting period and minutes 17-20 of the re-experiencing part of the social competence interview. 
Subsequently, stress reactivity in heart rate, HRV and SCL were calculated by subtracting the rest value 
from the value during the social competence interview. To characterize cortisol reactivity to stress, we 
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calculated a difference score by subtracting cortisol levels during rest from cortisol levels collected 20 
minutes after the social competence interview. Pearson correlation coefficients between autonomic and 
cortisol measures during baseline and social competence interview were calculated. 
The focus of our analyses was on stress reactivity measures. To investigate if reactivity measures 
of autonomic and HPA axis functioning predicted anxiety symptoms at one-year follow-up, linear 
regression analyses were conducted for reactivity measures of SCL, HRV, heart rate and cortisol levels, 
separately. Anxiety symptoms at one-year follow-up were entered as dependent variable. To control for 
possible effects of age, gender, pre-treatment anxiety symptoms and depressive symptoms at one-year 
follow-up, all were entered to the first model as independent variables. Subsequently, reactivity 
measures of SCL, HRV, heart rate and cortisol in response to the social competence interview were 
additionally entered in the second block as independent variables, all controlled for their respective rest 
measures. Second, these analyses were repeated separately for rest measures of SCL, HRV, heart rate 
and cortisol. 
Finally, the analyses described above for anxiety symptoms at one-year follow-up were repeated 
with depressive symptoms at one-year follow-up as the outcome measure. These analyses were 
controlled for possible effects of pre-treatment depressive symptoms and anxiety symptoms at one-year 
follow-up. 
Effect sizes are reported as R squared, with .01 defined as a small effect size, .09 as a medium 
effect size and .25 as a large effect size (Cohen, 1988). A post hoc power calculation was performed to 
compute the achieved power given the final sample size and effect size. The achieved power was 0.71, 
based on an α-error probability of 0.05. All statistical analyses were performed with SPSS 21.0. 
 
RESULTS 
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Sample characteristics 
Group characteristics, diagnoses and comorbidity at pre-treatment and at one-year follow-up are 
presented in Table 1. Thirty-seven percent had a primary diagnosis of separation anxiety disorder, 30.5 
% a primary diagnosis of generalized anxiety disorder, 18.8% a primary diagnosis of social phobia and 
12.3 % a primary diagnosis of specific phobia. Comorbidity rates at pre-treatment were high; 55.3% had 
a single clinical anxiety disorder only, 30.9% had two clinical anxiety disorders, 11.8% had three clinical 
anxiety disorders, and 2.0% had four clinical anxiety disorders (Dieleman et al., 2015). A paired samples 
T-test showed that anxiety and depressive symptoms measured at one-year follow-up were, on average, 
lower than at pre-treatment (respectively T=12.81, p< .001; T=12.8, p<.001). After treatment, 75% of the 
sample recovered from their anxiety disorder under standardized CBT treatment. The prevalence of 
comorbid behavioral and mood disorders was reduced by approximately 50% at one-year follow-up. 
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Table 1. Sample characteristics 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. SD = standard deviation, ADIS-C= Anxiety Disorders Interview Schedule for DSM-IV, GAD = generalized 
anxiety disorder, SoPh = social phobia, SAD = separation anxiety disorder, SpPh = specific phobia, PD = panic 
disorder, OCD = obsessive compulsive disorder, PTSD = posttraumatic stress disorder, ADHD = attention deficit 
hyperkinetic disorder, ODD = oppositional defiant disorder, CD = conduct disorder, DD = depressive disorder, DysD 
= dysthymic disorder, *= p<.05, **=p<.01, ***=p<.001. 
 
 
 
 
Measures 
At baseline 
 
Mean (SD) 
N=152 
At one year follow up 
 
Mean (SD) 
N=143 
Age 10.2 (1.54) - 
Gender 53.3% boys, 46.7% girls - 
Anxiety symptoms*** 51.37 (17.72) 27.57 (15.36) 
Depressive symptoms*** 9.61 (7.04) 3.43 (4.72) 
Loss to follow-up - 9 (5.9) 
Anxiety disorders ADIS-C 
At baseline 
 
Count (% of total sample) 
At one year follow up 
 
Count (% of total sample) 
No anxiety diagnosis - 114 (75.0) 
GAD 75 (49.3) 14 (9.2) 
SoPh 49 (32.2) 9 (5.9) 
SAD 46 (30.3) 13 (8.6) 
SpPh 48 (31.6) 14 (9.2) 
Comorbid disorders ADIS-C 
At baseline 
 
Count (% of total sample) 
At one year follow up 
 
Count (% of total sample) 
PD - 1 (.7) 
OCD - 1 (.7) 
PTSD - - 
ADHD 15 (9.7) 7 (4.6) 
ODD 10 (6.5) 3 (2.0) 
CD 3 (1.9) - 
DD 2 (1.3) 4 (2.7) 
DysD 8 (5.2) 1 (.7) 
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Table 2. Pre-treatment descriptives of the autonomic and cortisol parameters during rest and stress, for the whole group 
Parameters 
 
Mean (SD) 
Cortisol 
during rest^ 
(nmol/l) 
Cortisol 
following stress^ 
(nmol/l) 
Skin conductance 
level during rest^ 
(μS) 
Skin conductance 
level during stress^ 
(μS) 
Heart rate variability 
during rest^ 
(ms2) 
Heart rate variability 
during stress^ 
(ms2) 
Heart rate 
during rest 
(bpm) 
Hea   
dur   
(bp  
Cortisol during rest^ 
.76 nmol/l (.25)  
1 .73** -.06 -.12 .12 .14 
 
.05 
 
.14 
Cortisol following stress^ 
.71 nmol/l (.23)  
 1 -.24** -.28** .09 .10 
 
.03 
 
.06 
Skin conductance level during rest^ 
.57 μS (.28)  
  1 .92** -.10 -.07 
 
.20* 
 
.24  
Skin conductance level during stress^ 
.71 μS (.28) 
   1 -.11 -.10 
 
.16 
 
.25  
HF Heart rate variability during rest^ 
3.40 ms2(.41) 
    1 .64** 
 
-.41** 
 
-.31  
HF Heart rate variability during stress^ 
3.45 ms2 (.32) 
     1 
 
-.45** 
 
-.44  
Heart rate during rest 
81.0 bpm (11.0) 
      
 
1 
 
.92  
Heart rate during stress 
80.0 bpm (10.5) 
      
  
1 
Note. ^ log transformed , significant correlations are indicated with: *= p<.05, **=p<.01 
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Descriptives 
During the social competence interview, we observed a significant increase in SCL as compared to rest 
levels (mean difference = .13, standard deviation = .11, paired samples T-test: T=12.41, p< .001). Mean 
(SD) levels and Pearson correlation coefficients of autonomic and cortisol measures are presented in 
Table 2. Pearson correlation coefficients showed that all measures during rest were significantly 
correlated with the equivalent measures during the social competence interview. There were no 
significant relations between SCL, HRV, heart rate and cortisol measures during rest and anxiety 
symptoms or depressive symptoms at one-year follow-up. 
 
Longitudinal association of stress physiology with anxiety symptoms at one-year follow-up 
The results of the regression analyses for reactivity measures and anxiety symptoms at one-year follow-
up are presented in Table 3. As shown, SCL reactivity to stress was positively associated with change of 
anxiety symptoms at one-year follow-up. The effect size was small to medium with a R2change of .06. In 
other words, higher SCL reactivity was associated with less decrease in anxiety symptoms at one-year 
follow-up. To check that our significant results were not due to medication effects, we did a secondary 
analysis controlled for medication use. The effect size and p-value were comparable (R2change=.07, 
p=.008, N=91), which indicated that our findings were not influenced by the use of medication. 
 
Longitudinal association of stress physiology with depressive symptoms at one-year follow-up 
The association of reactivity measures with depressive symptoms at one-year follow-up is presented in 
Table 4. As shown, there was a weak negative association of cortisol reactivity to stress with change of 
depressive symptoms at one-year follow-up. The effect size was small with a R2change of .03. In other 
words, lower cortisol reactivity was associated with less decrease in depressive symptoms at one-year 
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Table 3. Longitudinal association of pre-treatment autonomic and cortisol measures with anxiety symptoms at one-year follow-up 
   
Anxiety symptoms at 1 year follow-up 
N=107~ 
 
 
 
Variable  B SE B Beta T R2change F for change in  R2 p for chang     
 
Age .3 .9 .03 .3 
 
 
 
 
              .17 
       
            6.0***              .000 
 
Gender 4.0 2.7 .13 1.5 
 
Anxiety symptoms pretreatment .13 .08 .15 1.6 
Depressive symptoms at 1 year follow-up^ 13.2 3.5 .3 3.8*** 
 
Reactivity measures        
 
Cortisol difference adj^ (nmol/l) 7.2 9.5 .09 .8 .01 .6 .45 
 
Skin conductance level (μS) difference adj^ (μS) 33.1 12.3 .26 2.7 .06    7.3** .008 
HF Heart rate variability difference adj ^ (ms2) 2.3 5.3 .05 .4 .00 .2 .66 
Heart rate difference adj (bpm) -.05 .34 -.01 -.14 .00 .02 .89 
 
Note. HF= high frequency, ^ log transformed, difference= test-rest measure, adj=analysis is adjusted for rest measure. R2 change = explained variance for adding 
this step, ~ = number of patients available for cortisol difference analysis (for skin conductance level difference analysis N=100, for HF Heart rate variability 
difference N=105, for heart rate difference analysis N=105), # = p<.1, *= p<.05, **=p<.01, ***=p<.001.
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Table 4. Longitudinal association of pre-treatment autonomic and cortisol measures with depressive symptoms at one-year follow-up 
   
Depressive symptoms at 1 year follow-up 
N=105~ 
 
 
 
Variable  B SE B Beta T R2change F for change in  R2 p for chang     
 
Age -.01 .02 -.05 -.6 
 
 
 
 
               .24 
       
             9.3***              .000 
 
Gender -.04 .06 -.05 -.6 
 
Depressive symptoms pretreatment .4 .1 .36 4.4*** 
Anxiety symptoms at 1 year follow-up^ .01 .00 .3 3.8*** 
 
Reactivity measures        
 
Cortisol difference adj^ (nmol/l) -.4 .2 -.2 -1.9 .03 3.7 .058  
 
Skin conductance level (μS) difference adj^ (μS) .3 .3 .1 1.8 .01 .95 .33 
HF Heart rate variability difference adj ^ (ms2) .04 .13 .04 .3 .00 .09 .77 
Heart rate difference adj (ms) .01 .01 .09 .94 .01 .88 .35 
 
Note. HF= high frequency, ^ log transformed, difference= test-rest measure, adj=analysis is adjusted for rest measure. R2 change = explained variance for adding 
this step, ~ = number of patients available for cortisol difference analysis (for skin conductance level difference analysis N=100, for HF Heart rate variability 
difference N=105, for heart rate difference analysis N=105), # = p<.1, *= p<.05, **=p<.01, ***=p<.001. 
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follow-up. To check that our significant results were not due to medication effects, we did a secondary 
analysis controlled for medication use. The effect size and p-value were comparable (R2change=.03, 
p=.063, N=96), which indicated that our findings were not influenced by the use of medication. 
 
DISCUSSION 
 
Principal findings 
This clinical study of pediatric anxiety disorders showed that children with higher pre-treatment SCL 
reactivity to stress, as a proxy of sympathetic reactivity, responded less to treatment. Their anxiety 
symptoms decreased less over a one-year period as compared to children with a lower pre-treatment 
SCL reactivity. Furthermore, children with lower pre-treatment cortisol reactivity showed less decrease 
of depressive symptoms. 
 
Autonomic nervous system 
To our knowledge, this is the first longitudinal study that uses ANS functioning as a predictor of 
treatment outcome in children with an anxiety disorder. Heightened activity of the sympathetic nervous 
system is associated with anxiety disorders in children (Schmitz et al., 2011; Kossowsky et al., 2012; 
Dieleman et al., 2015). Our study showed that higher sympathetic reactivity in response to a stressor 
predicted less improvement in anxiety symptoms one year later. The autonomic nervous system 
regulates critical life functions on a moment-to-moment basis through its sympathetic and 
parasympathetic branches. To be able to respond to a threatening situation, the body prepares itself for 
fight or flight. This autonomic activation leads to an increase in heart rate, blood pressure, sweat gland 
activity, and respiration. Subjectively, the individual feels tense and flushed, has palpitations, shortness 
of breath and increased perspiration. We carefully speculate that anxiety disordered children with a 
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higher reactivity of the sympathetic nervous system, also experience more physiological and subjective 
arousal in response to daily fear or stress. As a consequence, higher sympathetic reactivity may 
influence the natural course of anxiety disorders or the efficacy of standardized CBT. 
Our study failed to show a longitudinal association of the parasympathetic function of the ANS 
(HRV) with anxiety or depressive symptoms one year later. Although ANS functioning, with a primary 
focus on parasympathetic functioning, has been repeatedly studied as a predictor of outcome in adult 
studies, results are inconsistent (Bornas et al., 2007; Alpers, Sell, 2008; Davies et al., 2015). Studies that 
have investigated the cross-sectional association between parasympathetic functioning and childhood 
anxiety disorders have been inconsistent as well (Schmitz et al., 2011; Kossowsky et al., 2012; Kristensen 
et al., 2014; Dieleman et al., 2015). 
 
HPA-axis 
A less responsive HPA-axis to stress predicted less decrease in depressive symptoms one year later. 
However, the effect size was small. Only a few studies investigated HPA-axis reactivity in response to a 
psychological stressor in depressed children in comparison with healthy controls (Luby et al., 2003; 
Hankin et al., 2010; Suzuki et al., 2013). Compared to non-depressed peers, depressed preschoolers 
show a blunted reactivity (Luby et al., 2003; Suzuki et al., 2013), but higher peak cortisol levels to a 
psychosocial stressor (Luby et al., 2003). The pattern of blunted reactivity to mild stressors remained at 
24-month follow-up in children with a history of major depressive disorder (Suzuki et al., 2013). Also, 
prepubertal dysphoric children exhibit cortisol hyporeactivity to a psychosocial challenge task (Hankin et 
al., 2010). 
Glucocorticoids can act both to augment and suppress sympathetically mediated changes in 
cardiovascular function, metabolism, and immune function. Normally, activation of these stress systems 
leads to behavioral and physical adaptive changes that improve an organism’s ability to survive 
P a g e  | 200 
 
(Sapolsky, 2002). Possibly, anxiety disordered children with a less responsive HPA-axis to stress might be 
more susceptible to persistence of depressive symptoms, because a less adaptive HPA-axis leads to 
more difficulties in mobilizing energy resources to sufficiently cope with stress (Hankin et al., 2010). This 
might underlie the impaired effects of treatment strategies and, as a result, persistence of depressive 
symptoms. 
Lower cortisol reactivity to stress has been consistently reported in depressive disorders across 
the age span (Burke et al., 2005; Lopez-Duran, Kovacs, George, 2009; Harkness, Stewart, Wynne-
Edwards, 2011; Suzuki et al., 2013). The mechanism underlying lower cortisol reactivity may reflect 
down-regulation of the HPA axis, because chronic stress repeatedly over-activates and eventually 
impairs the HPA axis (Gunnar, Vazquez, 2001; Herman et al., 2005; Juster, McEwen, Lupien, 2010; Suzuki 
et al., 2013). Our results are in line with such a habituation of the stress system. Thus, an alternative 
explanation is that this low HPA-axis reactivity signals a vulnerability of a subgroup of children with 
anxiety disorders. 
 
Strengths and limitations 
The strengths of our study include the large clinical cohort of pediatric anxiety disorders, the prospective 
design and the standardized treatment approach. Yet, some important limitations need to be addressed. 
First, results from our sample cannot be directly extrapolated to other clinical samples with different 
distributions of age, primary diagnoses, and comorbidity rates. Comorbidity rates and the distribution of 
primary anxiety diagnoses in this sample will exert its effects on the functioning of both stress systems. 
Nonetheless, selecting samples without comorbidity does not represent the reality of most clinical 
settings (Dieleman et al., 2015). Further research is needed to corroborate our findings in other clinical 
samples of anxiety disordered children. Second, several epidemiological studies have demonstrated that 
perceived family support is a protective factor for the development of affective symptoms in children 
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and adolescents (Klasen et al., 2015). In the present study, we did not control for the effect of perceived 
family support. However, a recent study by Jongerden et al. (2015) showed that most family and 
parenting variables do not predict referral in a non-referred sample of anxious children. Only child 
reported parental autonomy granting increased the odds of referral, while child reported overprotection 
decreased the odds of referral. Further, data on Tanner stage are lacking, but variation in developmental 
status is minimized through the inclusion of only children below 13 years. 
In the present study, we used only self-reported anxiety and depressive symptoms. However, 
although the outcome parameters were assessed with self-report measures, all predictors were 
objective biological measures, hence there is no risk of shared method variance bias. 
Another aspect is that the stress task did not elicit a significant increase in mean cortisol 
compared to baseline, or significant alterations in mean heart rate and HRV, although we observed a 
significant increase in SCL as compared to rest levels, which showed that the social competence 
interview is capable of eliciting an autonomic stress response. A possible explanation might be that 
coming into the laboratory itself may have served as a significant stressor for some of these anxiety 
disordered children, suggestive of anticipatory anxiety, with already high cortisol levels after the first 
resting period. To address this phenomenon, all reactivity values were corrected for their corresponding 
values during rest. 
Despite these limitations, the present findings may have several implications for further 
research and clinical practice. If replicated, our results suggest that pre-treatment HPA and ANS 
reactivity to stress are candidate predictors of a lack of symptom improvement in children with a clinical 
anxiety disorder. Given the small to medium effect sizes of HPA and ANS reactivity to stress as 
predictors of anxiety and depressive symptom improvement in this study, we emphasize the importance 
of combining multiple predictors, such as clinical and demographic factors, polygenic risk scores, and 
neuroimaging measures, to enhance the predictive power. In conclusion, our study shows that pre-
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treatment HPA and ANS reactivity to stress are longitudinally associated with a change in anxiety and 
depressive symptoms at one-year follow-up in a clinical sample of pediatric anxiety disorders. 
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Figure 1. Medication use during last two months 
 
 
 
Figure 2. Type of medication use in last two months 
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GENERAL DISCUSSION 
 
Anxiety is a basic emotion, not typically pathologic but commonly adaptive when it facilitates 
anticipation to a threat or danger. However, when children perceive the world as full of threats and 
dangers, with no possibility to relax and to regard their living environment as safe, anxiety becomes 
pathologic (Sapolsky, 2002). Variations in the activity of the hypothalamic-pituitary-adrenal (HPA) axis 
and the autonomic nervous system (ANS), two major physiological stress systems, have been 
implicated as possible biological markers of pathological anxiety in children (Feder et al., 2004; 
Dietrich et al., 2007). Normally, activation of these stress systems leads to behavioral and physical 
adaptive changes that improve an organism’s ability to survive. In children with an anxiety disorder, 
the persistent stress they experience might lead to an excessive and prolonged stress system 
activation. In the current thesis, we focused on the role of stress physiology as a cause, correlate, and 
predictor of pediatric anxiety disorders with the ultimate goal to improve treatment and prognosis. 
More specifically, the series of studies described in this thesis examined the specificity of the 
association of stress physiology with child anxiety problems, given the high co-occurrence with other 
anxiety, externalizing and depressive problems. In addition, the studies examined the trajectory of an 
anxiety disorder and the concomitant changes in stress physiology, and stress physiology as a 
predictor of therapy outcome. In this chapter the main findings are summarized and discussed in a 
broader context. The chapter concludes with implications for research and clinical practice together 
with considerations for future studies. 
 
MAIN FINDINGS 
 
Autonomic nervous system 
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Of fraidy-cats and wild tigers 
Pure anxiety problems have a low prevalence at toddler age, but become more prevalent with 
increasing age (Gilliom, Shaw, 2004; Basten et al., 2016). To some extent, many fears and anxieties in 
pre-school aged children are age-appropriate and reflect normal development (Egger, Angold, 2006). 
There is a need to discern persistent anxiety problems from normal development and to identify early 
risk factors for deviant developmental pathways. This is complicated by the fact that internalizing and 
externalizing problems in childhood often co-occur (Fanti, Henrich, 2010), show heterotypic stability 
(Basten et al., 2016), and have unique causes as well as shared causes (Mathiesen, Sanson, 2000). The 
study described in Chapter 4 was designed to disentangle the longitudinal associations between infant 
autonomic functioning and early childhood internalizing and externalizing problems, in a large general 
population sample. We showed that infant autonomic functioning (at 14 months) differentially predicts 
internalizing and externalizing problems at the age of 6, but only after mutually adjusting for the 
broadband scales. In a fully adjusted model, a higher infant heart rate and lower infant heart rate 
variability were associated with a stronger increase in internalizing symptoms during follow-up. In 
addition, lower infant heart rate and higher infant heart rate variability were associated with a less 
strong decrease of the child externalizing symptoms during follow-up. 
Ideally potential risk factors for the development of serious problem behavior would be 
measured before the onset of such behaviors. Most previous studies that examined the association 
between autonomic arousal and problem behavior in children used a cross-sectional study design 
(Posthumus et al., 2009; El-Sheikh, Hinnant, Erath, 2011) or, in case of a longitudinal design, measured 
autonomic arousal beyond infancy (Hinnant, El-Sheikh, 2013; Hastings, Kahle, Nuselovici, 2014). This 
increases the possibility of reverse causality, a situation in which the outcome precedes and causes the 
exposure instead of the other way around. This study stresses the importance of using a longitudinal 
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design over a developmental sensitive period when studying early risk factors for the continuity of 
problems among preschool children. 
 In a previous study in this sample, a higher heart rate in infants predicted more internalizing 
problems at the age of 3 years, but there was no association with externalizing problems at 18 months 
or 3 years (Dierckx et al., 2011, 2014). Results with diurnal cortisol measures in this sample were 
consistent with this finding (Saridjan et al., 2014). Explanations for the differences in results compared 
to the current study might lie in the developmental pathways of internalizing and externalizing 
problems. Externalizing problems tend to decrease beyond toddler age, while pure internalizing 
problems have a low prevalence at toddler age, but become more prevalent with increasing age 
(Gilliom, Shaw, 2004). Using latent profile analysis, the study by Basten et al. (2016) showed that a 
profile with predominantly internalizing problems was only discernible at 6 years, while at earlier ages 
internalizing problems were less prevalent, mild and typically accompanied by at least mild levels of 
externalizing problems. In contrast, a profile characterized by moderate externalizing problems and 
emotionally-reactive behavior was visible at all ages, but the prevalence of this profile was higher in 
infancy than in early childhood. Therefore, higher scores for externalizing problems are less common 
and arguably more deviant with increasing age. Our data suggest that low autonomic arousal is a marker 
for the development of more deviant, externalizing problems during childhood and shows less 
association with the highly prevalent emotional reactive externalizing behavior seen in infants and 
toddlers, while high autonomic arousal might be a marker of early and persistent internalizing problems. 
 
Of fraidy-cats 
Maladaptive and pathologic anxiety is characterized by persisting or extensive degrees of anxiety and 
avoidance associated with subjective distress or impairment (American Psychiatric Association, 2000). 
The study in Chapter 5 confirms previous findings in studies with children with anxiety symptoms 
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regarding autonomic functioning: children with a clinical anxiety disorder have a pattern of elevated 
sympathetic (re)activity, and lowered parasympathetic activity compared to same-aged children from a 
general population sample. With respect to sympathetic ANS functioning, there was a dose-response 
effect; children with a high anxiety ‘load’ exhibited higher levels of sympathetic activity in comparison 
with children with a low anxiety ‘load’. The results were consistent after correcting for externalizing and 
depressive symptoms. Our results are in support of the hypothesis that a child with a clinical anxiety 
disorder functions under chronic stressful conditions, with concomitant changes in the activity of the 
ANS. This notion is underlined by the finding that there is a dose-response effect between clinical ‘load’ 
and sympathetic functioning. This might indicate that there are already biological underpinnings of the 
‘load’ of anxiety disorders in childhood, which could be predictive of adverse outcomes later in life. 
Applying cross-sectional research designs, previous studies found high comorbidity rates among 
different types of anxiety problems (Newman et al., 1996; Masi et al., 1999; Essau, Conradt, Petermann, 
2000; Verduin, Kendall, 2003). The high degree of comorbidity amongst anxiety disorders in children and 
adolescents seems to point in the direction of one taxonomic construct, instead of separate disorders. 
The results of the clinical study of pediatric anxiety disorders in Chapter 5 underline the hypothesis that 
basal parasympathetic activity and sympathetic (re)activity relate to anxiety disorders in general. In 
addition, this study shows that only a clinical main diagnosis of specific phobia can be discerned from 
social phobia and separation anxiety disorder on higher sympathetic functioning during basal and stress 
conditions, even in the presence of high comorbidity rates and after correcting for externalizing and 
depressive symptoms. Other lines of research also support the idea of specific phobia as a distinct 
taxonomic entity. In a population-based twin registry, lifetime diagnoses for six anxiety disorders 
(generalized anxiety disorder, panic disorder, agoraphobia, social phobia, animal phobia, and situational 
phobia) were obtained during personal interviews (Hettema et al., 2005). The authors concluded that 
genetic factors predispose to two broad groups of disorders dichotomized as panic-generalized-
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agoraphobic anxiety versus the specific phobias. Social phobia was regarded as an intermediate as it was 
influenced by both genetic factors. Further evidence for specific phobia as a specific taxonomic entity 
comes from longitudinal studies: specific phobia exclusively predicts specific phobia from childhood or 
adolescence to adulthood (e.g. Pine et al., 1998). The psychophysiological correlates of clinical specific 
phobia in our study confirm the existing genetic and longitudinal evidence for specific phobia as a 
separate taxonomic construct. 
 
The need to treat 
As shown in Chapters 4 and 5, heightened autonomic arousal is longitudinally associated with early and 
persistent internalizing behavior and is cross-sectionally associated with anxiety disorders in children. 
The results of the clinical study of pediatric anxiety disorders in Chapter 7 show that children with higher 
pretreatment sympathetic reactivity in response to a stressor have less improvement in anxiety 
symptoms one year later. Their anxiety symptoms decreased less over a one-year period as compared to 
children with a lower pre-treatment sympathetic reactivity. We carefully speculate that anxiety 
disordered children with a higher reactivity of the sympathetic nervous system, also experience more 
physiological and subjective arousal in response to daily fear or stress. As a consequence, individuals 
with a more reactive sympathetic nervous system might be less capable of transferring treatment 
strategies from the therapy room into daily life, because they experience more physiological en 
subjective arousal when exposing themselves to anxious situations in daily life. Accordingly, higher 
sympathetic reactivity may influence the natural course of anxiety disorders or the efficacy of 
standardized cognitive behavioral therapy. This study failed to show a longitudinal association of the 
parasympathetic function of the ANS with anxiety or depressive symptoms one year later. Although ANS 
functioning, with a primary focus on parasympathetic functioning, has been repeatedly studied as a 
predictor of outcome in adult studies, results are inconsistent (Bornas et al., 2007; Alpers, Sell, 2008; 
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Davies et al., 2015). Studies that have investigated the cross-sectional association between 
parasympathetic functioning and childhood anxiety disorders have been inconsistent as well (Schmitz et 
al., 2011; Kossowsky et al., 2012; Kristensen et al., 2014; Dieleman et al., 2015). Based on the current 
and previous studies, I hypothesize that in children with a clinical anxiety disorder pretreatment 
sympathetic functioning as compared to parasympathetic functioning is a more informative predictor of 
posttreatment anxiety symptoms. 
 
Hypothalamic-pituitary-adrenal axis 
Of fraidy-cats and feeling blue 
A substantial body of evidence has shown that anxiety and depressive symptoms in children and 
adolescents are often comorbid (e.g. Essau, Conradt, Petermann, 2000, Costello et al., 2003; Ferdinand 
et al., 2005). Anxiety and depression can be two different valid constructs that often co-occur, or they 
could be different manifestations of the same underlying vulnerability. The tripartite model, by Clark 
and Watson (1991), hypothesizes that physiological hyperarousal is specific for anxiety. Physiological 
hyperarousal as defined by the model of Clark and Watson is a concept based on anxiety and depression 
questionnaires. The study described in Chapter 3 attempts to quantify the concept of physiological 
hyperarousal by using cortisol (re)activity as a proxy for physiological hyperarousal in order to make it 
more tangible and applicable. In a general population sample of children higher rates of depressive 
symptoms were associated with less reactive HPA-axis functioning in response to a stress task. There 
was no relation between anxiety symptoms and any of the cortisol measures. Our results provided some 
evidence that in a general population sample, reactive HPA-axis functioning can differentiate between 
anxiety and depressive problems in children. An explanation for the lack of significant findings for 
anxiety symptoms in relation to cortisol (re)activity could be that alterations in HPA-axis functioning only 
occurs in children with a clinical anxiety disorder. In this general population sample the number of 
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subjects with clinical anxiety and depression was relatively low. An alternative explanation for our 
findings could be that altered HPA-axis functioning, as a preexisting trait, leads to a clinical anxiety or 
depressive disorder, but is not related to normal variation in levels of anxiety. The results of the study 
described in Chapter 7 are in line with the results of the study described in Chapter 3, as this clinical 
study of pediatric anxiety disorders showed that children with lower pre-treatment cortisol reactivity 
showed less decrease of depressive symptoms. A less responsive HPA-axis to stress predicted less 
decrease in depressive symptoms one year later. This study is discussed in more detail later on in this 
discussion. 
 
Of fraidy-cats 
The chronic and pathological anxiety experienced by children and adolescents in a clinical population 
may have a great impact on the developing HPA-axis and impair its future functioning. The study in 
Chapter 5 focused on whether basal HPA-axis functioning could distinguish children (N=154) aged 8-12 
years with different primary clinical anxiety disorders (separation anxiety disorder, generalized anxiety 
disorder, social phobia and/or specific phobia) from a same-aged general population reference group 
(N=225) and from each other. This study showed that children with a clinical anxiety disorder have a 
pattern of hypoactivation of basal HPA-axis functioning compared to same-aged children from a general 
population sample. These results remained the same after correcting for externalizing and depressive 
symptoms. One of the most robust and striking results of this study is the low diurnal cortisol levels at 
noon and in the evening in children with a clinical anxiety disorder. Within the clinical anxiety group, the 
severity of the disorder, or the clinical ‘load’, resulted in an even lower diurnal cortisol level at noon and 
a trend for a lower diurnal cortisol profile in the evening. 
At least two causal pathways leading to hypocortisolism in clinical anxiety disorders are 
conceivable. First, altered physiological functioning, as a vulnerability factor, could influence the 
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expression of clinical anxiety disorders. Following this line of reasoning, moderate changes in stress 
physiology might predispose to increased internalizing problems. The findings of Saridjan et al. (2014) in 
the Generation R study support this theory. Basal HPA-axis functioning in predicted an increase of 
internalizing problems in pre-schoolers. These results suggest that variations in diurnal cortisol patterns 
early in life precede internalizing problems in a general population sample. Second, chronic and 
pathological anxiety problems, interfering with daily life and leading to a clinical anxiety disorder, might 
have a different effect on physiological functioning than temporarily heightened, subclinical anxiety 
symptoms. In subclinical anxiety, the first symptoms of exacerbated worrying, fear and anxiety might 
lead to an initial increase in adrenocortical activity, i.e. hypercortisolism. When anxiety symptoms 
become clinical and persist, compensatory mechanisms become activated and gradually result in an 
attenuation of cortisol secretion, i.e. hypocortisolism. Evidence in support of this theory comes from 
animal studies. Herman et al. (2005) state that chronic stress leads to two mechanisms in animals. First, 
facilitation: a new stressor leads to a stronger increase in cortisol in chronically stressed animals 
compared to non-stressed animals, and second, habituation: a chronic stressor in chronically stressed 
animals leads to a progressive decrease in cortisol. Our results are in line with the habituation 
hypothesis of chronic stress in animal research. 
 
The need to treat 
Persistence of an anxiety disorder in childhood could have life-long consequences for the 
neuroendocrine system, general health, and well-being, underscoring the need for prospective, 
longitudinal research. The study in Chapter 6 investigated associations between the trajectory of an 
anxiety disorder and the concurrent changes in cortisol levels in a clinical sample of children and 
adolescents during one year. All children and adolescents received a standardized stepped-care CBT-
program for childhood anxiety disorders. Overall, there was an increase in diurnal cortisol between pre-
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treatment baseline and one-year follow-up, which was dependent on the trajectory of the anxiety 
disorder. The mean increase in diurnal cortisol after treatment seems comparable to the mean diurnal 
cortisol of the reference group described in the study in Chapter 5. However we did find differences in 
cortisol levels at baseline  related to the subsequent course of the anxiety disorder;  the  increase in 
diurnal cortisol was most pronounced for non-remitters, intermediate in late remitters and less obvious 
in early remitters. Depression severity was higher in the late and non-remitter groups. In a meta-
analysis, Burke et al. (2005) showed that cortisol levels are generally elevated in depressive adults 
during recovery. Possibly, the relation between the trajectory of an anxiety disorder and concurrent 
changes in diurnal cortisol is confounded by comorbid depressive symptoms. However, we addressed 
this by correcting for depression severity in all our analyses. Another explanation for the differences 
between these trajectories might be that a stronger increase in diurnal cortisol signals a vulnerability of 
a subgroup of children with anxiety disorders that do not respond well to treatment. Overall, in this 
study cortisol morning rise did not differ significantly between baseline and follow-up. However, there 
was a trend for cortisol morning rise to increase in early and late remitters, whereas it decreased in non-
remitters. At one-year follow-up, this corresponded with significant differences between the groups, 
with lowest cortisol morning rise in non-remitters, followed by late remitters and the highest cortisol 
morning rise in non-remitters. These results are consistent with a dose–response effect,  the longer 
participants were anxious the more pronounced the changes in cortisol. 
Indeed, there are biological studies in animals and humans that suggest a potential underlying 
mechanism for our findings. Prolonged or repeated stress-induced elevations in cortisol levels result in 
atrophy of hippocampal neurons and loss of synapses (Magarinos, McEwen, 1995). Damage to or 
atrophy of the hippocampus affects the glucocorticoid feedback inhibition of CRH secretion and leads to 
higher CRH and daytime cortisol concentrations (Schloesser, Manji, Martinowich, 2009). In addition, 
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such atrophy or damage has been associated with a lowered or even absent cortisol morning rise 
(Buchanan et al., 2004; Pruessner et al., 2007).  
The study design did not allow us to compare the changes in cortisol levels during treatment for 
anxiety with changes in cortisol levels occurring as part of normal development in a one-year period. For 
that, a control group that did not receive any treatment during this period would have been necessary. 
However, it would have been unethical to deny children with a clinical aniety disorder treatment for the 
duration of one year. Hence, we cannot rule out that normal age-related changes underlie part of the 
observed changes in cortisol levels. However, the differences between early, late and non-remitters 
cannot be explained easily by such age-related changes as these are, most likely, very similar in all three 
groups. 
 In children and adolescents, research focusing on the relation between anxiety and the HPA-axis 
has mainly been cross-sectional in nature. Although straightforward, the cross-sectional approach has 
limited our understanding of the temporal interplay between anxiety and HPA-axis functioning, which 
may have contributed to the lack of agreement among the different cross-sectional studies. Prospective 
studies in a clinical setting have two advantages over studies in a general population sample. First, as 
anxiety symptoms are bound to be more pronounced in a clinical group, associated changes in HPA-axis 
functioning may also be more pronounced, and thus easier to detect. Second, one can study the 
association of treatment induced changes in anxiety with the concomitant pattern of cortisol levels. In 
addition to the benefits of a prospective and longitudinal design, research in children and adolescents is 
able to study the anxiety disorder while it is still developing.  
The study in Chapter 6 investigated associations between the trajectory of an anxiety disorder 
and the concurrent changes in cortisol levels in a clinical sample of children and adolescents during one 
year.This study gave insight into changes in cortisol functioning during the course of the anxiety 
disorder. Our findings seem to indicate that after receiving a standardized stepped-care CBT-program, 
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children with an anxiety disorder show changes in HPA-axis functioning which depend on the trajectory 
of the anxiety disorder.  Persistence of an anxiety disorder in childhood could have life-long 
consequences for the neuroendocrine system, which has repeatedly been linked to chronicity and 
recurrence of affective disorders and affective symptoms (Flory et al., 2009; Nicolson et al., 2010), 
underscoring the importance of early detection and adequate treatment of anxiety disorders. 
Despite the evidence of altered pre-treatment HPA axis and autonomic functioning in anxiety-
disordered children, studies that have assessed stress physiology as a predictor of therapy outcome in 
childhood anxiety disorders are lacking. The study in Chapter 7 aims to investigate the longitudinal 
association of stress physiology at pre-treatment baseline with anxiety and depressive symptoms at 
one-year follow-up in a clinical sample of anxiety disordered children treated with CBT. This clinical 
study of pediatric anxiety disorders showed that children with lower pre-treatment cortisol reactivity 
showed less decrease of depressive symptoms. A less responsive HPA-axis to stress predicted less 
decrease in depressive symptoms one year later. However, the effect size was small.  
Lower cortisol reactivity to stress has been consistently reported in depressive disorders across 
the age span (Burke et al., 2005; Lopez-Duran, Kovacs, George, 2009; Harkness, Stewart, Wynne-
Edwards, 2011; Suzuki et al., 2013). Only a few studies investigated HPA-axis reactivity in response to a 
psychological stressor in depressed children in comparison with healthy controls (Luby et al., 2003; 
Hankin et al., 2010; Suzuki et al., 2013). Compared to non-depressed peers, depressed preschoolers 
show a blunted reactivity (Luby et al., 2003; Suzuki et al., 2013). 
Glucocorticoids can act both to augment and suppress sympathetically mediated changes in 
cardiovascular function, metabolism, and immune function. Normally, activation of these stress systems 
leads to behavioral and physical adaptive changes that improve an organism’s ability to survive 
(Sapolsky, 2002). Possibly, anxiety disordered children with a less responsive HPA-axis to stress aremore 
susceptible to persistence of depressive symptoms, because a less adaptive HPA-axis leads to more 
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difficulties in mobilizing energy resources to sufficiently cope with stress (Hankin et al., 2010). This might 
underlie the impaired effects of treatment strategies and, as a result, persistence of depressive 
symptoms.  Another explantion is that the mechanism underlying lower cortisol reactivity may reflect 
down-regulation of the HPA axis, because chronic stress repeatedly over-activates and eventually 
impairs the HPA axis (Gunnar, Vazquez, 2001; Herman et al., 2005; Juster, McEwen, Lupien, 2010; Suzuki 
et al., 2013). Our results are in line with such a habituation of the stress system. Thus, an alternative 
explanation is that this low HPA-axis reactivity signals a vulnerability of a subgroup of children with 
anxiety disorders that appear to be less responsive to treatment. 
 
Physiological hyperarousal 
Of fraidy-cats and feeling blue 
The tripartite model by Clark and Watson (1991) is a model that is frequently cited with regard to the 
disentanglement of anxiety and depression as different constructs.This model hypothesizes that 
physiological hyperarousal is specific for anxiety.The study described in Chapter 3 attempts to quantify 
the concept of physiological hyperarousal by using perceived arousal to a real stressor as a proxy for 
physiological hyperarousal. Previous studies suggest that high anxious subjects tend to perceive 
physiological sensations as more severe than non-anxious subjects (Hoehn-Saric, McLeod, 2000), 
sometimes even in the absence of an actual difference in physiological measures (Edelmann, Baker, 
2002). 
Overall, the results from the study in Chapter 3 provide some evidence in support of the 
applicability of perceived arousal as a measure of physiological hyperarousal to differentiate anxiety 
from depressive symptoms in a general population sample of children. Although perceived arousal to a 
real stressor was related to both anxiety and depressive problems, perceived arousal showed a stronger 
association with anxiety than with depressive symptoms. Furthermore, when anxiety and depressive 
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problems were entered simultaneously in our statistical model, only anxiety problems predicted 
perceived arousal. These findings are in line with findings in child and adult literature (Brown, Chorpita, 
Barlow, 1998; Joiner et al., 1999; Chorpita, Daleiden, 2002). Together, the findings indicate that anxious  
children indeed perceive more arousal when exposed to daily fear or stress.  This increased perceived 
arousal might be a vulnerability factor for the development of pathologic anxiety, because  when 
children perceive the world as full of threats and dangers, with no possibility to relax and to regard their 
living environment as safe, anxiety becomes pathologic (Sapolsky, 2002), underscoring the importance 
of early detection and offering preventive strategies.   
 
Of fraidy-cats 
The study in Chapter 5 shows that perceived arousal during rest is higher in children with a clinical 
anxiety disorder compared to their non-anxious peers. However, after a stress-task perceived arousal is 
comparable between children with a clinical anxiety disorder compared to healthy controls. Apparently, 
anticipatory anxiety in children with a clinical anxiety disorder is high and has reached a plateau even 
before the stress task begins. This finding is supported by a study in healthy adults, relating neuroticism 
to exaggerated anticipatory anxiety experience (Drabant et al., 2011). 
Strikingly, within the group children with a clinical anxiety disorder, children with three or more 
anxiety disorders experienced less perceived arousal both in rest and after a stress-task in comparison 
with children with one or two anxiety disorders. There are several possible explanations: children with a 
high anxiety load 1) are alexithymic and cannot register their own perceived arousal, 2) actively direct 
their attention away from threatening bodily sensations and nervous feelings, or 3) already have a 
continuous plateau level of arousal which they rate as not deviant from normal. This last hypothesis 
could be in line with the general hypothesis that children with a high anxiety ‘load’ function under 
chronic stress conditions. 
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Methodological considerations 
Endophenotypes and biomarkers 
The terms endophenotype and biomarker are often used interchangeably in the psychiatric literature, 
yielding conceptual confusion (Lenzenweger, 2013a). The overall liability to mental illness consists of a 
heritable substrate in interaction with other genetic liabilities as well as environmental and epigenetic 
inputs. According to Gottesman and Gould (2003, 2006) “an endophenotype is a measurable 
component, unseen by the unaided naked eye, that lies along (i.e., within) the pathway between disease 
(i.e., observable phenotype) and distal genotype”. An endophenotype is a manifestation of the 
underlying disease liability that is not visible to common observation, exists in the person, and predates 
observable signs and symptoms of the illness (Lenzenweger, 2013b). 
Endophenotypes are heritable, biomarkers are not necessary subject to genetic influences. “The 
biomarker term captures the domain of any biologically influenced factor or deviation in relation to 
psychopathology (including endophenotypes)” (Lenzenweger, 2013b). Thus, a biomarker could be 
correlated with psychopathological symptoms, but not fall within the genotype to phenotype pathway. 
It may be useful to discern biological factors that develop secondary to an illness, but fall outside the the 
genotype to phenotype pathway, i.e. state markers (Lenzenweger, 2013b). To summarize: alle 
endophenotypes are biomarkers, but not all biomarkers are endophenotypes. 
In order to define whether a candidate measurement is reflective of a biomarker or an 
endophenotype Lenzenweger (2013b) gives clear guidance to the questions we have to ask ourselves: 
1. Is this candidate measurement/process heritable? 
2. Is this candidate measurement/process reflective of the origin of the illness or the effect of the 
illness? 
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3. Does a deviation on the candidate measurement/process predate the onset of the illness, and can it 
be detected earlier in development, well before the onset of clinical symptomatology and signs of 
illness? 
4. Is the candidate measurement/disease process merely a variable that speaks to elevated risk for a 
disorder but, as a process, lies outside of the core pathological process(es) in the 
disorder/condition? 
 
In other words, is there a correlational or causal relationship between a candidate measurement and 
the illness? Cross-sectional studies merely allow us to identify correlates and to generate initial 
hypotheses about potential risk factors. Prospective longitudinal studies are necessary to show that a 
factor precedes the outcome and can therefore be considered a risk factor or a prospective non-causal 
biomarker. The study in Chapter 4, which measured stress physiology in infancy before the longitudinal 
assessment of internalizing and externalizing problems in order to decrease the possibility of reverse 
causation, shows that alterations in stress physiology precede problem behavior and may therefore be 
regarded as a biomarker. Although it is tempting to define it as a causal risk factor, even with this design 
we are not able to definitively pin down causality as we cannot rule out other factors that have 
influenced infant stress physiology from conception till infancy. For instance, during the first three 
months of life even small variations in caregiving are reflected in HPA-axis activity (e.g. Albers et al., 
2008). 
The other cross-sectional and longitudinal studies described in this thesis are conducted in both 
general population and clinical samples. Clinical and general population samples might differ in 
impairment, severity, and duration of symptoms and therefore different conclusions can be inferred on 
the role of stress physiology in anxiety. The studies in Chapters 3, 5 and 6 suggest that stress physiology 
is a biological state marker for the severity and course of the disease. The study in Chapter 7 implies 
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stress physiology as a predictor for treatment outcome. Altered stress reactivity in response to daily 
stressors might underlie the impaired effects of treatment strategies and result in persistence of 
symptoms. 
In conclusion, the results of the studies described in this thesis suggest that stress physiology is a 
biological marker for the onset, severity, and course of anxiety problems in childhood. Based on this 
thesis, there is not enough scientific evidence to state that stress physiology can be seen as an 
endophenotype for childhood anxiety. 
I propose a bidirectional relationship between stress physiology and childhood anxiety. Altered 
physiological functioning of the stress systems, as a vulnerability factor, could influence the expression 
of clinical anxiety disorders. In addition, chronic and pathological anxiety problems, interfering with daily 
life and leading to a clinical anxiety disorder, have a different effect on physiological functioning than 
temporarily heightened, subclinical anxiety symptoms. 
 
Structure of psychopathology 
All studies in this thesis show that in anxious children there is most often both homotypic (other anxiety 
symptoms/disorders) and heterotypic (i.e. depressive and externalizing symptoms/disorders) 
comorbidity. When using diagnostic criteria according to DSM-5 (American Psychiatric Association, 
2013) in clinical practice, many children meet the criteria for multiple diagnoses; comorbidity is the rule 
rather than the exception across common psychiatric disorders and development. For parents and 
children seeking consultation for their problems, this comorbidity might result in the unjust implication 
of increased severity, just because the symptoms of the child do not neatly fall into one diagnostic 
category multiple diagnoses are given by a clinician. 
In recent years, concurrently with the development of the DSM-5, there is increasing notion that 
neither psychiatric disorders nor their etiologies may be as specific as assumed. Both the observed 
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psychiatric phenotypic manifestations and the underlying etiological factors show great transdiagnostic 
overlap and within-diagnostic heterogeneity. This increased notion does justice to the complexity of 
psychopathology, especially to the field of developmental psychopathology, because developmental 
changes and differences are per definitionincompatible with static diagnostic categories. This view on 
developmental psychopathology is actually not new and was already described in the eighties by 
Achenbach (Achenbach, Edelbrock, 1983). The renewed interest is fueled by recent advances in 
neuroimaging and genetic techniques, advances in statistical and machine learning data analytic 
approaches that make it possible to extract information from complex and high-dimensional data, and 
increasing emphasis on using biological data to tailor therapy to the needs of the individual patient 
(Marquand et al., 2016). 
Recently, Lahey et al. (2014) showed in adults that mental disorders are not fixed and 
independent entities; each diagnosis is robustly related to other diagnoses in a correlational structure 
that is manifested both concurrently and in patterns of heterotypic continuity over time. This co-
variation cuts across not only specific diagnostic categories, but also higher-order dimensions of 
psychopathology such as internalizing and externalizing dimensions, with correlations >0.5 (Murray, 
Eisner, Ribeaud, 2016). Furthermore, there is both homotypical and heterotypical continuity of 
childhood psychopathology into adulthood (Lahey, 2015). 
Hierarchical dimensional models are an alternative to diagnostic categories, generating 
dimensional scores in relation to norms for the child’s age and gender, type of informant, and 
appropriate multicultural norms. Correlations between particular subsets of symptoms can be embodied 
in higher-order dimensions, such as externalizing, internalizing and general psychopathology 
(Achenbach, 2015). The results of the study in Chapter 2 are in line with the existence of a higher-order 
internalizing dimension. Hierarchical-dimensional conceptualizations of psychopathology hypothesize 
that each form of psychopathology has both unique and broadly shared etiologies and mechanisms. 
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Interestingly, recent studies have suggested that the structure of psychopathology may be usefully 
represented in terms of a general factor of psychopathology (p-factor) capturing variance common to a 
broad range of symptoms transcending higher-order dimensions of psychopathology in addition to 
specific factors capturing variance common to smaller subsets of more closely related symptoms (Caspi 
et al., 2014; Murray, Eisner, Ribeaud, 2016). Using multi-informant testing the Generation R study 
recently showed that in addition to the existence of a general psychopathology factor, both an 
externalizing and internalizing factor exist independently of the general factor and of each other 
(Neumann et al., 2016). This model with a general p-factor results in a still strong, but negative 
correlation between the internalizing and externalizing factor. This suggests the presence of a single 
internalizing/externalizing dimension in young children, once accounted for the general 
psychopathology factor. Another important finding is that the genetic correlation between an 
externalizing and internalizing factor defined in a second model is 0.8, suggesting that very much the 
same factors contribute to the two symptom domains. 
Because internalizing and externalizing factors are correlated in many samples, we may find that 
covarying one type of score out of the other type of score changes associations with other variables, risk 
factors, endophenotypes or biomarkers (Madigan et al., 2013; Achenbach et al., 2016). These results are 
strengthened by the conclusion of the study described in Chapter 4. In conclusion, this study showed 
that infant stress physiology functions as an antagonistic predictor of early childhood internalizing and 
externalizing problems. In studying early risk factors for the continuity of problems among preschool 
children, we emphasize the importance of considering developmental changes in and the co-occurrence 
of internalizing and externalizing problems, because biomarkers that increase one type of problem 
behavior and decrease the other, such as stress physiology, might remain undetected when internalizing 
and externalizing problems are not disentangled.The mutual adjustment for internalizing and 
externalizing problems in our analyses created statistically homogeneous phenotypes, a theoretical 
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construct, which is scientifically relevant in understanding mechanisms of the development of problem 
behavior. 
However, there are also some critical notes when using only hierarchical-dimensional 
conceptualizations of psychopathology, also called ‘lumping’. Lumping might obscure possible etiologic 
substrates for specific phenotypic dimensions of psychopathology. As a result, we might miss some 
opportunities for treatment and cure. 
For the future it will continue to be important to use both approaches: on the one hand careful 
clinical examinations, detailed history taking, and phenotypic specification as essential elements of 
clinical practice and clinical research, while on the other hand examining large, representative (clinical) 
epidemiologic cohorts. With an increased understanding of the substrates for the heterogeneous 
presentation of psychopathology, we will be able to make better informed decisions about whether and 
when we should be taking a more general or specific approach to psychopathology in daily clinical 
practice (Leventhal, 2012). 
 
Theoretical perspectives on stress and development 
The past decades our understanding of the systems that are involved in the stress response has 
increased, along with the recognition that the stress system reacts uniquely to different types of 
stressors, and whose patterning of responses changes over time and development (Joëls, Baram, 2009; 
Doom, Gunnar, 2013). For instance, we have to acknowledge that elevations in cortisol, once almost 
synonymous with stress, may be only one way in which the HPA-axis responds to stressors. Chronic 
activation of the stress system may lead to both low or high levels of cortisol depending on 
development, life-events and the type of affective psychopathology (Doom, Gunnar, 2013). Several 
theoretical models have been developed to capture the complexity of the stress response. 
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Allostasis is a theoretical concept which refers to the physiological short-term adaptations that 
maintain homeostasis through change via allostatic mediators. Allostasis is a fundamental process which 
enables organisms to actively adjust to both predictable and unpredictable events. Allostatic load refers 
to the cumulative cost of allostasis to the body.  The wear-and-tear on the body and the brain, resulting 
from chronic dysregulation of physiological systems that are normally in place to adapt to 
environmental challenge, is referred to as allostatic overload (McEwen, Wingfield, 2003). Based on 
Sterling and Eyer’s (1988) allostasis concept, McEwen and Wingfield (2003) proposed that the allostatic 
load model could provide a framework for understanding how an animal copes with unpredictable 
challenges. McEwen and Gianaros (2010) state that a state of prolonged anxiety and anticipation can 
theoretically result in allostatic load, because anticipation can drive the output of allostatic biomediators 
(McEwen, Gianaros, 2010). This model could be applied to the study in Chapter 5, which shows the 
impact of experienced persistent stress in children with a clinical anxiety disorder, as indexed by the 
activity of both the stress systems. 
Diathesis-stress models postulate that a predispositional vulnerability, when present in 
individuals, is activated in poor environments to produce worse outcomes in comparison to individuals 
without that vulnerability. The term diathesis derives from the Greek term (διάθεσις) for a 
predisposition, or vulnerability. A diathesis can take the form of genetic, psychological, biological, or 
situational factors (Ingram, Luxton, 2005). Diathesis-stress models are often not sufficient for studying 
factors that may lead to differential effects depending on the environment, because the sensitivity to 
positive effects of  a positive environment is not included in the model. Belsky theorized from an 
evolutionary perspective that children should vary in their susceptibility to both adverse and beneficial 
effects of rearing styles within a family. The differential susceptibility hypothesis extends the diathesis-
stress model to include a sensitivity to positive environments as well as negative environments or stress 
(Belsky, Pluess, 2009). Individuals are differentially susceptible to environmental influences due to 
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plasticity factors that promote maladaptation in some contexts and enhance adaptation in others. An 
example of this hypothesis is, for instance, a study by Kochanska et al. (2007) which shows that highly 
fearful infants experiencing high levels of power-assertive paternal discipline had the highest chance to 
cheat in a game as toddlers, however when cared for in a supportive those same highly fearful infants   
manifested the most rule-compatible conduct as toddlers. The biological sensitivity to context theory 
argues that all ranges of (re)activity are evolutionary adaptive to (future) contexts (Boyce, Ellis, 2005).  
 
 
Figure 1. Graphical display of the diathesis-stress and differential susceptibility model. By Mpluess - own 
work, public domain 
 
The above described well-known models of stress address changes over time, but are not explicitly 
sensitive to developmental changes. Extensive research has shown that stressors have differential 
impact depending on when in development they are experienced. Furthermore, animal research has 
shown that part of the shaping of the stress system takes place very early in life, possibly even 
prenatally, with consequences for disorders in adult life (Barker, 2007; Doom, Gunnar, 2013).  
Recently, Hankin et al. (2016) have developed a developmental sensitive heuristic conceptual 
model aimed at the comorbidity, continuity and discontinuity of internalizing psychopathology across 
development, based on a modern latent dimensional structural model of psychopathology. In this model 
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risk traits interact with environmental stressors to confer risk for broad latent psychopathology 
dimensions or specific symptom manifestations. The model uses five levels of analysis: 1) neural and 
endocrine systems implicated in internalizing psychopathology, 2) latent vulnerability traits, which are 
fairly stable individual differences in cognitive and affective vulnerabilities, 3) latent psychopathology 
liabilities, which are broad psychopathology liability dimensions that span disorders, 4) symptom specific 
syndromes, which are specific constellations of internalizing symptoms that systematically and 
characteristically group together as part of a coherent pattern, and 5) stressors, from different domains 
and types of events, transpiring across the lifespan that may trigger symptom specific syndrome 
manifestations at particular points during development. A similar approach has recently been applied to 
externalizing psychopathology (Beauchaine, McNulty, 2013). Given the accumulating evidence from 
studies into stress physiology and studies into the developmental structure of psychopathology (see 
previous sections in the discussion of this thesis) in my opinion a heuristic conceptual model which 
incorporates the general psychopathology, the externalizing and the internalizing latent factor would be 
more appropriate.This view is strengthened by the conclusion of the study described in Chapter 4, which 
showed that infant stress physiology functions as an antagonistic predictor of early childhood 
internalizing and externalizing problems. We showed that stress physiology can increase one type of 
problem behavior and decrease the other. Stress physiology might therefore remain undetected as a 
relevant biomarker for certain behaviors in models that do not enter internalizing and externalizing 
latent factors simultaneously.  
The studies conducted in this thesis underline the complexity and plasticity of the stress system.   
Therefore, a careful, modest approach to studying normative and atypical patterns of the stress system 
in relation to psychopathology is needed. 
 
POTENTIAL LIMITATIONS 
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Several other issues must also be considered when interpreting the findings of the studies in this thesis. 
 
Confounders in stress physiology 
Many of the possible confounding variables in pediatric stress physiology research find their origin in 
adult research (thesis Saridjan, 2015). Although useful, not all of these possible confounding factors are 
relevant for stress physiology research in early life. In the relationship between stress physiology and 
psychiatric disorders, most often effect sizes are small. In large general population samples it is possible 
to take into account several confounding factors, however in smaller clinical samples correcting for too 
many potential confounding variables could lead to type II errors due to insufficient power to detect 
small effects. This is reflected in the number of potential confounding variables taken into account in the 
studies described in this thesis. 
In the study described in Chapter 4 gender of the child, gestational age, weight at birth, age of 
the infant at physiological measurement, maternal age, smoking and drinking behavior during 
pregnancy, and level of highest completed education by the mother were studied as covariates, based 
on previous reports (Dierckx et al., 2014). All the studies described in this thesis corrected the 
associations of interest for age and gender (for a review of gender and age differences during childhood, 
see Van der Voorn et al., 2017), most studies corrected for body mass index or used gestational age at 
birth and birth weight as a proxy for body constitution. All studies described in this thesis were also 
ethnically homogeneous,ruling out confounding and effect modification by ethnicity, which as a 
consequence limits the generalizability of our results to other ethnic populations. Pubertal status is an 
important determinant of cortisol levels (Shirtcliff et al., 2015). Data on Tanner stage, a proxy for 
pubertal status, are lacking in the described studies, but variation in pubertal status is minimized 
through the inclusion of only children below 13 years in most studies. Only the study described in 
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Chapter 6 included adolescents up to 16 years. Should pubertal status be related to remission status as 
well, this could have led to confounding. However, because we have a broad age range and adjusted for 
age, this is not very likely. 
 
Measures of stress physiology 
We assessed HPA-axis functioning by measuring the end product of this axis, cortisol. However, the HPA-
axis is a very complex system and for instance, its activity is regulated by multiple hormones (Sapolsky, 
Romero, Munck, 2000; De Kloet, 2003; Herman et al., 2005). Hence, the measurement of only the end 
product is a relatively crude way to measure a possible altered functioning of this system. For instance, 
Young, Abelson and Cameron (2004) did find alterations in ACTH levels in depressed children with a 
comorbid anxiety disorder in response to a stressor, but not in cortisol levels. Thus, the lack of 
significant findings regarding cortisol in some of the studies described in this thesis, does not necessarily 
mean that HPA-axis functioning is not altered in these subjects. These alterations might occur on 
different levels in the HPA-axis. 
Furthermore, the availability of only one cortisol diurnal profile can be seen as a limitation. 
Rotenberg et al. (2012) show that the cortisol awakening response requires at least 3 weekdays of 
sampling to yield a stable estimate. However, a review by Golden et al. (2011) states that the use of 
sampling multiple salivary cortisol measures across the diurnal curve (including awakening cortisol), as 
we did in most of the described studies, likely reflects chronic cortisol burden and has the highest 
between-visit reliability of all cortisol measures (r = 0.63-0.84). 
Sampling compliance was based on child-reported time of saliva collection combined with 
parent-initiated times on a daily log sheet. Use of electronically monitored timing would improve the 
precision and accuracy of sample timing, as well as the ability to screen for potentially invalid samples. 
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Another notable weakness of the current studies is the lack of consistency in the available stress 
measures during rest, stress, and recovery between the different studies. For instance for the study in 
Chapter 5 heart rate variability measures and cortisol measures during stress were not available due to 
differences in the applied stress task between cases and controls. The stress task that was applied in 
both groups consisted of the mental arithmetic task, a cognitive task that compared to a public 
speaking/cognitive task combination is less capable of eliciting a substantial cortisol stress response 
(Kirschbaum et al., 1993; Dickerson, Kemeny, 2004). Furthermore, it is a task in which speech limits the 
possibility to control HF HR variability for respiratory frequency, therefore, HF HR variability was not 
analyzed during the MAT. 
 
Informants 
The studies described in Chapters 2, 3 and 4 used only one informant to assess psychiatric symptoms. 
One could argue that the use of multiple informants (e.g. parent- and self-report) would lead to a more 
valid assessment of these symptoms (Grills, Ollendick, 2003; Comer, Kendall, 2004). Multiple informant 
agreement is higher for externalizing than for internalizing problems; a possible explanation for this 
phenomenon can be that internalizing problems tend to be inwardly focused upon the self (Grills, 
Ollendick, 2003). Therefore, the choice for self-report questionnaires in Chapters 2 and 3 instead of 
parent-report is defendable given the focus on internalizing problems in children and adolescents. 
The study described in Chapter 4 included children that were not able to fill in self-report 
questionnaires, given their age. A study by Ivanova et al. (2010) showed that parents are sufficiently 
capable of objectively rating their children’s problem behavior using the CBCL/1½–5. In addition, 
although the outcome parameters in Chapters 2, 3, 4, 6 and 7 were assessed with parent-report or self-
report measures, all predictors were objective biological measures, hence there is no risk of shared 
method variance bias. 
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IMPLICATIONS FOR RESEARCH AND PRACTICE 
 
First, this thesis showed that infant stress physiology functions as an antagonistic predictor of early 
childhood internalizing and externalizing problems. In particular, our data suggest that low autonomic 
arousal is a marker for the development of more deviant, externalizing problems during childhood and 
shows less association with the highly prevalent emotional reactive externalizing behavior seen in 
infants and toddlers, while high autonomic arousal might be a marker of early and persistent 
internalizing problems. In studying early biomarkers for the continuity of problems among preschool 
children, we emphasize the importance of considering developmental changes in and the co-occurrence 
of internalizing and externalizing problems. Because biomarkers that are associated with a heightened 
risk for one type of problem behavior and decrease of the other, such as stress physiology, might remain 
undetected when internalizing and externalizing problems are not disentangled. Future research should 
extend the follow-up of internalizing and externalizing problems across the lifespan, with repeated 
measurements of basal and reactive stress physiology through experience sampling methods, and 
measurement of relevant environmental factors. This will elucidate the relation between stress 
physiology and the development of psychiatric symptoms and ultimately the incidence of psychiatric 
disorders. Further, it would be interesting to conduct the same measurements and analyses over time in 
a sample at-risk for internalizing and externalizing disorders, and an unselected clinical sample. 
 Second, this thesis showed that children with an anxiety disorder can be distinguished on 
several psychophysiological characteristics from healthy children. Children with a clinical anxiety 
disorder have a pattern of elevated sympathetic (re)activity, and lowered parasympathetic activity 
compared to same-aged children from a general population sample. We report that children with a 
clinical anxiety disorder have a pattern of hypoactivation of basal HPA-axis functioning compared to 
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same-aged children from a general population sample. These results are in support of the hypothesis 
that a child with a clinical anxiety disorder experiences persistent stress, indexed by the activity of both 
the stress systems. This notion is underlined by the finding that a high clinical load in the clinical sample 
was associated with an even further deviation of perceived arousal, basal HPA-axis functioning and 
sympathetic functioning. The load of anxiety disorders during adolescence has been associated with 
later risks of anxiety disorders, major depression, substance dependence, suicidal behavior and other 
adverse outcomes, such as educational underachievement and early parenthood (Woodward, 
Fergusson, 2001). These findings underscore the importance of early detection and adequate treatment 
of anxiety disorders. Interestingly, in studies finding evidence of low cortisol in association with 
posttraumatic stress disorder or posttraumatic stress disorder risk, there was also evidence of greater 
sympathetic arousal as reflected by catecholamine levels (Radley et al., 2011). Possibly, hypocortisolism 
in non-stressful conditions due to ‘habituation’ in children with a clinical anxiety disorder (i.e. a chronic 
stressor leads to a progressive decrease in cortisol) alters the ability of the HPA-axis to restore 
homeostasis following exposure to stress, resulting in increased sympathetic activation. This might 
indicate that there are already biological underpinnings of the severity of anxiety disorders in childhood, 
which might be predictive of adverse outcomes later in life. Future longitudinal studies are needed to 
study the predictive value of stress physiology as a marker for severity and predictor of adverse 
outcomes of childhood anxiety disorders later in life.  
Third, only a clinical main diagnosis of specific phobia can be discerned from social phobia and 
separation anxiety disorder on higher sympathetic functioning during basal and stress conditions. The 
psychophysiological correlates of clinical specific phobia in our study, confirm the existing genetic and 
longitudinal evidence for specific phobia as separate taxonomic construct. 
Finally, if replicated, our results suggest that pre-treatment HPA and ANS reactivity to stress are 
candidate predictors of a lack of symptom improvement in children with a clinical anxiety disorder. We 
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carefully speculate that anxiety disordered children with a higher reactivity of the sympathetic nervous 
system, also experience more physiological and subjective arousal in response to daily fear or stress. As 
a consequence, higher sympathetic reactivity may influence the natural course of anxiety disorders or 
the efficacy of standardized cognitive behavioral therapy. Further, anxiety disordered children with a 
less responsive HPA-axis to stress might be more susceptible to persistence of depressive symptoms, 
because a less adaptive HPA-axis leads to more difficulties in mobilizing energy resources to sufficiently 
cope with stress (Hankin et al., 2010). This might underlie the impaired effects of treatment strategies 
and, as a result, persistence of depressive symptoms. However, our findings seem to indicate that after 
receiving a standardized stepped-care CBT-program children with an anxiety disorder show restoration 
of HPA-axis functioning, underscoring the importance of early detection and adequate treatment of 
anxiety disorders. Current treatments for childhood anxiety disorders are aimed at reducing anxiety 
symptoms through cognitive behavioral therapy and sometimes pharmacotherapy, which also has an 
influence on the stress system. It might be interesting to study the effects of a more direct approach to 
influence the stress system by biofeedback  aimed at both the sympathetic and parasympathetic 
nervous system. 
In summary, this thesis focused on the role of stress physiology as a cause, correlate, and 
predictor of pediatric anxiety disorders with the ultimate goal to improve treatment and prognosis. The 
results of the studies described in this thesis suggest that stress physiology is a biological marker for the 
onset, severity, and course of anxiety problems in childhood. Altered physiological functioning of the 
stress systems, as a vulnerability factor, could influence the expression of clinical anxiety disorders. In 
addition, chronic and pathological anxiety problems, interfering with daily life and leading to a clinical 
anxiety disorder, have a different effect on physiological functioning than temporarily heightened, 
subclinical anxiety symptoms. Given the small magnitude of the associations in this thesis, it is unlikely 
that stress physiology will be sufficiently sensitive and specific to serve as a biomarker for diagnosis, 
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treatment outcome, or prognosis. Our studies provide a small but important contribution to the overall 
knowledge concerning stress physiology in anxious children. 
Future research is needed to replicate our findings in other clinical samples. Furthermore, the 
cross-sectional character of the case-control study makes it difficult to draw conclusions regarding the 
causality of deviations in stress physiology in children with an anxiety disorder, therefore longitudinal 
case-control studies in children, matched for age and gender, in which the course and severity of anxiety 
symptoms and disorders are related to basal and reactive stress physiology are needed. Changes in 
stress physiology during the course of normal development can be controlled for in a case-control 
design over time. Moreover, in such a design the bidirectional relationship between psychiatric 
symptoms and stress physiology over time can be investigated. This will help to gain insight in the 
etiological pathways of childhood anxiety. 
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SUMMARY 
 
Anxiety is a basic emotion, not typically pathologic but commonly adaptive when it facilitates 
anticipation to a threat or danger. However, when children perceive the world as full of threats and 
dangers, with no possibility to relax and to regard their living environment as safe, anxiety becomes 
pathologic. Variations in the activity of the hypothalamic-pituitary-adrenal (HPA) axis and the autonomic 
nervous system (ANS), two major physiological stress systems, have been implicated as possible 
biological markers of pathological anxiety in children. Normally, activation of these stress systems leads 
to behavioral and physical adaptive changes that improve an organism’s ability to survive. In children 
with an anxiety disorder, the persistent stress they experience might lead to an excessive and prolonged 
stress system activation. In the current thesis, we focused on the role of stress physiology as a cause, 
correlate, and predictor of pediatric anxiety disorders with the ultimate goal to improve treatment and 
prognosis. More specifically, the series of studies described in this thesis examined the specificity of the 
association of stress physiology with child anxiety problems, given the high co-occurrence with other 
anxiety, externalizing and depressive problems. In addition, the studies examined the trajectory of an 
anxiety disorder and the concomitant changes in stress physiology, and stress physiology as a predictor 
of therapy outcome. 
The high degree of comorbidity amongst anxiety disorders in children and adolescents seems to 
point in the direction of one taxonomic construct, instead of a number of separate disorders. The study 
in Chapter 2 assessed homotypic and heterotypic continuity of symptoms of separation anxiety disorder, 
generalized anxiety disorder, social phobia, panic disorder, and obsessive compulsive disorder in 
individuals from a community sample, who were assessed for the first time when they were aged 10 to 
12 years, and for the second time two years later. In conclusion, this study extended the existing 
knowledge about the taxonomy of anxiety problems in young adolescents with longitudinal data. Given 
P a g e  | 250 
 
the magnitude of heterotypic continuity in this study, a higher order factor is likely to be present. 
However, this study also showed that considerable homotypic continuity is present as well, occurring 
separately from a general propensity for high anxiety levels. This indicates that each type of anxiety 
problem may, at least partly, represent a distinct taxonomic construct. 
Much evidence has shown that anxiety and depressive symptoms in children and adolescents 
occur frequently and are often comorbid. Childhood anxiety and depression might be two different 
disorders that often co-occur, or they could be different manifestations of the same underlying 
vulnerability. There are many models that have tried to disentangle these constructs. An interesting 
theoretical framework to address this question is the tripartite model, in which symptoms of anxiety and 
depression are viewed along three dimensions. This model groups symptoms of depression and anxiety 
into 3 subtypes: negative affectivity, a measure for general affective distress, positive affectivity (PA), a 
measure representing pleasurable engagement with the environment, and physiological hyperarousal 
(PH), a measure representing somatic tension and arousal. In Chapter 3 we examined in a general 
population sample of 231 children whether (a) basal and reactive HPA-axis functioning, as a proxy for 
physiological hyperarousal, and (b) perceived arousal before, during and after stress differentiate 
anxious from depressive children. Together, our findings indicate that perceived arousal to a challenge 
might be a useful tool to assess the PH component of the tripartite model in a general population 
sample of school-aged children. 
The study described in Chapter 4 was designed to examine the longitudinal associations 
between infant autonomic functioning and early childhood internalizing and externalizing problems 
simultaneously, in a large general population sample (N=464). Lower infant heart rate was associated 
with less decrease of childhood externalizing problems, whereas higher infant heart rate was associated 
with a stronger increase of internalizing problems. Consistently, higher infant heart rate variability was 
associated with less decrease of childhood externalizing problems, whereas lower infant heart rate 
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variability was associated with a stronger increase of internalizing problems. In conclusion, this study 
showed that both infant heart rate and heart rate variability function as antagonistic predictors of early 
childhood internalizing and externalizing problems. Our study emphasizes the importance of using a 
longitudinal design over a developmental sensitive period when studying early risk factors for the 
continuity of problems among preschool children. The mutual adjustment for internalizing and 
externalizing problems in our analyses created statistically homogeneous phenotypes, which enabled us 
to study the specificity of autonomic arousal as a predictor for change of internalizing or externalizing 
problems at follow-up in a large non-homogeneous general population sample of children in which co-
occurrence of internalizing and externalizing problems was high. 
The study in Chapter 5 focused on whether HPA-axis (basal), ANS (basal and reactive) and 
perceived arousal measures can distinguish children (N=154) aged 8-12 years with different primary 
diagnoses (separation anxiety disorder, generalized anxiety disorder, social phobia and/or specific 
phobia) of clinical anxiety disorders from each other, and from a same-aged general population 
reference group (N=225). Our findings indicate that children with an anxiety disorder can be 
distinguished on several psychophysiological characteristics from healthy children. The results underline 
the hypothesis that ANS and HPA-axis functioning relate to anxiety disorders in general, and only 
heightened sympathetic (re)activity is a specific correlate for specific phobia, which confirms the existing 
genetic and longitudinal evidence for specific phobia as separate taxonomic construct. Furthermore, our 
study found some evidence in support of the hypothesis that a child with a clinical anxiety disorder 
functions under chronic stressful conditions, with concomitant changes in the activity of both the stress 
systems. This notion is underlined by the finding that a high clinical ‘load’ in the clinical sample was 
associated with an even further deviation of basal HPA-axis functioning and sympathetic functioning. 
This might indicate that there are already biological underpinnings of the ‘load’ of anxiety disorders in 
childhood, which might be predictive of adverse outcomes later in life. 
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The study in Chapter 6 investigated associations between the trajectory of an anxiety disorder 
and the concurrent changes in cortisol levels in a clinical sample of children and adolescents. All children 
and adolescents received a standardized stepped-care cognitive behavioral program for childhood 
anxiety disorders. Overall, there was an increase in daytime AUC cortisol between pre-treatment 
baseline and one-year follow-up, which was dependent on the trajectory of the anxiety disorder. This 
increase was most pronounced for non-remitters, intermediate in late remitters and less obvious in 
early remitters. Depression severity was higher in the late and non-remitter groups. An explanation for 
the differences between these trajectories might be that a stronger increase in diurnal cortisol signals a 
vulnerability of a subgroup of children with anxiety disorders. Overall, cortisol morning rise did not differ 
significantly between baseline and follow-up. 
Chapter 7 explores the longitudinal association of stress physiology at pre-treatment baseline 
with anxiety and depressive symptoms at one-year follow-up in a clinical sample of anxiety 152 
disordered children treated with cognitive behavioral therapy. This clinical study of pediatric anxiety 
disorders showed that children with higher pre-treatment skin conductance reactivity to stress, as a 
proxy of sympathetic reactivity, responded less to treatment. Their anxiety symptoms decreased less 
over a one-year period as compared to children with a lower pre-treatment sympathetic reactivity. 
Furthermore, children with lower pre-treatment cortisol reactivity showed less decrease of depressive 
symptoms. If replicated, our results suggest that pre-treatment HPA and ANS reactivity to stress are 
candidate predictors of a lack of symptom improvement in children with a clinical anxiety disorder. 
  
P a g e  | 253 
 
SAMENVATTING 
 
Voor kinderen met een angststoornis kan de wereld er uit zien als een plek vol met stressvolle situaties 
die voortdurende waakzaamheid en coping vereisen, zonder de mogelijkheid om te ontspannen en de 
omgeving als veilig te beschouwen. Variaties in de activiteit van de hypothalamus-hypofyse-bijnier (HPA) 
-as en het autonome zenuwstelsel (ANS), twee belangrijke fysiologische stresssystemen, worden gezien 
als mogelijke biologische markers voor angstklachten bij kinderen. In dit proefschrift hebben we ons 
gericht op de rol van stressfysiologie bij angstklachten op de kinderleeftijd, met als uiteindelijk doel de 
behandeling en prognose van angststoornissen op de kinderleeftijd te verbeteren. We onderzoeken de 
specificiteit van de samenhang van stressfysiologie met pediatrische angststoornissen, gezien de hoge 
mate waarin angststoornissen op deze leeftijd samen voorkomen met gedragsproblemen en 
depressieve klachten. Daarnaast onderzoeken we in hoeverre stressfysiologie bij kinderen betrekking 
heeft op angststoornissen in het algemeen, of dat er een specifiek verband is tussen stressfysiologie en 
de verschillende soorten angststoornissen op de kinderleeftijd. Verder onderzoeken we het traject van 
een angststoornis op de kinderleeftijd en de daarmee gepaard gaande verandering in stressfysiologie, 
en stressfysiologie als een voorspeller van de uitkomst van de therapie. 
De hoge mate van comorbiditeit tussen angststoornissen bij kinderen en adolescenten lijkt te 
wijzen in de richting van één taxonomisch construct, in plaats van een aantal afzonderlijke 
angststoornissen. De studie in Hoofdstuk 2 beoordeelde homotypische en heterotypische continuïteit 
van symptomen van separatieangststoornis, gegeneraliseerde angststoornis, sociale fobie, 
paniekstoornis en obsessieve compulsieve stoornis bij individuen uit de algemene bevolking, die voor de 
eerste keer werden onderzocht toen ze tien tot twaalf jaar oud waren, en voor de tweede keer twee 
jaar later. Concluderend breidde dit onderzoek de bestaande kennis over de taxonomie van 
angstproblemen bij jonge adolescenten met longitudinale gegevens uit. Gezien de omvang van 
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heterotypische continuïteit in dit onderzoek, is waarschijnlijk een hogere ordefactor aanwezig. Echter, 
deze studie toonde ook aan dat ook een aanzienlijke homotypische continuïteit aanwezig is, los van een 
algemene neiging tot hoge angstniveaus. Dit geeft aan dat elk type angstprobleem, ten minste 
gedeeltelijk, een duidelijk taxonomisch construct kan vertegenwoordigen. 
Eerder onderzoek heeft aangetoond dat angst- en depressieve symptomen bij kinderen en 
adolescenten vaak voorkomen en vaak comorbide zijn. Angst en depressie kunnen twee verschillende 
stoornissen zijn die vaak samen voorkomen, of ze kunnen verschillende manifestaties zijn van dezelfde 
onderliggende kwetsbaarheid. Er zijn veel modellen die hebben geprobeerd om deze stoornissen te 
onderscheiden. Een interessant theoretisch kader om deze vraag te beantwoorden is het tripartite 
model, waarin symptomen van angst en depressie worden bekeken langs drie dimensies. Dit model 
groepeert symptomen van depressie en angst in 3 subtypes: negatieve affectiviteit, een maat voor 
negatieve emotionaliteit, positieve affectiviteit (PA), een maat die weergeeft hoe enthousiast, energiek 
en alert iemand met zijn omgeving omgaat, en fysiologische hyperarousal (PH), een maat voor 
lichamelijke spanning, zoals bijvoorbeeld hartkloppingen, zweethanden en droge mond. In Hoofdstuk 3 
onderzochten we in een algemene populatiesteekproef bij 231 kinderen of (a) basale en reactieve HPA-
as werking, als een maat voor fysiologische hyperarousal, en (b) waargenomen lichamelijke spanning 
vóór, tijdens en na stress angstige kinderen van depressieve kinderen konden onderscheiden. Deze 
studie vond enig bewijs ter ondersteuning van het tripartite model. Samen geven onze bevindingen aan 
dat ervaren lichamelijke spanning een nuttige maat kan zijn om de PH-component van het tripartiete 
model te meten in een algemene populatiesample van schoolgaande kinderen. De reactiviteit van de 
HPA-as, gemeten door cortisolwaardes tijdens een stresstaak, kan onderscheid maken tussen angst en 
depressie. 
De studie beschreven in Hoofdstuk 4 onderzocht de longitudinale associaties tussen autonoom 
functioneren bij zeer jonge kinderen en internaliserende en externaliserende problemen tijdens de 
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kleutertijd, in een grote algemene populatiesample (N=464). Lagere hartfrequentie bij het zeer jonge 
kind was geassocieerd met minder afname van externaliserende problemen bij kleuters, terwijl een 
hogere hartfrequentie werd geassocieerd met een sterkere toename van internaliserende problemen. 
De resultaten voor hartritmevariabiliteit, een maat voor parasympathisch functioneren, lieten 
vergelijkbare resultaten zien. Een hogere hartritmevariabiliteit van het zeer jonge kind was geassocieerd 
met minder afname van externaliserende problemen bij kleuters, terwijl lagere hartritmevariabiliteit 
geassocieerd waren met een sterkere toename van internaliserinde problemen op de kleuterleeftijd. 
Concluderend toonde deze studie aan dat zowel de hartfrequentie als de hartritmevariabiliteit van zeer 
jonge kinderen fungeren als antagonistische voorspellers van internaliserende en externaliserende 
problemen op de kleuterleeftijd. Onze studie benadrukt het belang van het gebruik van een 
longitudinaal studiedesign gedurende een voor de ontwikkeling gevoelige periode bij het bestuderen 
van vroege risicofactoren voor de continuïteit van problemen bij kleuters. De onderlinge correctie voor 
internaliserende en externaliserende problemen in onze analyses creëerde statistisch homogene 
fenotypen. Dit stelde ons in staat om de specificiteit van autonoom functioneren op zeer jonge leeftijd 
als voorspeller voor verandering van internaliserende of externaliserende problemen inde ontwikkeling 
tot kleuter te onderzoeken in een grote niet-homogene algemene bevolkingssample van kinderen, 
waarin co-incidentie van internaliserende en externaliserende problemen hoog was. 
De studie in Hoofdstuk 5 concentreerde zich op de vraag of het functioneren van de HPA-as 
(basaal), het AZS (basaal en reactief), en waargenomen lichamelijke spanning kinderen (N=154) van 8-12 
jaar met verschillende primaire klinische angststoornissen (separatieangststoornis, gegeneraliseerde 
angststoornis sociale fobie en / of specifieke fobie) kunnen onderscheiden van elkaar en van een 
populatie-referentiegroep van dezelfde leeftijd (N=225). Onze bevindingen laten zien dat kinderen met 
een angststoornis kunnen worden onderscheiden op verschillende psychofysiologische kenmerken van 
gezonde kinderen. De resultaten onderschrijven de hypothese dat AZS en HPA-as functioneren in 
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verband staan met angststoornissen in het algemeen, en laten zien dat alleen verhoogde sympathische 
(re) activiteit een specifiek correlaat is voor specifieke fobie, hetgeen het bestaande genetische en 
longitudinale bewijs voor specifieke fobie als afzonderlijke taxonomische entiteit bevestigt. Bovendien 
heeft onze studie enig bewijs gevonden voor de hypothese dat een kind met een klinische angststoornis 
functioneert onder chronische stressvolle omstandigheden, met bijbehorende veranderingen in de 
activiteit van beide stresssystemen. Deze hypothese wordt versterkt door de bevinding dat een hoge 
klinische 'belasting' in de groep van kinderen met een angststoornis geassocieerd was met een nog 
verdere afwijking van het functioneren van beide stresssystemen. Dit zou erop kunnen wijzen dat er al 
een biologisch fundament bestaat voor de klinische 'belasting' van angststoornissen in de kindertijd, wat 
zou kunnen leiden tot nadelige effecten op latere leeftijd. 
In Hoofdstuk 6 werd de associatie tussen het traject van een angststoornis en de gelijktijdige 
veranderingen in cortisolspiegels in een klinische groep van kinderen en adolescenten met een 
angststoornis onderzocht. Alle kinderen en adolescenten kregen een gestandaardiseerd stepped-care 
cognitieve gedragstherapie programma voor angststoornissen bij kinderen en adolescenten. Over het 
algemeen was er een toename van diurnaal afgegeven cortisol tussen baseline, voorafgaand aan de 
behandeling, en follow-up één jaar na aanvang van het behandelprogramma. De mate van toename was 
afhankelijk van het traject van de angststoornis. Deze toename was het meest uitgesproken voor 
kinderen wiens angststoornis niet was verdwenen, intermediair bij kinderen bij wie er sprake was van 
een laat herstel en het minst uitgesproken bij kinderen die een vroeg herstel lieten zien. De depressieve 
klachten waren ernstiger in de groep kinderen bij wie de angststoornis niet was verdwenen en de groep 
kinderen die een laat herstel lieten zien. Een verklaring voor de verschillen tussen deze trajecten zou 
kunnen zijn dat een sterkere toename van het diurnaal cortisol de kwetsbaarheid van een subgroep van 
kinderen met angststoornissen aangeeft. Over het algemeen was de ochtendstijging van cortisol niet 
significant verschillend tussen baseline en follow-up. 
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Hoofdstuk 7 onderzoekt de longitudinale associatie van stressfysiologie bij baseline, 
voorafgaand aan de behandeling, met angst- en depressieve symptomen na één jaar follow-up in een 
klinische groep van 152 kinderen met een angststoornis die werden behandeld met cognitieve 
gedragstherapie. Deze klinische studie van pediatrische angststoornissen toonde aan dat kinderen met 
een hogere reactiviteit van huidgeleiding in reactie op stress, als proxy van sympathische reactiviteit, 
minder reageerden op de behandeling. Hun angstsymptomen daalden minder gedurende een periode 
van een jaar in vergelijking met kinderen met een lagere sympathische reactiviteit vóór de behandeling. 
Bovendien vertoonden kinderen met een lagere cortisolreactiviteit vóór de behandeling minder 
vermindering van depressieve symptomen. Indien gerepliceerd, suggereren onze resultaten dat HPA-as 
en ANS stressreactiviteit voorafgaand aan de behandeling kandidaat-voorspellers zijn van verminderde 
symptoomverbetering bij kinderen met een klinische angststoornis. 
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